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ABSTRACT
RNA is synthesized with specific isotopic labels (2 H, 13 C, and 15N) to alleviate
spectral crowding and broad linewidth problems encountered in large RNA NMR
spectroscopy. A combined chemical and enzymatic synthesis is described in which
glycerol (U-d8) is chemically converted into 3',4',5',5"- 2 H4-D,L-ribose, and then the
3',4',5',5"- 2 H4-D-ribose is enzymatically converted into the four NTPs of RNA.
Enzymes of purine salvage and pyrimidine biosynthesis are overexpressed and purified in
order to catalyze the nucleotide forming reactions. Several isotopically labeled forms of
glucose are enzymatically converted into the four NTPs of RNA. The pentose phosphate
pathway is utilized to convert glucose into ribose-5-phosphate and to accomplish specific
hydrogen exchange of the HI' and H2' protons of ribose-5-phosphate. The enzymes
previously used to convert ribose derived from glycerol into nucleotides are also used to
convert ribose-5-phosphate derived from glucose into nucleotides. Methods for deuterating
and heteronuclear labeling the base moieties of RNA are discussed. The isotopically
labeled NTPs produced from glycerol and glucose are used in T7-transcription reactions to
produce the 30 nucleotide HIV-2 TAR RNA. NMR experiments are conducted on the
different isotopically labeled forms of TAR RNA to determine the usefulness of the
different isotopic labeling patterns. Specific deuteration of RNA is demonstrated to have a
dramatic effect on reducing spectral crowding and simplifying RNA NMR spectra.
Specific deuteration is also shown to reduce relaxation rates of the remaining RNA protons.
Spectral editing of heteronuclear RNA NMR spectra is demonstrated using specifically
deuterated, heteronuclear labeled RNA derived from isotopically labeled glucose. Methods
for improving both homonuclear and heteronuclear NMR spectra of large RNA molecules
with labeling patterns produced using these techniques are discussed. All of the H1' and
H2' chemical shifts for the 11 uridine nucleotides in a 65 nucleotide RNA are identified
using specific deuteration patterns derived from these synthetic techniques. Improved
transfer of magnetization is also demonstrated using specifically deuterated, 13 C labeled
RNA. Application of the isotopic labeling patterns and synthetic strategies described in this
thesis to NMR studies of RNA should prove very valuable.
Thesis Supervisor: James R. Williamson
Title: Associate Professor of Chemistry
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1. Introduction
Background
With the discovery of group I self-splicing introns the study of RNA has rapidly
expanded (Cech, 1990). From the ever increasing amount of biochemical information on
RNA, it is clear that it plays an important role in gene expression and cellular function.
RNA forms a bridge between DNA and proteins, being intricately involved in protein
synthesis, with the ribosome being made up of approximately 66% RNA (Voet & Voet,
1995), messenger RNA transporting genetic information from DNA to the ribosomes, and
tRNA bringing amino acids to the ribosomes. Evidence suggests that RNA is directly
involved in the peptidyl transferase activity of ribosomes. The most compelling of this
evidence is the resistance of this peptidyl transferase activity of ribosomes to protein
extraction procedures (Noller et al., 1992). Intracelluar localization of mRNA establishes
polarity in cells, and is very important in development. An example of this is in drosophila
development where gradients of maternal bicoid mRNA in oocytes helps specify the
development of the head, thorax, and abdomen (St. Johnston, 1995). RNA protein
interactions are involved several cellular processes including activation of transcription,
regulation of translation, and regulation of splicing. One example of RNA protein
interactions is the Tat-TAR interaction of HIV-2, where the binding of the TAR RNA to
the Tat protein is required for activation of transcription (Calnan et al., 1991; Brodsky &
Williamson, 1997). A second example of RNA protein interactions is the interaction of the
iron responsive element (IRE) RNA with the IRE binding protein (IREbp), where the
translation of the mammalian protein ferritin is suppressed by the binding of the IREbp to
the IRE RNA at low iron concentration (Klausner et al., 1993). A third example of RNA-
protein interactions is the regulation of splicing that occurs when the HIV-1 Rev protein
binds to the Rev response element (RRE) RNA (Olsen et al., 1990; Zapp et al., 1991;
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Battiste et al., 1996). RNA is also very important in the spliceosome which requires
several small nuclear RNAs for assembly and function (Madhani & Guthrie, 1992). Group
I and II self splicing introns catalyze reactions similar to the spliceosome without the help
of proteins (McPheeters & Abelson, 1992). Finally, the ability of RNA to both catalyze
chemical reactions and store genetic information has allowed in vitro selection methods to
be designed which have produced RNAs with ligase activities (Wright & Joyce, 1997) and
RNA aptamers which are able to bind small molecules (Dieckmann et al., 1996).
The importance of RNA in the cell and the amount biochemical knowledge that has
accumulated about functional RNAs over the past decade has been the impetus for several
structural studies of RNA. Although the chemical structure of RNA differs from DNA
only in the 2' hydroxyl on the ribose ring and uracil replacing thymine, the helical
conformation differs in that RNA usually adopts A-form helical structure while DNA
adopts B-form structure. RNA forms a wide variety of intramolecular structures where
single stranded RNA folds back upon itself to form intramolecular base pairs. Many
functional RNAs have large regions of single stranded RNA within their predicted
secondary structures which are conserved phylogenetically (Gutell et al., 1985). These
supposedly single stranded regions are are most likely regions of "unknown structure"
(Pace, 1993) rather than unstructured regions, and base triples, AA platforms (Doudna &
Cate, 1997), 2'-hydroxyl hydrogen bonds, and other non-standard structure probably
lurk within these undefined regions. It has been interest in these unknown structural
regions and how RNA accomplishes its multitude of tasks that has fueled many RNA
structural studies.
Nuclear Magnetic Resonance Structural Studies of RNA
NMR spectroscopy is a powerful tool for studying the structure of RNA
oligonucleotides (Varani et al., 1996), and it has been used to determine the structures of
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RNA molecules of up to 40 nucleotides in size (Chang & Varani, 1997; Ramos et al.,
1997). Some examples of the wide variety of RNA and RNA complexes whose structures
have been determined with NMR spectroscopy include tetraloops (Jucker & Pardi, 1995),
pseudoknots (Puglisi et al., 1990), hairpins (Puglisi et al., 1997), 'kissing' hairpin
interactions between two stem loops (Marino et al., 1995), RNA-peptide (Puglisi et al.,
1995; Ye et al., 1995; Battiste et al., 1996; Peterson et al., 1994) and protein complexes
(Allain et al., 1996), RNA aminoglycoside interactions (Fourmy et al., 1996; Recht et al.,
1996), RNA amino acid complexes (Puglisi et al., 1992; Brodsky & Williamson, 1997),
RNA aptamers (Dieckmann et al., 1996; Jiang et al., 1996), and others (Greenbaum et al.,
1995; Nowakowski & Tinoco, 1996; Glemarec et al., 1996). NMR structural studies of
RNA complexes that have proven difficult to study by other methods have been successful
in obtaining structures, including several cases that were highly sought after such as the
HIV Tat-TAR (Puglisi et al., 1992; Brodsky & Williamson, 1997; Aboul-ela et al., 1995)
and Rev-RRE (Peterson et al., 1994; Battiste et al., 1996) RNA interactions.
Unfortunately extension of NMR structural studies to RNAs larger than 40 nucleotides has
been difficult because of spectral crowding and broad linewidths in RNA NMR spectra.
Since there are many biologically interesting RNAs that are significantly larger than 40
nucleotides, such as t-RNA (=76-80 nucleotides), it is important to develop techniques
that would allow the study of these larger RNAs using NMR spectroscopy.
Information which can be obtained from NMR spectroscopy (NMR Observables)
A general discussion of structure determination with NMR will be made here with
emphasis on the use of the information that can be extracted from NMR spectra (NMR
observables) in structure determinations. A much more detailed discussion of NMR
spectroscopy and structure determination with NMR spectroscopy can be found in Derome
(Derome, 1990), Wiithrich (Withrich, 1986), Cavanagh et. al. (Cavanagh et al., 1996),
and Carrington McLachlan (Carrington & McLachlan, 1967). Nuclear magnetic resonance
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spectroscopy of biological macromolecules can provide several types of information which
can be used to determine structures. The main types of information that are used in
determining NMR structures of macromolecules are the nuclear Overhauser effect (NOE),
scalar coupling (spin-spin coupling or J-coupling), and chemical shift.
Nuclear Overhauser Effect (NOE). The nuclear Overhauser effect (NOE) is a
through space transfer of magnetization from one proton to another that can be used to
estimate the distance between two protons. The intensity of an NOE has a 1/r6 dependence
and can be observed for distances less than or equal to 5 A. Nuclear Overhauser Effects
are one of the most important types of NMR information because they can be used to link
two parts of a macromolecule close in space even though they may be separated distantly in
primary sequence. In addition, patterns of NOEs can be indicative of certain types of
structural motifs, such as a-helical or f3-sheets in proteins, and A-form or B-form helical
structure in nucleic acids.
Scalar Coupling. Another important type of NMR information is scalar coupling
between covalently bonded nuclei. Scalar coupling between nuclei can generally be
observed through at least 3 bonds, and the magnitude of the scalar coupling constant (J)
depends on several factors related to molecular orbital overlap including bond length,
hybridization, and dihedral angle. Observation of coupling between two nuclei establishes
a through bond interaction between the nuclei and is therefore useful in assigning NMR
spectra. In addition, three bond coupling constants are used in structural studies to
determine the dihedral angle between protons on adjacent carbons via the Karplus equation
(Karplus, 1963) which relates the magnitude of the J-coupling to the dihedral angle. This
yields information about the conformation of the carbon chain to which the protons belong.
Chemical Shift. Chemical shift is the frequency that a nucleus resonates at relative
to an arbitrary standard (usually TSP or TMS). Chemical shift can be influenced by the
hybridization of an atom and also the electronegativity of the substituents that are attached
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to that atom or neighboring atoms. The chemical shift of a nucleus yields information
about the type of chemical environment that the nucleus is in, and is mainly used to
identify the type of chemical bonding that a nucleus is involved in. Changes in chemical
shift can indicate structural changes, those changes due to ligand binding for example, and
can be used to identify areas in macromolecules of particular interest.
RNA NMR Observables
When NMR spectroscopy is conducted on a particular RNA, several of the NMR
observables described above can be translated directly into structural information about the
RNA. In particular, base pairing, sugar pucker, and glycosidic torsion information can
be extracted directly from RNA NMR spectra, and these are summarized in Figure 1.1.
More detailed information about the RNA structure can be obtained by assigning all of the
interactions within RNA NMR spectra and using them as constraints in molecular modeling
(Varani et al., 1996).
Base pairing. NMR spectra of the exchangeable protons of RNA yield information
about the base pairing of RNA oligonucleotides. The imino protons of guanine and uracil
exchange with solvent rapidly and are unobservable in NMR spectra of the free
nucleotides, but when guanine and uracil form base pairs in RNA the exchange rates of the
imino protons are slowed and they often become observable with NMR spectroscopy,
Figure 1.1A. Imino protons within base pairs resonate far downfield of other RNA
protons at approximately 11-14 ppm, and so have little spectral crowding and are easily
identified. Observation of imino protons within RNA NMR spectra obtained in 90% H20
and 10% D20 is very important in determining RNA structures because the observed imino
protons indicate secondary structure.
Sugar pucker. Three bond scalar coupling constants between ribose protons can be
used to determine the conformation of the ribose ring , or sugar pucker, via the Karplus
A. Secondary structure: observation of imino protons
H5
H6  
-O H
N N HN
O N
H2  N I
R
B. Sugar pucker: H1 '-H2' scalar coupling
H3'
C H Base
0H Hi
H2'
C, HT Base
H00
C3' endo
J1'- 2' = 1 hz
C2 endo
J1'-2' = 8 hz
C. Glycosidic torsion: Hl'to base NOEs
HHN/H
N 'N H
NN H2
HO_
H1'
OH OH
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Hl NN H
HN
H2 N
HO 2
OH OH Hi'
OH OH
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Figure 1.1 RNA NMR Observables
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equation (Karplus, 1963). J-coupling between the H1' and H2' ribose protons are most
often used to determine sugar pucker since H1'-H2' COSY crosspeaks occur in an
uncrowded region of RNA NMR spectra. Nucleic acids usually adopt two sugar puckers,
C3'-endo and C2'-endo, shown in Figure 1.1B. C3'-endo is the preferred conformation
of sugar pucker in A-form RNA, and C2'-endo is the preferred conformation of sugar
pucker in B-form DNA and free nucleotides. Unfortunately the coupling constant between
the H1' and H2' for C3'-endo sugar pucker is very small, less than 3 Hz, and so is
unobservable in large RNA NMR spectra. In contrast, the coupling constant between the
H 1' and H2' for C2'-endo is large enough to be observed, being greater than 8 Hz, and
nucleotides with this conformation are generally observed in RNA NMR spectra.
Observation of COSY crosspeaks for C2'-endo conformation within RNA NMR spectra
usually indicates non A-form or unstructured regions of RNA.
Glycosidic torsion. The glycosidic conformation of a nucleotide can be determined
by the magnitude of intra-nucleotide NOEs between non-exchangeable ribose and base
protons, Figure 1.1C. Ribose HI' to base H6 or H8 NOEs are especially useful for the
determination of the glycosidic torsion because the H' to base NOEs occur in an
uncrowded region of RNA NMR spectra and the H1' is close to the base protons. Anti
conformation of the glycosidic torsion results in a HI' to base distance of approximately
3.8 A, and is the energetically preferred conformation. Syn conformation of the glycosidic
torsion results in a H1' to base distance of approximately 2.5 A, and this conformation
sometimes occurs in RNA structures. Observation of strong H1' to base NOEs can
indicate syn glycosidic conformation and unusual RNA structure.
Sequential Assignment of RNA NMR spectra
NMR spectra of RNA contain a wealth of structural information, but unfortunately
that information is encoded in a complicated manner. To translate the chemical shifts,
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NOEs, and coupling constants observed in RNA NMR spectra into structures, a
sequential assignment of RNA NMR spectra is necessary which involves correlating the
chemical shifts of resonances to specific nuclei within an RNA molecule (Wiithrich, 1986).
Once a specific assignment of the RNA NMR spectra has been made, the intensities of
NOEs and magnitudes of coupling constants can be translated directly into distances and
dihedral angles of specific parts of the RNA, and then used as constraints in molecular
modeling to determine RNA structures (Varani et al., 1996).
Obtaining a sequential assignment of RNA NMR spectra is not always a simple
task, as can be demonstrated by considering a 30 nucleotide RNA. There are on average 8
non-exchangeable protons per nucleotide and thus approximately 240 non-exchangeable
protons in a 30 nucleotide RNA. Most of the protons within the RNA will give rise to
more than one NOE yielding several hundred NOEs in the entire molecule. Each and every
NOE represents rough distance information about a specific proton-proton interaction, and
if that NOE can be assigned to a specific part of the RNA and its intensity measured, then
that distance information can be used in molecular modeling to determine the RNA's
structure. If that NOE cannot be assigned and measured, then its presence simply
complicates the assignment of other NOEs. When no sequential assignment of RNA NMR
spectra can be made, structural studies are not possible.
NOESY Based Sequential Assignment of Non-exchangeable RNA Spectra.
Patterns of NOEs in RNA NMR spectra which are due to the chemical structure of RNA
and the conformations it adopts can be combined with the known primary structure of the
RNA to obtain a sequential assignment of RNA NMR spectra. RNA in A-form helical
geometry has a regular repeating structure which gives rise to patterns of inter-nucleotide
and intra-nucleotide NOEs which can be used to identify the peaks in an NMR spectra. A
list of some of the predicted inter-nucleotide and intra-nucleotide distances for which NOEs
can be expected for an A-form RNA helix are shown below:
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Distances (A)
Intra-nucleotide Inter-nucleotide (3' to 5')
H 1't:H6/H8 3.5 H1' , H6/H8 4.5
H2',t-H6/H8 4.0 H2't= H6/H8 2.0
H3'%=H6/H8 2.7-3.0 H3'c-*H6/H8 3.0
H5<=>H6 2.4 H6/H8#H6/H8 4.5
Table 1.1 Intra-nucleotide and inter-nucleotide distances for which NOEs can be
expected between protons in A-form RNA (Arnott & Hukins, 1973; Puglisi, 1989).
(Hx=:>Hy is the distance between Hx and Hy in A.)
NOESY-based sequential assignment of RNA depends upon linking NOEs from
protons on one nucleotide to the next nucleotide in the sequence, then repeating the
process. Two NOEs (leaps through space) are required using this method to link one
nucleotide to the next. The first leap through space is necessary to link the ribose protons
of a nucleotide to the base protons of that same nucleotide, and the next leap through space
is necessary to link the ribose protons to the base proton that is 3' to it in the RNA strand.
Figure 1.2 shows a graphical representation of this where intra-nucleotide NOEs are shown
as arrows numbered 1 and inter-nucleotide NOEs are shown as arrows numbered 2. By
tracing the NOEs from H6/H8 protons to ribose protons on the same nucleotide, then from
those ribose protons to the H6/H8 base proton that is 3' to that ribose, an NMR
spectroscopist can follow the sequential assignment of the NMR spectra from one
nucleotide to the next 3' nucleotide. This is termed a 'NOESY walk'.
The H1' to base (H2, H6, or H8 protons) region of RNA NOESY spectra is
particularly important to the NOESY based sequential assignment of RNA, because the
placement of the H 1' proton in A-form RNA is such that NOEs can be expected for both
inter-nucleotide and intra-nucleotide H1' to base proton interactions (table 1.1). This is
advantageous because a single H 1' proton can be used to link one nucleotide through space
to the next, Figure 1.2. An additional advantage is that the Hi' to base NOE region is
5 N 2
- o 0 21 1p/ HO
o0/ \ 2O
H 3 H3' 6 NN
3 1'0 HO 2 i
spectra. 1 = intra-nucleotide NOE, 2 = inter-nucleotide NOE.
spectra. 1 = intra-nucleotide NOE, 2 = inter-nucleotide NOE.
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relatively uncrowded, having only H l'to base NOEs and H5-H6 pyrimidine NOEs,
making the assignment of this region much easier than other ribose to base NOE regions.
H6 base protons from pyrimidines (Y) are distinguished from H8 base protons from
purines (R) by the presence of H5-H6 crosspeaks for the H6 pyrimidine protons in COSY
and NOESY spectra. Patterns of purines and pyrimidines in sequence such as 5'-RRYR-3'
can then be identified knowing the primary sequence of the RNA as 5'-AGUG-3'.
Other ribose protons can also be used to help in NOESY based sequential
assignment, most notably the H2' and H3' ribose protons. The H2' ribose proton is very
close to the base proton that is 3' to it in A-form RNA, =2.0 A, and thus gives a very
strong NOE to the 3' base proton. This NOE is helpful in RNA sequential assignment
because it can yield a second piece of evidence for the identity of the 3' base proton,
Figure 1.2. The H3' ribose proton is much like the HI' ribose proton, often having both
inter-nucleotide and intra-nucleotide NOEs (table 1.1). Unfortunately both the H2' to base
and H3' to base NOEs fall in a very crowded region of RNA NMR spectra, and are thus
difficult to assign.
While much of the RNA NMR structural work that has been done to date has relied,
at least in part, upon NOESY based sequential assignment, this type of assignment has the
drawback that A-form helical structure must be assumed during the assignment procedure.
When A-form helical structure does not exist, the assignment procedure breaks down.
Since some of the most interesting RNA structures are non A-form, this is a large
drawback. Generally the A-form sections of RNAs are assigned leaving holes where non-
A-form structure can then be assumed to exist. By assigning as many NOEs and coupling
constants in these non A-form regions, the unusual structures can be determined. Much
work in the field of heteronuclear NMR spectroscopy has focused on developing through-
bond assignment procedures of RNA which rely less on assumptions and are less prone to
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error than NOESY based sequential assignment (Dieckmann & Feigon, 1994; Pardi,
1995).
Problems with the application of NMR spectroscopy to larger RNAs
In solution NMR studies of large macromolecules both spectral crowding and
increased resonance linewidth combine to prevent assignment of NMR spectra and
ultimately limit the size of macromolecules that can be effectively studied (Wagner, 1993;
Clore & Gronenborn, 1994). In the extreme case of very large macromolecules spectral
crowding becomes severe because of the increased number of resonances, and most
heteronuclear NMR experiments are inefficient due to rapid T2 relaxation. Figure 1.3
shows a comparison of the NOESY spectra of a 30 nucleotide RNA with that of a 65
nucleotide RNA. The NMR techniques of 1994-95 were capable of determining the
structure of the 30 nucleotide RNA, but the study of the 65 nucleotide RNA with NMR is
still problematic in 1997 due to severe spectral crowding and broad linewidths.
Spectral Crowding. Spectral crowding is a large problem for RNA NMR
spectroscopy because of poor distribution of the non-exchangeable RNA proton chemical
shifts. While the base, imino, and Hl' protons in RNA have good chemical shift
dispersion, the remaining protons of the ribose ring, comprising over half of the non-
exchangeable protons in RNA, resonate between 4-5 ppm. A 1-dimensional spectra of the
nonexchangeable protons of RNA (Figure 1.4) demonstrates this, where the overlap of the
H2', H3', H4', H5', and H5" ribose protons results in severe spectral overlap between
4-5 ppm. In a 2-dimensional NOESY spectra of RNA, this 1-dimensional overlap results
in severe spectral crowding in NOESY regions where NOEs from the H2', H3', H4',
H5', and H5" ribose protons fall, regions A, B, and C of the NOESY spectra of RNA
shown in Figure 1.5. While the number of protons within an RNA increases linearly with
the number of nucleotides, the spectral width that RNA protons resonate in does not
change with the size of the RNA, and this causes proton resonances to pile up upon one
at
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Figure 1.5 2-dimensional NOESY spectra of the non-
exchangeable protons of RNA. The overlap of the ribose
H2', H3', H4', H5', and H5" proton chemical shifts results
in severe spectral crowding in NOESY regions A, B, and
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another in larger RNA NMR spectra. Spectral overlap in RNA molecules larger than 40
nucleotides becomes so severe that assignment of the ribose 4-5 ppm regions of NMR
spectra becomes impossible.
Line Broadening. As the macromolecules studied with NMR spectroscopy increase
in size, the linewidths of resonances in NMR spectra become broader. This phenomenon
is due to faster relaxation of magnetization in larger macromolecules as opposed to smaller
molecules. A detailed discussion of the causes and effects of spin relaxation is outside the
scope of this text, but a qualitative discussion of the effects that spin relaxation has on
NMR spectra will be presented here. (More detailed discussions of relaxation can be found
in Derome (Derome, 1990), Carrington and McLachlan (Carrington & McLachlan, 1967),
or Cavanagh et. al. (Cavanagh et al., 1996).) NMR experiments rely upon detecting non-
equilibrium bulk magnetic moments which relax back to equilibrium with roughly
exponential rates termed T1 and T2 relaxation rates (longitudinal and transverse) which
describe the relaxation of z and x,y magnetization respectively. The lifetime of detectable
magnetization during the acquisition phase of an NMR experiment (the duration of
detectable signal in the Free Induction Decay or FID of an NMR experiment) determines the
linewidth of the resulting NMR lines, and this lifetime depends mostly on the T2 relaxation
rate. Longer lived detectable magnetization produces narrower linewidths in NMR
experiments. The rate of relaxation of a certain spin back to equilibrium magnetization is
dependent upon fluctuations of local magnetic fields, which in turn are dependent on the
thermal motions of a macromolecule. The overall rate of tumbling for a macromolecule is
dependent upon the size and shape of the macromolecule, as well as the viscosity and
temperature of the medium which it is in. These factors are often summarized as the overall
correlation time of the macromolecule tc. In this manner, the broadness of NMR
resonances can be related to relaxation times of magnetic spins and most importantly the
size of the macromolecules. Figure 1.6 shows the fourier transform of the same free
FID
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Figure 1.6 Effect of magnetization lifetime on linewidth.
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induction decay (FID) with three different simulated T2 relaxation times (The different T2
relaxation times were simulated by multiplying the same FID by increasingly negative
exponentials.). As lifetimes of the detectable magnetization become shorter in the FIDs,
broader linewidths result in the NMR spectra. Peaks that were clearly distinct in the first
spectra are blurred together in the last broadest NMR spectra. Similar line broadening
effects are seen for larger macromolecules because of their increased correlation times
relative to smaller molecules.
Shorter T2 relaxation times also have an effect on the intensity of the signal that is
observed. Relaxation back to equilibrium begins the instant non-equilibrium magnetization
is established, so depending on the pulse sequence that is used, significant decay of
detectable magnetization can occur by the time acquisition begins, which is the start of the
FID. In the case of very large macromolecules with very short T2's, detectable
magnetization can decay so fast that there is no magnetization to detect during the
acquisition phase of NMR experiments. This situation is often encountered in
heteronuclear NMR spectroscopy of large macromolecules (Kay & Gardner, 1997).
Altering NMR spectra with isotopic labeling
Introduction of above normal levels of stable isotopes into macromolecules can
greatly alter their NMR properties while only slightly altering their chemical properties
(Kainosho, 1997). This can be utilized to change NMR spectroscopic properties of
macromolecules so that their structures can be more easily be studied with NMR. Two
types of isotopic labeling which have been used to increase the size of molecules that can be
studied with NMR spectroscopy are deuteration and heteronuclear labeling, which can be
incorporated into macromolecules either uniformly or specifically.
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Figure 1.7 Deuteration of hydrogens within macromolecules removes those
resonances from NMR spectra and also reduces dipolar relaxation of the remaining protons
resulting in narrower linewidths. (solid arrows represent strong 1H- 1IH dipolar relaxation,
and dashed arrows represent weaker 2H- 1H dipolar relaxation)
Deuterium Labeling. Deuterium has a natural abundance of 0.015%, while
hydrogen has a natural abundance of 99.985%. Increasing the level of deuterium in
macromolecules above the natural abundance can have several effects that are beneficial to
NMR spectroscopy (Markley et al., 1968; Crespi et al., 1968; LeMaster & Richards, 1988;
LeMaster, 1990). For example, replacing a hydrogen with deuterium will make that
position silent in proton NMR spectroscopy. Even though deuterium has a spin, the
energy of transition for deuterium is sufficiently different from that of hydrogen so that no
deuterium resonances are observed in proton NMR spectra. Deuterium can be used to
reduce the intensity of a proton or even remove certain resonances from NMR spectra. In
addition, deuterium has a gyromagnetic ratio that is approximately 6.5 time smaller than
hydrogen. Dipolar interactions which give rise to T2 relaxation are greatly reduced when
deuterium is substituted for hydrogen resulting in longer T2 relaxation times and narrower
linewidths for the remaining hydrogens. There are two types of deuterium labeling which
have different effects on NMR spectra, one is termed random fractional deuteration and the
other is specific deuteration (LeMaster, 1990).
Random fractional deuteration is the term used to describe biological
macromolecules which are labeled with deuterium by growing organisms on partially
deuterated carbon source in a partial D20 mixture. Scrambling of the protons of the carbon
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source during metabolism places deuterium relatively randomly (depending on the carbon
source and the metabolic pathway) on the proteins, nucleic acids, and other molecules
produced by the organism during metabolism. Proteins overexpressed in bacteria grown
on 75% deuterated medium will have a random fractional deuteration level of approximately
75%, which means that there is about a 75% probability that any nonexchangeable proton
on the protein will be deuterium. The advantage of random fractional deuteration is that it
greatly reduces dipole-dipole interactions which give rise to relaxation, resulting in
narrower linewidths (LeMaster, 1990). The disadvantage of random fractional deuteration
is that it reduces the intensity of all of the resonances within a macromolecule (Figure
1.8b). Random fractional deuteration of a biological macromolecule gives rise to an
ensemble of deuterated molecules where each position of the macromolecule is deuterated
in some of the molecules in the ensemble. The NMR spectra of the entire ensemble of
molecules gives rise to all of the resonances of the unlabeled molecule, but with narrower
linewidths and reduced intensity due to the level of deuteration. Random fractional
deuteration has proven to be very useful in improving the spectra of the exchangeable
protons in proteins and nucleic acids, because the nonexchangeable protons are deuterated
to a high level reducing dipolar relaxation, but the exchangeable protons are present at 90%
protonation due to exchange with solvent and therefore not having reduced intensities in
NMR spectra.
Specific deuteration of macromolecules refers to placing deuterium into specific
positions of the macromolecule with either specific metabolic pathways or chemical
synthesis, and has somewhat different effects than random fractional deuteration on the
NMR spectra of macromolecules (LeMaster, 1990). Specific deuteration results in a
homogeneous group of isotopically labeled macromolecules where certain protons have
been deuterated and certain others have been left protonated. Deuteration of the specific
protons leads to reduced dipolar interactions and narrower linewidths for the remaining
protons as it does in random fractional deuteration, but specific deuteration does not result
a. Unlabeled
Hc Ha Hd Hb
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Hd - Hc
b. Random fractionally deuterated
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c. Specifically deuterated
Ha ------ Db
Dd DC
Figure 1.8 Effect of deuteration on NMR spectra. a) Unlabeled: all possible dipolar
interactions are present, peaks are at full intensity. b) Random fractionally deuterated:
NMR sample is made up of an ensemble of molecules with different deuteration
patterns, linewidths are narrower due to reduced dipolar interactions and the intensity
of all peaks are reduced because of deuteration. c) Specifically deuterated: linewidths
of the remaining protons are narrower because of reduced dipolar interactions and the
spectra is simplified by the specific removal of several resonances.
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in a uniform reduction of intensity as random fractional deuteration does (Figure 1.8c).
Instead, specific deuteration results in a close to 100% reduction in signal for the
specifically deuterated protons, and no reduction of intensity for the protons which are not
deuterated (Hsu & Armitage, 1992). Because of this, specific deuteration of
macromolecules can be used to remove unwanted resonances from NMR spectra reducing
spectral crowding and simplifying the interpretation of the remaining resonances.
Heteronuclear or 13 C and 15 N labeling. 13C and 15 N are both spin 1/2 nuclei
which have low natural abundance (1.11% 13 C, 0.37% 15N). Incorporation of elevated
levels 13C and 15 N nuclei into macromolecules, termed here 'heteronuclear labeling',
results in drastically different effects than deuteration (Wagner, 1993; Clore &
Gronenborn, 1994; Pardi, 1995). Rather than reducing dipolar interactions like
deuteration, introduction of heteronuclei into macromolecules actually introduces extra
scalar and dipolar interactions which increase line broadening by adding large one bond
1H-13C and/or 1H-15N dipolar interactions into the NMR spectra. The advantage of
heteronuclear labeling lies not in reducing linewidths or removing resonances from NMR
spectra, but in being able to transfer magnetization from protons to heteronuclei and then
back to protons through the large one bond scalar couplings between protons directly
bound to heteronuclei. This allows multidimensional heteronuclear NMR and through
bond assignment of macromolecules.
Multidimensional heteronuclear NMR reduces spectral crowding by spreading
proton resonances out over a heteronuclear chemical shift dimension (Figure 1.9). HMQC
(Heteronuclear Multiple Quantum Correlation spectroscopy) NMR spectra correlate 1H
chemical shifts with the chemical shifts of 13C or 15 N nuclei which the 1H is attached to.
By combining HMQC NMR experiments with two dimensional proton-proton NMR
experiments such as NOESY, COSY (Correlational SpectroscopY), or TOCSY (Total
Correlational SpectroscopY), a third heteronuclear dimension can be added to the NMR
3D NOESY-HMQC
-- 1H , --
o 0
13 C
Figure 1.9 Heteronuclear labeling reduces spectral crowding by spreading out proton information
over a heteronuclear dimension.
2D NOESY
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spectra. This additional chemical shift axis serves to reduce spectral crowding by
increasing the overall spectral volume over which the same information is spread out over,
and also separates proton information by the chemical shift of the carbon or nitrogen that it
is directly attached to. The reduction in spectral overlap that results from multidimensional
heteronuclear NMR has increased the size of proteins that can be studied with NMR from
10 to 25 kDa (Wagner, 1993; Clore & Gronenborn, 1994).
Heteronuclear labeling also enables through bond assignment of labeled
macromolecules, which is less prone to error in interpretation than NOESY based
assignment (Clore & Gronenborn, 1994). Heteronuclear TOCSY NMR experiments allow
the transfer of magnetization between distantly separated protons by transferring
magnetization through large one bond proton-heteronuclei and heteronuclei-heteronuclei
scalar couplings. Observation of correlations between two protons in an HCCH-TOCSY
NMR experiment (Figure 1.10) establishes a through bond relationship between the
protons, indicating that they are in the same spin system (such as an amino acid side chain
in a protein, or a ribose moiety from a nucleic acid).
a d
a b c d
Figure 1.10 HCCH-TOCSY NMR experiments transfer magnetization from
protons to heteronuclei and then back to protons through large one bond scalar couplings.
Observation of correlations between Ha and Hd in an HCCH-TOCSY NMR experiment
establishes a through bond relationship between the protons, indicating that they are in the
same spin system.
Heteronuclear and deuterium labeling combined. Within the last five years
heteronuclear labeling and deuteration have been combined to successfully study proteins
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on the order of 40-60 kDa (Kay & Gardner, 1997; Grzesiek et al., 1993; Markus et al.,
1994; Yamazaki et al., 1994b; Farmer & Venters, 1995; Muhandiram et al., 1995;
Nietlispach et al., 1996; Rosen et al., 1996; Matsuo et al., 1996; Shan et al., 1996;
Yamazaki et al., 1997). This approach combines the benefits of deuteration with
multidimensional heteronuclear NMR, and has started to be applied to RNA in the form of
random fractional deuteration of RNA in combination with heteronuclear labeling (Batey et
al., 1996; Nikonowicz et al., 1997). Deuteration greatly increases the T2's of heteronuclei
by replacing the strong dipolar coupling between 13 C and hydrogen with the weaker 13 C-
deuterium interaction. The increase in the lifetime of carbon magnetization enables
heteronuclear NMR experiments to work on larger protein molecules than would be
possible without the advantages of deuteration.
Uniform vs. Specific Isotopic Labeling. Isotopic labeling for NMR purposes can
be divided into roughly two types of labeling, uniform labeling and specific labeling, with
each type having different advantages and disadvantages. For the purposes of this text,
uniform isotopic labeling is defined as uniform incorporation of an isotope or isotopes into
every position of a macromolecule with a roughly equal percentage of incorporation for
each position, and specific isotopic labeling is defined as non-uniform incorporation of an
isotope or isotopes into the positions of a macromolecule with unequal percentages of
incorporation for the different possible positions. With these definitions random fractional
deuteration will be considered uniform isotopic labeling, because in a 75% random
fractionally deuterated protein, each hydrogen position has a roughly 75% probability of
being deuterated, and incorporation of 13C labeled G into otherwise unlabeled RNA will
be considered specific labeling since the 13 C labeling will be approximately 100% for G
carbons and 1% for the other carbons. These definitions make a distinction between the
types of effects that are observed in NMR spectra where uniform isotopic labeling will
affect the NMR spectra of every atom of the types that are labeled in the macromolecule,
and specific labeling will only affect a subset of all of the atoms in the NMR spectra.
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Much of the NMR isotopic labeling that has been used over the last decade to
extend the size of macromolecules that can be studied with NMR has been of the uniform
isotopic labeling type. Uniform heteronuclear labeling of proteins and nucleic acids has
greatly increased the size of macromolecules that can be studied with NMR (Clore &
Gronenborn, 1994). One advantage of uniform isotopic labeling is that the benefits of
isotopic labeling are experienced for the entire molecule in a single NMR sample, rather
than for only certain parts of the molecule as in specific isotopic labeling. This allows all of
the possible NMR information of a macromolecule to be obtained from a single NMR
sample, or at most a few NMR samples, and because of this, less work need be spent
preparing NMR samples when uniform isotopic labeling is used. Another advantage of
uniform isotopic labeling is that it can be accomplished in a fairly straightforward manner
for most biological macromolecules by harvest of the macromolecules or their precursors
from bacteria grown on isotopically labeled minimal media (Kainosho, 1997). These two
advantages make uniform isotopic labeling the most attractive option for the study of
proteins or RNA with NMR until the size of macromolecules increase to the point that
spectral crowding and relaxation problems become insurmountable by uniform isotopic
labeling alone.
As the size of the macromolecules to be studied with NMR spectroscopy increases,
specific isotopic labeling becomes a more attractive labeling option because it can be used to
simplify NMR spectra by focusing on a subset of all of the resonances of a macromolecule.
Specific isotopic labeling can be designed so that the subset of resonances that are observed
in NMR spectra will reduce spectral overlap, simplify assignment, and contain the most
structural information possible for the remaining resonances. For extremely large
macromolecules where no specific assignment of resonances can be made due to spectral
crowding, the use of specific isotopic labeling to focus on a subset of resonances can make
assignment of NMR spectra possible where uniform labeling fails. In addition, specific
deuterium labeling can be used to increase the relaxation times of the remaining protons
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without the loss of signal that is inherent with random fractional deuteration. This can be
valuable when large macromolecules with relaxation problems are studied. Unfortunately
the synthetic methods required to accomplish specific isotopic labeling of macromolecules
is usually more difficult and involved than uniform isotopic labeling, requiring either
chemical synthesis or growth of bacteria on specifically labeled media (usually obtained by
chemical synthesis). Even though specific isotopic labeling is chemically more difficult to
accomplish, as NMR spectroscopist start to study larger macromolecules, specific labeling
techniques have been utilized more frequently (Kay & Gardner, 1997).
Goal: Incorporate isotopic labels into RNA in order to facilitate
NMR studies
The nature of the problems encountered with RNA NMR spectroscopy make RNA
a good candidate for the application of specific isotopic labeling patterns. Spectral overlap
problems encountered in RNA are severe for many reasons which specific isotopic labeling
can alleviate. Unlike proteins, where there are 20 residues with widely varying side
chains, RNA has only 4 residues, A, G, U, and C nucleotides. This means for an RNA
and protein of the same number of residues, the RNA will most often have more repeated
residues than the protein. In addition, each nucleotide of RNA contains a ribose moiety
whose proton chemical shifts do not vary significantly with the type of base which is
attached to the ribose. Because of this, the identification of the type of nucleotide which a
ribose proton belongs to is not a simple matter since the ribose resonances for all nucleotide
types overlap. This is unfortunate because ribose protons comprise over half of the non-
exchangeable protons in RNA, and five out of the six non-exchangeable ribose protons
overlap in proton chemical shift. This results in spectral crowding in RNA NMR spectra
which is largely due to the overlap of different types of ribose protons and also overlap of
ribose protons from different types of nucleotides. Isotopic labeling of RNA so that
specific types of ribose protons and/or specific types of nucleotides were labeled differently
would result in a great reduction of the spectral crowding encountered in RNA NMR
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spectroscopy, and might make the study of larger RNA molecules with NMR possible.
The work on this project was initiated to explore what utility specific isotopic labeling of
RNA might have in the study of larger RNAs with NMR spectroscopy.
Good methods for incorporating a wide variety of specific deuterium and
heteronuclear labeling patterns into RNA did not exist at the time this project was initiated,
so a large part of the work described in this thesis deals with developing procedures which
can be used to specifically isotopically label RNA. Previous procedures used to produce
isotopically labeled nucleoside triphosphates and nucleosides, the precursors of RNA,
were used as a starting point for the design of syntheses which would produce specific
isotopic labeling patterns. In the end the goal was to develop RNA isotopic labeling
patterns which would be of general use in the study of RNA structure with NMR
spectroscopy, so much consideration was given to the cost, level of difficulty, and
flexibility of the synthesis that was to be developed since if the cost of the synthesis was
too high, the amount of work necessary too much, or the synthesis too inflexible, it
would be unlikely that the synthesis would become generally used in the field of RNA
NMR spectroscopy.
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2. Synthesis of d4-NTPs
As described in Chapter 1, structural studies of RNA using proton NMR
spectroscopy are limited in the size of RNAs that can be effectively studied to about 20-35
nucleotides because of spectral crowding and linewidth problems. Isotopic labeling can be
used to extend the size of macromolecules that can be studied with NMR by reducing
spectral crowding and linewidth problems in larger macromolecules. It was the purpose of
the research described in this thesis to explore the use of specific incorporation of 2H, 13C,
and 15N labels into RNA to extend NMR structural studies to larger RNA molecules. The
first RNA isotopic labeling pattern to be synthesized in this thesis was the 3',4',5',5"-d4-
RNA labeling pattern, which was designed to simplify homonuclear NMR spectra by
specific removal of ribose protons which cause spectral crowding. By attempting to first
synthesize a labeling pattern that only contained deuterium labels, it was possible to work
out the problems of incorporating specific labels into RNA with relatively inexpensive
deuterated starting materials as opposed to more expensive heteronuclear labeled starting
materials.
The 3',4',5',5"-d4-RNA (D4-RNA) labeling pattern was designed to alleviate the
spectral crowding and large linewidth problems that are encountered in large RNA NMR
spectroscopy. The spectral crowding problems of RNA are quite evident in the one
dimensional spectra of the non-exchangeable protons of RNA shown in Figure 1.4 in
Chapter 1. While the base, imino, and Hl' protons in RNA have good chemical shift
dispersion, the remaining protons of the ribose ring, comprising over half of the non-
exchangeable protons of RNA, resonate between 4-5 ppm. In a two dimensional NOESY
spectra of RNA this overlap of the H2', H3', H4', H5', and H5" resonances results in
severe spectral crowding in regions A, B, and C shown in Figure 1.5 of Chapter 1. NOEs
falling in these regions can arise from interactions of any of the five types of ribose protons
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that resonate between 4-5 ppm with other RNA protons. Selective deuteration of the ribose
3', 4', 5', and 5" protons would simplify RNA NMR spectra while still retaining much of
the structural information available from RNA NMR spectroscopy. Glycosidic torsion,
sugar pucker, and base pairing information can be obtained from NMR spectra using only
the base protons, the ribose HI' and H2' protons, and the exchangeable protons as
summarized in Chapter 1 Figure 1.2. Deuteration of the H3', H4', H5', and H5" protons
would still permit this information to be obtained, but the spectral assignment would be
greatly simplified due to the removal of over half of the non-exchangeable RNA protons
from NMR spectra. In addition, the D4-RNA labeling pattern would reduce the linewidths
of the remaining protons by substituting strong 1H-1H dipolar interactions with weaker
2H-1H interactions. The reduced dipolar relaxation of the remaining protons of the D4-
RNA would result in longer relaxation times and narrower linewidths. For these reasons
the D4-RNA labeling pattern would be a valuable tool for NMR structural studies of large
RNAs, but unfortunately common methods for isotopically labeling RNA would not easily
allow for selective deuteration of the 3', 4', 5' and 5" protons of RNA. New synthetic
methods needed to be developed in order to allow for selective isotopic labeling of RNA in
the D4-RNA labeling pattern, and also to make other selective isotopic labeling patterns
possible.
Strategy
NMR structural studies of RNA usually require between 0.25-1.5 gmole of
purified RNA to prepare a single RNA NMR sample. RNA can be synthesized in these
NMR quantities by either chemical RNA synthesis (Wincott et al., 1995) or T7 RNA
polymerase catalyzed transcription (Wyatt et al., 1991). These methods require either
phosphoramidites or nucleoside triphosphates (NTPs) respectively to produce RNA, and
so to isotopically label RNA it is first necessary to develop procedures for isotopically
labeling these starting subunits. Although chemical RNA synthesis can incorporate
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different types of isotopic labels at each nucleotide of an RNA sequence, it is not the most
generally used method of incorporating isotopic labels into RNA. This is partially because
chemical RNA synthesis has a low coupling yield, lower than chemical DNA synthesis,
making it difficult to synthesize RNAs larger than 50 nucleotides in significant quantities,
and partially because chemical RNA synthesis requires phosphoramidites as starting
materials, which require several chemical steps to synthesize from isotopically labeled
nucleosides. T7 RNA polymerase catalyzed transcription is by far the preferred method of
incorporating isotopic labels into RNA, since it has the ability to produce NMR quantities
of short RNA sequences as low as 12 nucleotides and also RNA sequences larger than 400
nucleotides. The nucleoside triphosphates required for T7 transcription reactions can be
produced in a single enzymatic phosphorylation reaction from isotopically labeled
nucleoside monophosphates derived from biological sources (Batey et al., 1992), making
the synthesis of the NTPs required for T7 transcription much easier than the synthesis of
the phosphoramidites required for chemical RNA synthesis. T7 RNA polymerase
catalyzed transcription was chosen as the method for synthesizing the RNA labeling
patterns described in this thesis because the 3',4',5',5"-d4-RNA labeling pattern was to be
applied to the study of RNAs larger than 50 nucleotides, and also to minimize the synthetic
effort required to produce RNA.
Since T7 RNA polymerase catalyzed transcription (Wyatt et al., 1991) was to be
used to synthesize the 3',4',5',5"-d4-RNA labeling pattern, the goal was to prepare
3',4',5',5"-d4-NTPs (d4-NTPs). One method for producing isotopically labeled NTPs is
to harvest total cellular RNA from bacteria that have been grown on isotopically labeled
media, enzymatically digest the RNA to nucleoside monophosphates (NMPs), and finally
enzymatically convert the NMPs to NTPs. Uniform 13C, 15N, and 13C/ 15N labeling of
NTPs has been accomplished by this method by growing E. coli or M. methylotrophus on
13C and/or 15N labeled media (Nikonowicz et al., 1992; Hoffman & Holland, 1995; Batey
et al., 1995). Unfortunately it is difficult to incorporate specific isotopic labels with this
Chapter 2
method due to isotopic scrambling during biosynthesis. A second method that can be used
for producing deuterated NTPs involves selective oxidation of one of the hydroxyl groups
of ribose, followed by reduction with deuteride. This method has been used to deuterate
both the H5' and H5" of thymidine, as well as the H3' of adenosine (Frank et al., 1991;
Robins et al., 1990). Although schemes using selective oxidation/reduction of nucleosides
to incorporate deuterium labels work well for incorporation of deuterium on a single
carbon, they become cumbersome when applied to deuteration of multiple carbons, and
also do not readily offer the possibility for 13C and 15N incorporation. A third method for
incorporating isotopic labels into nucleotides is to isotopically label the ribose or base
separately, followed by chemical coupling to form a nucleoside (Vorbriggen et al., 1981).
This method allows a large flexibility in isotopic labeling since the ribose or the bases can
be prepared and labeled separately, and then combined. A variety of isotopic labels have
been incorporated into nucleosides using this general scheme including ribose deuterated by
Raney nickel-D20 exchange (F61desi et al., 1992), H1 deuterated ribose (Toyama et al.,
1993), H2 deuterated ribose (Cook & Greenberg, 1994), and ribose 13C labeled at the Cl
or C2 (Lancelot et al., 1993; Kline & Serianni, 1990). This method also presents
problems, however, since to chemically couple ribose to a base, D-ribose must first be
protected as 1-O-acetyl-2,3,5-tri-O-benzoyl-b-D-ribofuranoside or some equivalent, which
is a multistep synthetic process. Furthermore, once nucleosides have been formed
chemically, they must still be converted into NTPs, which requires additional chemical and
enzymatic steps (SantaLucia et al., 1995). Another method that has been used, and the one
that we chose to adopt, is isotopic labeling of the ribose or base separately, followed by
enzymatic coupling to form a nucleotide. Enzymatic coupling allows the direct conversion
of ribose into nucleotides or nucleosides without the use of protecting groups, which
greatly simplifies the synthetic effort required to produce isotopically labeled NTPs from
ribose. This strategy has been used to produce 1'-14C-AMP and 1'-3H-AMP starting with
isotopically labeled ribose and adenine using adenine phosphoribosyltransferase (Parkin et
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al., 1984). Purine nucleoside phosphorylases have also been used to couple C8-13C-
purines to ribose-1-phosphate to form C8- 13C-purine nucleosides (SantaLucia et al.,
1995).
To synthesize 3',4',5',5"-d4-RNA we have developed a synthetic strategy that uses
both chemical and enzymatic methods as outlined in Figure 2.1. By using T7 RNA
polymerase catalyzed transcription to produce large RNAs we have avoided the chemical
protection steps required to convert nucleosides into phosphoramidites. Greater flexibility
of isotopic labeling is afforded by chemically synthesizing the isotopically labeled ribose
separately and then coupling that ribose to bases. With this strategy the isotopically labeled
ribose and bases can be derived by a variety of methods, and then coupled to form
nucleotides. The use of enzymatic synthesis accomplishes coupling of ribose to the bases
in a single coupled enzymatic reaction, avoiding the multistep, laborious process of
coupling ribose to bases chemically. One drawback of using enzymatic synthesis to
accomplish coupling of ribose to bases was that seven enzymes needed to be purified since
they were not commercially available in forms that could be used. While this represented a
major obstacle, it was reasoned that by expending a larger initial amount of effort in
purifying the enzymes and working out the procedures for the enzymatic reactions, the
production of subsequent isotopic labeling patterns would be simplified. This is not the
case for chemical coupling of ribose to bases since each time it is repeated the same amount
of work must be expended to produce nucleotides.
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Figure 2.1 Synthetic strategy for the synthesis of 3',4',5',5"-d4-RNA
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Figure 2.2 Schematic of previous syntheses of D-ribose from 2,3-0-
isopropylidene-D-glyceraldehyde (6) using a) a route that utilizes Sharpless asymmetric
epoxidation, or b) a route that utilizes osmium tetraoxide dihydroxylation.
For the chemical synthesis, our strategy was to build upon well-established
carbohydrate syntheses to produce D-d4-ribose (-1) from commercially available,
isotopically labeled starting materials. The ribose synthesis was based on acyclic
carbohydrate syntheses, where 2,3-O-isopropylidene-D-glyceraldehyde (6) is extended by
a Wittig reaction, and the resulting double bond is then dihydroxylated with either osmium
tetroxide dihydroxylation (Cha et al., 1984) or Sharpless epoxidation with subsequent ring
opening, Figure 2.2 (Ko et al., 1990; Katsuki et al., 1982). The desired labeling pattern
can be obtained if the protected D-glyceraldehyde is prepared perdeuterated, since the 3, 4,
and 5 carbons of ribose will arise from D-glyceraldehyde. Unfortunately, common
methods of synthesizing 2,3-O-isopropylidene-D-glyceraldehyde, such as the periodate
oxidation of 1,2:5,6-di-O-isopropylidene-D-mannitol (Jackson, 1988), do not
conveniently allow for deuteration, so a method for obtaining perdeuterated 2,3-0-
isopropylidene-D-glyceraldehyde (7) was needed.
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Figure 2.3 Retrosynthetic analysis of the synthesis of perdeuterated 2,3-0-
isopropylidene-D-glyceraldehyde (7) using D20, deuterated formaldehyde, lithium
aluminum deuteride, and acetylene as starting materials.
Initial attempts at preparing protected perdeuterated-D-glyceraldehyde (7) used
acetylene, deuterated paraformaldehyde, lithium aluminum deuteride, and D20 as starting
materials. The retrosynthetic strategy is outlined in Figure 2.3. Acetylene and deuterated
paraformaldehyde would be condensed to form 1,1-d2-propargyl alcohol, and then the
ethynyl proton of the alcohol would be exchanged with D20 under basic conditions to
produce perdeuterated propargyl alcohol (9) (McMichael, 1967; Baldwin & Black, 1983).
The perdeuterated propargyl alcohol would then be reduced with lithium aluminum
deuteride, and the resulting aluminum-allyl alcohol adduct would be hydrolyzed with D20
to form perdeuterated allyl alcohol (8). Perdeuterated allyl alcohol could then be
stereospecifically converted into a protected form of glycerol by Sharpless asymmetric
epoxidation and subsequent ring opening (Klunder et al., 1986; Ko et al., 1990), or
asymmetric dihydroxylation of the protected allyl alcohol (Sharpless et al., 1992). The
protected glycerol would then be oxidized by Swern oxidation to form protected
perdeuterated D-glyceraldehyde (7). The lithium aluminum hydride reduction of propargyl
alcohol occurs with regioselectivity (Baldwin & Black, 1983), which allows the synthesis
of virtually any deuteration pattern of D-glyceraldehyde by using this synthetic strategy
with different combinations of deuterated and protonated starting materials. After much
experimentation it was determined that this approach would require at least 7-10 synthetic
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steps with some of the steps suffering from very low yield, making this strategy an
impractical starting point for the synthesis of RNA.
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Figure 2.4: Two step racemic synthesis of the cyclohexyl ketal of perdeuterated
D,L-glyceraldehyde (12) from deuterated glycerol (10). a) cyclohexanone, (MeO)3CH,
H+ b) oxalyl chloride, DMSO, Et3N.
A more practical two step synthesis of protected perdeuterated D,L-glyceraldehyde
(12) was developed that utilized commercially available deuterated glycerol (10) as a
starting material, Figure 2.4. First deuterated glycerol (10) was protected as the
cyclohexyl ketal (11), then Swern oxidation was used to oxidize the unprotected alcohol to
form deuterated D,L-glyceraldehyde (12). The synthesis is racemic, but since the ultimate
product of the chemical synthesis, D,L-ribose, can be subsequently resolved by the
enzymes used to convert D-ribose into NTPs, the disadvantage of a racemic synthesis was
offset by the high total yield of D-glyceraldehyde and ease of preparation. The cyclohexyl
ketal of perdeuterated D,L-glyceraldehyde (12) was unstable to silica gel purification so the
unpurified product of the Swern oxidation was submitted directly to Wittig reactions.
Synthesis of D.L-3',4',5',5"-d4-ribose (±1)
The synthesis of D,L-d4-ribose (+1) from glycerol (U-d8) (10) is shown in Figure
2.5. Glycerol (U-d8) (10) is converted into a protected form of D,L-glyceraldehyde (12)
as described above, and then coupled to the Wittig reagent
(carbethoxymethylene)triphenylphosphorane (Ph3P=CHCO 2Et). The Wittig reagent
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Figure 2.5 Synthesis of D,L-3',4',5',5"-2H4-ribose (±1).
(a) cyclohexanone, (MeO) 3CH, H+ (b) oxalyl chloride, DMSO, Et3N
(c) Ph 3P=CHCO 2Et, MeOH (d) DIBAL-H, CH 2CI2 (e) BnBr, NaH,
(nBu) 4NI, THF (f) Os04, N-methyl morpholine N-oxide, acetone:H 20 (8:1)
(g) 2-methoxy propene, H+ (h) Pd on C, H2 (i) oxalyl chloride, DMSO,
Et3N (j) H+, THF, H20
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Ph3P=CHCO 2Et was used in this synthesis because it can be derived from ethyl
bromoacetate (Isler et al., 1957), which is commercially available in several 13 C labeled
forms offering the possibility of 13C labeling of the Cl and/or the C2. In this way the C3,
C4, and C5 carbons of ribose are derived from glycerol (U-d8), and the Cl and C2
carbons are derived from a Wittig reagent that can be 13C labeled if desired. Protection of
glycerol (U-d8) (10) is followed by Swern oxidation of ketal (11), resulting in D,L-
1,2,3,3'-d4-glyceraldehyde ketal (12). The triethylamine from the Swern oxidation was
carefully neutralized to prevent deuterium exchange by enolization that can occur under
basic protic conditions (Ko et al., 1990). The crude aldehyde was unstable to silica gel
purification, and was directly submitted to a Wittig reaction with Ph3P=CHCO2Et in
methanol at 0" C, which preferentially forms the Z olefin (Katsuki et al., 1982), to produce
(13) in a 76% yield. Reduction of the ester with DIBAL-H, and protection of the resulting
alcohol (14) afforded the benzyl ether (15). Facial diastereoselectivity in the osmium
tetroxide cis dihydroxylation of the Z olefin (Cha et al., 1984) resulted in the desired
protected ribitol (±16) and protected lyxitol diastereomers in a 7:3 ratio. After
chromatographic separation of the diastereomers, protection of the cis diol, and removal of
the benzyl ether, Swern oxidation of (±18) gave the protected ribose (±19). Again, the
triethylamine was carefully neutralized by an aqueous workup, to prevent epimerization
under basic conditions (Ko et al., 1990). The aldehyde (±19) was unstable to silica gel
purification, and hydrolysis of the crude aldehyde (±19) afforded crude D,L-d4-ribose
(+1). The yield of ribose was quantified by enzymatic assay of the crude racemic ribose
mixture. The overall yield of the 10 step synthesis was 12% D-d4-ribose (-1), (24% +1),
as calculated from the starting material glycerol (U-d8) (10). The crude D,L-d4-ribose
(±1) prepared in this manner was suitable for direct use in the subsequent enzymatic
reactions.
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Enzymatic Synthesis
AMP - ATP
D-Ribose - PRPP GMP - GTTPI
UMP - UTP o CTP
Figure 2.6 Strategy for the enzymatic synthesis.
The strategy used for the enzymatic conversion of D-ribose into the 4 NTPs of
RNA synthesis is outlined in Figure 2.6. Phosphoribosyltransferases were utilized for
coupling of 5-phospho-D-ribosyl o -1-pyrophosphate (PRPP) with nitrogenous bases to
form nucleoside monophosphates. Reactions catalyzed by phosphoribosyltransferases can
be easily linked to enzymatic PRPP synthesis and NTP formation, allowing conversion of
ribose into a nucleoside triphosphate in a single coupled enzymatic reaction as has been
shown previously by Schramm (Parkin et al., 1984). Preparative scale enzymatic reactions
for PRPP synthesis from ribose (Gross et al., 1983), and NTP formation from NMPs
(Simon et al., 1989) have been described previously. Enzymatic procedures for converting
ribose into AMP and UMP have been reported, offering enzymatic routes to ATP (Parkin et
al., 1984) and UTP (Gross et al., 1983). We have developed enzymatic reactions that
produce GTP from ribose and CTP from UTP, to complete the set of 4 NTPs required for
RNA synthesis. By combining these methods we were able to form d4-NTPs (2-5) from
D-d4-ribose (-1) in a minimum number of steps in high yield.
Seven of the enzymes necessary for the enzymatic conversions were commercially
unavailable or only available in costly or low specific activity forms. E. coli
overexpressing strains of ribokinase (RK), PRPP synthetase, orotate
phosphoribosyltransferase (OPRT), OMP decarboxylase, and CTP synthetase were
acquired by generous donation, and the enzymes adenine phosphoribosyltransferase
(APRT) and xanthine-guanine phosphoribosyltransferase (XGPRT) were cloned from the
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E. coli genome. Since partially purified enzymes were suitable for conducting the
nucleotide forming reactions, a great deal of effort was avoided by not purifying all seven
enzymes to homogeneity. The enzymes were purified using a general purification scheme
which readily afforded partially purified enzymes. The enzyme purification scheme used
requires at most one chromatographic step, and results in preparations that are free from
undesirable contaminating activities, such as nonspecific ATPases. Each enzyme
preparation from 1 L of bacterial culture yielded enough enzyme to catalyze several,
ranging from 7 to 180, reactions (0.5 mmole scale) depending on the enzyme.
PRPP synthesis.
The PRPP used in NTP formation was generated in situ from D-ribose in a manner
similar to that used by Gross et. al. (Gross et al., 1983) D-d4-ribose (-1) was first
phosphorylated by ribokinase to produce 3',4',5',5"-d4-ribose-5-phosphate (d4-R5P),
which was pyrophosphorylated by PRPP synthetase to form 3',4',5',5"-d4-PRPP (d4-
PRPP, 20), as shown in Figure 2.7. In all of the enzymatic reactions, the ATP consumed
was regenerated by a PEP/pyruvate kinase/myokinase system, where the
phosphoenolpyruvate (PEP) used to drive the reaction was generated in situ from an excess
of 3-phosphoglycerate (Simon et al., 1989; Hirschbein et al., 1982) (3PGA), also shown
in Figure 2.7. Reactions containing PRPP synthetase were carried out in potassium
phosphate buffer to prevent the inactivation of PRPP synthetase that occurs at low
phosphate concentration (Gross et al., 1983). One difficulty encountered in PRPP
synthesis was the inhibition of PRPP synthetase by ADP in the presence of ribose-5-
phosphate, resulting in extremely slow nucleotide formation in our reactions due to a
buildup of ADP and ribose-5-phosphate (Switzer & Gibson, 1978). The buildup of ADP
was prevented by reducing the amount of myokinase and increasing the amount of pyruvate
kinase added to the reactions, to insure that the rate of ADP formation from AMP was
much less than the rate of ATP formation from ADP and PEP.
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Figure 2.7 Enzymatic synthesis of labeled PRPP from labeled D-ribose. Also shown is ATP
regeneration by PEP/PK/MK system driven by 3PGA. Enzymes are (a) ribokinase (b) PRPP
synthetase (c) myokinase (d) pyruvate kinase (e) enolase (f) 3-phosphoglycerate mutase.
PRPP synthesis was coupled directly to ATP, GTP and UTP formation shown in Figure 2.8 and
2.10.
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ATP synthesis.
3',4',5',5"-d4-ATP (d4-ATP, 2) was formed in a coupled enzymatic reaction from
D-ribose in a manner similar to that described by Schramm (Parkin et al., 1984). d4-PRPP
(20) was first generated in situ as described above, and the purine salvage enzyme adenine
phosphoribosyltransferase (APRT) was used to catalyze the condensation of d4-PRPP
(20) and adenine to form d4-AMP, shown in Figure 2.8. d4-ATP (2) was then formed in
the same reaction by the sequential action of myokinase and pyruvate kinase on d4-AMP.
A catalytic amount of unlabeled ATP was added to the d4-ATP forming reaction to initiate
the reaction. In all of the other reactions, d4-ATP was used as a cofactor to prevent
dilution of the isotopic labels. The initial rate of ATP formation was very slow, but the
reaction rate increases quickly as the concentration of ATP increases. d4-ATP (2) was
produced from (-1) in 78% isolated yield by this method.
GTP synthesis.
The synthesis of 3',4',5',5"-d4-GTP (d4-GTP, 3) was accomplished by utilizing
the E. coli purine salvage enzyme xanthine-guanine phosphoribosyltransferase (XGPRT).
First, d4-PRPP (20) was generated in situ, and then xanthine-guanine
phosphoribosyltransferase was used to couple d4-PRPP (20) and guanine to form d4-
GMP, as shown in Figure 2.8. Once d4-GMP had been formed, the sequential action of
guanylate kinase and pyruvate kinase in the same reaction produced d4-GTP (3). Although
guanine has a very low solubility in water, GMP formation occurs at an appreciable rate
when solid guanine is added to the reaction in a slurry. Figure 2.9a shows HPLC traces
during the course of a preparative GTP synthesis. Only a small guanine peak can be
detected in the HPLC traces, but 2 equivalents (per ribose) of solid guanine were present in
the reaction. During the course of the reaction, GMP formation can be observed at 9 and
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Figure 2.8 Enzymatic synthesis of purines ATP and GTP using purine salvage. Enzymes are(c) myokinase (d) pyruvate kinase (g) adenine phosphoribosyltransferase (h) xanthine-guanine
phosphoribosyltransferase (i) guanylate kinase.
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22 hours, and the conversion of GMP to GTP is seen in the final HPLC trace. d4-GTP (3)
was produced in 75% yield from D-d4-ribose (-1) by this method.
UTP synthesis.
3',4',5',5"-d4-UTP (d4-UTP, 4) was synthesized from D-d4-ribose (-1) using
two pyrimidine biosynthetic enzymes, orotate phosphoribosyltransferase and orotidine 5'-
monophosphate decarboxylase (OMP decarboxylase), which catalyze the formation of
UMP from PRPP and orotate. Gross et. al. (Gross et al., 1983) have used these two
enzymes to form UMP from PRPP and orotate, and we have extended this method to
produce UTP from D-ribose and orotate. As in the d4-ATP (2) and d4-GTP (3) forming
reactions, d4-PRPP (20) was first generated in situ, and then orotate
phosphoribosyltransferase was used to catalyze the condensation of orotate and PRPP to
form d4-OMP, which was then decarboxylated by OMP decarboxylase forming d4-UMP,
shown in Figure 2.10. The sequential action of nucleoside monophosphate kinase and
pyruvate kinase then produced d4-UTP (4) in 90% isolated yield from (-1).
CTP synthesis.
3',4',5',5"-d4-CTP (d4-CTP, 5) was synthesized from d4-UTP (4) by ATP
dependent amination of UTP with glutamine or ammonia using the E. coli pyrimidine
biosynthetic enzyme CTP synthetase, as shown in Figure 2.10. CTP synthetase proved to
be a difficult enzyme to work with since the activity of the enzyme is regulated by the
concentration of substrates and products in solution (Long & Pardee, 1967; Anderson,
1983). The substrates ATP and UTP are activators for CTP synthetase, and the product
CTP can act as an inhibitor. Using conditions similar to those used for synthesis of the
other nucleotides, no CTP production was observed with CTP synthetase. After trying
several different reaction conditions, it was found that by diluting UTP concentration from
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approximately 5.5 mM to 1 mM and increasing the ATP concentration from 0.17 mM to
0.22 mM, it was possible to convert UTP into CTP. Under these conditions CTP
concentration is low enough to prevent feedback inhibition, and the ATP concentration is
high enough to keep the enzyme active at low UTP concentrations. Because of the
problems encountered with CTP synthetase, CTP was produced from UTP rather than the
large coupled enzymatic reactions where ATP, GTP, and UTP were produced directly from
ribose. In addition, a small amount of GTP was added as a positive affector of glutamine
dependent amine transfer (Long & Pardee, 1967). The conversion of UTP into CTP
catalyzed by CTP synthetase was monitored by HPLC as shown in Figure 2.9b. The
amount of ATP relative to the other nucleotides is much greater in the CTP forming reaction
than in the GTP forming reaction, (Figure 2.9a) and additional ATP was added after 3.5
hours in order to increase the rate of the reaction. During the course of the conversion of
UTP into CTP, a number of NDP species become visible, but these are eventually
converted to NTPs in the final HPLC trace. After careful optimizing, this deceptively
simple single enzyme reaction coupled with ATP regeneration produced d4-CTP (5) in
87% yield from d4-UTP (4).
Conclusion:
The chemical synthesis of D,L-d4-ribose (±1) described in this chapter uses
perdeuterated glycerol as a starting material and produces (+1) in 24% overall yield. Three
multi-enzyme reactions are discussed that mimic purine salvage and pyrimidine biosynthetic
pathways to convert D-d4-ribose (-1) into d4-ATP (2), d4-GTP (3), and d4-UTP (4) in
78%, 75%, and 90% yields respectively. Another enzymatic reaction was used to convert
d4-UTP (4) into d4-CTP (5) in 87% yield. These enzymatic reactions represent an
efficient method for incorporating isotopically labeled ribose or bases into the four NTPs
required for RNA transcription. The chemical and enzymatic synthesis that is described in
this chapter was used to synthesize d4-NTPs (2-5) in quantities sufficient to produce at
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least 2 RNA NMR samples. In Figure 2.11, the 1H NMR spectra of unlabeled UTP is
compared to d4-UTP. The aromatic and anomeric regions of both NMR spectra are
similar, but the ribose region of the d4-UTP is much less crowded due to the removal of
the H3', H4', H5' and H5" protons. Only the H2' ribose proton remains, and it is a
doublet due to the removal of coupling to the H3' proton by deuteration. The conversion
of the d4-NTPs (2-5) into D4-TAR RNA and the evaluation of the NMR spectroscopic
properties of the D4-RNA labeling pattern is described in Chapter 4.
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3. Other Methods for Specific Isotopic Labeling of RNA
The successful synthesis of the D4-RNA labeling pattern paved the way for other
specific isotopic labeling patterns of RNA to be synthesized. By purifying the enzymes
and developing the enzymatic methods necessary for coupling ribose to bases to make the
four NTPs of RNA, most of the work for converting ribose and bases into NTPs had
already been accomplished. Isotopically labeled ribose or bases could be derived from a
variety of sources and coupled enzymatically to form NTPs. In addition, any isotopically
labeled form of UTP that was synthesized could be converted into CTP in a single
enzymatic reaction. This would allow several isotopic labeling patterns to be synthesized
which would have been difficult to produce before the enzymatic synthesis had been
worked out, and there were several reasons to develop labeling patterns other than the D4-
RNA labeling pattern.
While the D4-RNA labeling pattern was successful in reducing spectral crowding
and altering relaxation properties of the remaining protons in the RNA (see Chapter 4)
(Tolbert & Williamson, 1996) it would not solve all of the problems of studying large RNA
molecules with NMR. There are certain areas of RNA NOESY spectra where the D4-RNA
labeling pattern does not reduce spectral crowding. One area in particular, the H1', H5 to
base NOE region, is very important in RNA sequential assignment and it was desirable to
reduce spectral crowding in this area of an RNA NOESY spectra. In addition, even though
the D4-RNA labeling pattern greatly reduces spectral crowding by removing all but the H2'
proton in the 4-5 ppm region of RNA proton spectra, it was conceivable that RNA
molecules would be studied that were so large that the sheer number of H2's in the
molecule would cause severe spectral crowding in the 4-5 ppm region. For these reasons it
was desirable to synthesize new specific deuterium labeling patterns of RNA which would
simplify RNA NMR spectra even further than the D4-RNA labeling pattern.
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It was also desirable to develop techniques for incorporating 13 C and 15N labels
into RNA. Shortly after the synthesis of the D4-RNA labeling pattern had begun, general
methods for uniform incorporation of 13C and/or 15N labeling into RNA were published
(Nikonowicz et al., 1992; Batey et al., 1992). These methods became widely used, and
several heteronuclear multidimensional NMR techniques were developed that have had
great impact on RNA structural studies (Pardi, 1995; Dieckmann & Feigon, 1994; Hall,
1995; Varani et al., 1996). In the field of protein NMR spectroscopy, which has usually
been one or two steps ahead of RNA NMR spectroscopy, researchers have combined 13C
and 15N labeling of proteins with random fractional deuteration to help reduce the
relaxation problems that were being encountered in the NMR spectroscopy of heteronuclear
labeled proteins larger than 25 kDa. The combination of random fractional deuteration with
heteronuclear labeling has made the study of proteins as large as 40-60 kDa possible with
NMR spectroscopy (Grzesiek et al., 1993; Markus et al., 1994; Yamazaki et al., 1994a;
Farmer & Venters, 1995; Muhandiram et al., 1995; Nietlispach et al., 1996; Matsuo et al.,
1996; Shan et al., 1996). Due to the success of this approach in proteins, methods for
incorporating uniform 13C and 15N labeling in combination with random fractional
deuteration of RNA have been developed, but the impact that these methods have on RNA
NMR spectroscopy has yet to be fully assessed (Batey et al., 1996; Nikonowicz et al.,
1997). More recently in protein NMR spectroscopy, there have been several methods
reported which allow selective incorporation of protons into perdeuterated, 13C/ 15N labeled
proteins, such as the methyl groups of aliphatic side chains (Rosen et al., 1996) or the Ca
protons (Yamazaki et al., 1997). These methods allow NMR spectroscopist to benefit
from gains in 13C relaxation due to high levels of deuteration while still having protons
within the molecule to transfer magnetization to and from. Taking the advances of RNA
and protein heteronuclear NMR spectroscopy into consideration lead to the conclusion that
incorporation of 13C and 15N labels in combination with specific deuterium labeling would
be useful in reducing the problems encountered in large RNA NMR spectroscopy.
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Isotopic labeling of the ribose moieties of RNA with glucose
We wanted to develop a general approach to specific isotopic labeling of RNA
where several isotopic labeling patterns, both 2 H and 13C, could be incorporated into the
ribose moieties of RNA with a minimum amount of effort from a starting material that was
affordable and commercially available in several isotopically labeled forms. The chemical
synthesis of the d4-ribose (-1) described in Chapter 2 could produce ribose with certain
types of deuterium and 13C labels, but the flexibility of the synthesis was limited, the
amount of work necessary to produce the ribose was large, and the cost of the starting
materials in 13 C labeled forms was too expensive to be practical. To overcome this we
searched for a method for converting a commercially available starting material that is both
inexpensive and available in several isotopically labeled forms into NTPs in a minimum
amount of effort. The strategy we found was one where the pentose phosphate pathway is
used to convert glucose into 5-phospho-D-ribosyl ao-1-pyrophosphate (PRPP), and then
the PRPP is converted to the four NTPs of RNA using phosphoribosyltransferases as
described in Chapter 2, Figure 3.1 (Tolbert & Williamson, in press). This type of strategy
has been used very successfully by Schramm to produce several isotopically labeled forms
of AMP and NAD + including 1'-2H1-5'- 3H1-AMP, 5'-14C1-AMP, and HN1'- 3H1-NAD +
(Parkin et al., 1984; Parkin & Schramm, 1987; Rising & Schramm, 1994), and it has also
been used to incorporate 13C labeled glucose into UTP (Gilles et al., 1995).
O2  AMP ATP
Glucose R5P - PRPP GMP - I-GTP
UMP -O-UTP CTP
Figure 3.1 Synthetic strategy for incorporating glucose into NTPs. Glucose is
converted into ribose-5-phosphate (R5P) by enzymes of the pentose phosphate pathway,
and then procedures described in Chapter 2 are be used to convert R5P into ATP, GTP,
UTP, and CTP.
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Glucose is an attractive starting material for incorporation of isotopic labels into the
ribose moieties of RNA for NMR studies because it is commercially available in a variety
of 13C and/or deuterium labeled forms, including uniformly deuterated, uniformly 13C
labeled, and uniformly 13C and 2H labeled. In addition, it has been shown that glucose-6-
phosphate isomerase, 6-phosphogluconic dehydrogenase, and ribose-5-phosphate
isomerase can be used to exchange the protons on glucose destined to become the H 1' and
H2' protons on nucleotides (Lienhard & Rose, 1964; Parkin & Schramm, 1987; Rising &
Schramm, 1994). By combining the wide range of commercially available isotopically
labeled glucose with the ability of exchanging hydrogen or deuterium into the 1' or 2'
position of nucleotides, many isotopic labeling patterns that will be useful for RNA NMR
studies can be created. To demonstrate the flexibility and utility of these methods we
synthesized several isotopic labeling patterns of nucleotides.
Enzymatic Synthesis.
The strategy for the enzymatic synthesis of isotopically labeled RNA from glucose
utilizes enzymes of the pentose phosphate pathway to convert glucose into PRPP and also
to exchange the H1' and H2' protons with solvent, Figure 3.2 (Parkin et al., 1984; Parkin
& Schramm, 1987; Rising & Schramm, 1994; Gilles et al., 1995; Lienhard & Rose,
1964). Once PRPP has been formed from glucose it can be converted enzymatically into
the four nucleoside triphosphates required for RNA by the methods described in Chapter 2.
The enzymes of the pentose phosphate pathway required to convert glucose into PRPP are
all commercially available. These enzymes are phosphoglycerate mutase, enolase,
pyruvate kinase, glutamic dehydrogenase, hexokinase, glucose-6-phosphate
dehydrogenase, 6-phosphogluconate dehydrogenase, phosphoribose isomerase, PRPP
synthetase, and glucose-6-phosphate isomerase. Of the remaining enzymes required to
convert PRPP into the four NTPs, only adenine phosphoribosyltransferase (APRT),
xanthine-guanine phosphoribosyltransferase (XGPRT), CTP synthetase, and uracil
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phosphoribosyltransferase (UPRT) are not commercially available in high activity forms.
The purifications of the first three enzymes are described in Chapter 2 and the detailed
experimental is in Chapter 6. The final enzyme, uracil phosphoribosyltransferase
(Andersen et al., 1992; Rasmussen et al., 1986) was cloned and purified to allow uracil to
be used to form the pyrimidine nucleotides rather than orotic acid as was described in
Chapter 2. This was done first, because heteronuclear labeled forms of uracil are available
in a wider variety and are less expensive than heteronuclear labeled forms of orotic acid,
and secondly, it was desirable to conduct some of the glucose nucleotide forming reactions
in D20 without the deuteration of the H6 of the pyrimidines which occurs when orotic acid
is converted into UMP in D20 (described in greater detail in the base deuteration section of
this chapter).
To reduce the number of steps required to produce labeled RNA from glucose, we
attempted to produce all four nucleotides from glucose in one reaction, rather than
synthesize each nucleotide separately as we did in Chapter 2. Since all four nucleotides are
mixed together during transcription reactions, simultaneous synthesis of the nucleotides
together would reduce the number of reactions and purifications necessary to produce
uniformly labeled RNA. Unfortunately, CTP synthetase, which is required to convert UTP
into CTP, is inhibited by some component or combination of components in the
multienzyme reactions that form NTPs from glucose (Long & Pardee, 1967; Anderson,
1983), so it was not possible to produce CTP from glucose directly. Instead, it was
necessary to convert glucose into ATP, GTP, and UTP in a single coupled enzymatic
reaction, then half of that purified reaction mixture could be used to convert UTP into CTP
in a separate reaction. In this way, all four NTPs can be produced from glucose in only
two reactions.
Enzymatic conversion of glucose into nucleoside triphosphates requires 5
phosphate equivalents, supplied by ATP and PEP, and 2 oxidizing equivalents, supplied
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by NADP+. To prevent dilution of the isotopic label, and also to keep the cost of the
reactions down, the cofactors ATP and NADP+ were added in catalytic amounts and
regenerated during the nucleotide forming reactions. The ATP that was consumed during
the enzymatic reactions was regenerated by a PEP/pyruvate kinase/myokinase system
where the PEP used to drive the reaction was generated in situ from an excess of 3-
phosphoglycerate (Hirschbein et al., 1982; Simon et al., 1989). The NADP+ required for
oxidation of glucose 6-phosphate and 6-phosphogluconate was regenerated by reductive
amination of x-ketoglutarate with NADPH and ammonia catalyzed by glutamic
dehydrogenase (Rising & Schramm, 1994).
Enzyme catalyzed hydrogen exchange. The HI' proton of NTPs can be exchanged
with solvent during enzymatic synthesis by using glucose-6-phosphate (G6P) isomerase,
as shown in Figure 3.2 (Parkin & Schramm, 1987). G6P isomerase catalyzes the
isomerization of a Cl aldose (G6P) into a C2 ketose fructose-6-phosphate (F6P) through
an enediolate intermediate (Figure 3.3a). The mechanism of the isomerization involves a
protein base abstracting a C2 proton and then replacing it on the Cl for the conversion of
the aldose into the ketose. While the abstracted proton resides on the protein there is the
possibility of exchange with solvent, and if the isomerization is carried out for a long
enough time, complete exchange of the proton can be achieved. By exchanging the proton
on the C2 of G6P, the proton that will become the H1' of NTPs is exchanged with solvent.
This is due to the pentose phosphate pathway oxidatively removing the Cl of glucose,
making what was the C2 of glucose into the Cl of ribose-5-phosphate (Figure 3.2). The
H 1' exchange can be accomplished by phosphorylation of glucose with hexokinase in the
presence of G6P isomerase, allowing sufficient time to pass before beginning the
conversion of glucose-6-phosphate into NTPs. In addition, elevating the temperature of
the reaction to 340 C facilitates complete exchange with solvent. Approximately 60% H1'
exchange with solvent was observed in the reaction that was used to produce nucleotides
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32-34 when the exchange reaction was carried out at room temperature for 2 days. In
contrast, 100% exchange of the HI' was observed in the 3',4',5',5'- 2H4-UTP (4)
forming reaction when it was heated to 340 C for 20 hours while exchanging the H ' for
approximately 2 days.
Exchange of the proton destined become the H2' proton of NTPs with solvent is
unavoidable when using the pentose phosphate pathway to convert glucose into NTPs.
This is due to 6-phosphogluconate dehydrogenase removing the only proton on the C3 of
6-phosphogluconate during the oxidation of the 3 hydroxyl group by NADP+ (Figure
3.3b). During the decarboxylation of the resulting f3-keto-carboxylic acid, a solvent proton
is stereospecifically placed on the Cl of Ru5P (Lienhard & Rose, 1964). This former
solvent proton is stereospecifically removed from the Cl of Ru5P by ribose-5-phosphate
isomerase and replaced onto the C2 to produce R5P (reverse of the general reaction in
Figure 3.3a). This results in the H2 of R5P being equilibrated with solvent as a side effect
of the enzymatic conversion of 6-phosphogluconate to R5P. Because of this, the solvent
that the oxidation and isomerization are conducted in must be the same hydrogen or
deuterium composition that the H2' is to be labeled with. When 1H labeling of the H2' is
desired the reactions simply need be conducted in H20, but when deuterium labeling is
desired, the chemicals and enzymes must be exchanged with D20 and the reactions must be
conducted in D20 to achieve a high level of deuteration.
Different isotopic labeling patterns from glucose.
The use of glucose as a starting material for isotopic labeling of RNA allows several
different isotopic labeling patterns to be created from glucose with only slight variations in
the same general reaction conditions. By simply changing the type of isotopically labeled
glucose that is used as a starting material, whether glucose-6-phosphate isomerase is added
to the reaction, and whether the reaction is conducted in D20 or H20, many different
Chapter 3
labeling patterns can be derived, Figure 3.4. We have used this general strategy to produce
three new isotopic labeling patterns, as well as a more efficient synthesis of the
3',4',5',5"-d4-labeling pattern which was produced from chemical synthesis in Chapter 2.
The synthesis of 1',2',3',4',5',5'- 2H6[-ATP (24), -GTP (25), and -UTP(26)]
(d6-NTPs) was achieved in a single reaction beginning with 1,2,3,4,5,6,6- 2H7-D-glucose
(21). No glucose-6-phosphate isomerase was added to this reaction since no exchange of
the H1' of the NTPs was desired. The reaction was conducted in D20, and the enzymes
and chemicals used in the reaction were exchanged into D20 to insure a high level of
deuteration at the H2' of NTPs. In this reaction 84% of the starting 2H7-glucose was
converted into d6-ATP (24), d6-GTP (25), and d6-UTP (26). d6-CTP (27) was
prepared from d6-UTP (26) in a separate reaction catalyzed by CTP synthetase.
The synthesis of 3',4',5',5'- 2H4-UTP (4) (d4-UTP) from 1,2,3,4,5,6,6- 2H7-D-
glucose (21) was carried out in H20 so that the protons that would become the HI' and
H2' of ribose were exchanged with solvent by the action of glucose-6-phosphate
isomerase, 6-phosphogluconic dehydrogenase, and ribose-5-phosphate isomerase. First
glucose was phosphorylated by hexokinase, and once glucose-6-phosphate had been
formed, the reaction was heated to 340 C in the presence of glucose-6-phosphate isomerase
to speed the exchange of the H2 of glucose-6-phosphate. Then the reaction was cooled and
the remaining enzymes and chemicals required for UTP formation were added. This
reaction converted 67% of the starting 2H7-glucose into d4-UTP (4).
The synthesis of l',2',3',4',5'-13C5 [-ATP (28), -GTP (29), and -UTP (30)]
(13C5-ribose-NTPs) was effected in a single reaction from 1,2,3,4,5,6- 13C6-D-glucose
(22). No glucose-6-phosphate isomerase was added to this reaction since no exchange of
the H1' of the NTPs was desired. The reaction was conducted in H20 since the desired
labeling of the H2' of the NTPs was hydrogen. This reaction converted 88% of the
starting 13C6-glucose into 13C5-ribose[-ATP (28), -GTP (29), and -UTP (30)]. 13C5-
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Figure 3.4 Different isotopically labeled NTPs synthesized from
1,2,3,4,5,6,6-drglucose (21), 1,2,3,4,5,6-13C6-glucose (22), and
1,2,3,4,5,6,6-dr-1,2,3,4,5,6- 13C6-glucose (23) in this thesis.
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ribose-CTP (31) was prepared from 13C5-ribose-UTP (30) in a separate reaction catalyzed
by CTP synthetase.
The synthesis of 3',4',5',5'- 2H4-1',2',3',4',5'- 13C5[-ATP (32), -GTP (33), and
-UTP (34)]* (d4-13C5-ribose-NTPs) was achieved from 1,2,3,4,5,6,6- 2H7-1,2,3,4,5,6-
13C6-D-glucose (23) in H20 so that the protons that become the H1' and H2' of ribose are
exchanged with solvent by the action of glucose-6-phosphate isomerase, 6-
phosphogluconic dehydrogenase, and ribose-5-phosphate isomerase. This reaction was
conducted in a manner similar to the reaction that produced d4-UTP (4), except that it was
not heated above room temperature during the glucose-6-phosphate isomerase step,
resulting in only approximately 60% exchange of the HI' position with H20. The
glucose-6-phosphate exchange was carried out at room temperature for 2 days, then the
remaining enzymes and chemicals required for ATP, GTP, and UTP formation were added
to the reaction. In this reaction, 92% of the starting 2H7- 13C6-glucose was converted into
d4-13 C5-ribose[-ATP (32), -GTP (33), and -UTP (34)]. d4-13 C5-ribose-CTP (35) was
produced in a separate reaction from d4-13 C5-ribose-UTP (34) with CTP synthetase.
* [The 3',4',5',5'- 2 H4 -1',2',3',4',5'- 13 C5 -NTPs prepared in this thesis are
present as a 3:2 mixture of 3',4',5',5'-2 H4 -1',2',3',4',5'- 13 C5 -NTPs and 1',3',4',5',5'-
2 H5 -1',2',3',4',5'- 13 C5 -NTPs due to partial deuteration of the Hi'. The entire mixture is
characterized in the experimental, but since the 3',4',5',5'- 2 H4 -1',2',3',4',5'- 13 C5 -NTPs
give rise to the NMR spectra of interest, this mixture is referred to as d4 -13 C5 -NTPs.]
The strategy described here for labeling RNA with glucose is very efficient and
flexible. This method requires only two reactions to convert glucose into all four NTPs
required for RNA synthesis, with yields ranging from 67-92% conversion. The amount of
labeled glucose required to make nucleotides is low when compared to other methods of
isotopically labeling nucleotides with glucose. For instance, it has been reported that
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harvesting nucleoside monophosphates from E. coli grown on isotopically labeled glucose
medium results in 58 milligrams of NMPs per gram of glucose added (Batey et al., 1995).
In contrast, using these enzymatic methods over a gram of isotopically labeled NMPs can
be prepared from one gram of glucose. Granted the isotopically labeled NMPs prepared by
the enzymatic synthesis will only be labeled in the ribose moieties, but this difference in
yield emphasizes the gains that can be obtained when isotopically labeled starting material is
directly converted into molecules of interest rather than relying on cellular biosynthesis to
make them as a byproduct of metabolism. By combining enzymatic conversion of labeled
glucose into NTPs with enzyme catalyzed hydrogen or deuterium exchange, many RNA
isotopic labeling patterns that will be useful in NMR structural studies can be produced
with a minimum amount of effort. Several specifically deuterated forms of RNA can be
produced by exchanging either hydrogen or deuterium into the H 1' or H2' positions, and
the same specifically deuterated forms of RNA can be made with 13C labeling by simply
starting with the 13C labeled forms of glucose.
Incorporation of isotopic labels into the bases of RNA
Thus far the discussion of specific isotopic labeling of RNA has focused on the
ribose moieties of nucleotides. Isotopic labeling need not be restricted to ribose moieties,
however, and here the isotopic labeling of the base moieties of nucleotides is discussed.
The enzymatic synthesis developed for incorporating isotopically labeled ribose moieties
into RNA in Chapter 2 and earlier in this chapter can also be utilized to incorporate
isotopically labeled bases into RNA. This can be done by simply adding the isotopically
labeled bases to enzymatic nucleotide forming reactions since no protection of the bases is
necessary unlike chemical methods of base coupling. In addition, the use of enzymatic
synthesis to phosphorylate NMPs to form NTPs and also to convert UTP into CTP has
advantages in labeling base moieties. Nucleoside monophosphates can be subjected to
harsh chemical conditions which would dephosphorylate NTPs, and then the NMPs can
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be enzymatically phosphorylated in a single reaction to NTPs. In this way the analysis of
labeling reactions is not complicated by mixtures of different phosphorylated forms of the
nucleotides. Also, the more chemically stable uracil can be labeled under conditions which
would hydrolyze cytidine, and then that uracil can be converted enzymatically into
cytidine. In this way both UTP and CTP can be labeled from a common precursor such as
UMP or OMP.
Base Deuteration
NOEs from ribose to the non-exchangeable base protons of RNA are the basis of
sequential NOESY "walk" assignments of RNA NMR spectra (see Chapter 1). Because an
NOE requires two protons, one from which magnetization arises and one to which
magnetization is transferred and detected on, NOESY spectra can be simplified by
specifically removing one of the two protons within an interaction. Synthetic methods have
been discussed in Chapter 2 and earlier in this chapter which deal with simplifying NMR
spectra by deuterating ribose protons. Here synthetic methods are discussed for
deuterating the other half of the ribose to base NOEs that are important for sequential
assignment, the base protons.
H5 deuteration
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Figure 3.5 Treatment of UMP with Ammonium Sulfite in D20
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Treatment of UMP with ammonium bisulfite in D20 at pH 8.5 and 550 C will result
in the exchange of the H5 of uracil with D20 by the mechanism shown in Figure 3.5 going
through a sulfite adduct to the uracil (Wataya & Hayatsu, 1972). Adjusting the pH to 10
and allowing the reaction to cool to room temperature will cause conversion of all the sulfite
adduct back to uracil. This reaction has been used to deuterate the H5 of uracil for
simplification of NMR spectra of nucleic acids (Brush et al., 1988; Puglisi et al., 1990). A
similar reaction, hydroxyl catalyzed H5 exchange (Rabi & Fox, 1973; Glemarec et al.,
1996), has also been used to exchange the H5 of uracil with D20. Cytidine undergoes H5
exchange in both of these reactions, but the conditions under which the hydrogen exchange
occurs also causes deamination of the cytidine resulting in uridine. This makes it very
difficult to achieve high levels of deuteration of the H5 of CMP without converting the
CMP into UMP. To achieve high levels of deuteration of the H5 of cytidine nucleotides,
UMP or uridine has first been exchanged with sulfite or hydroxyl, and then chemically
converted into CMP or cytidine after the exchange reaction was completed (Glemarec et al.,
1996). We have taken a similar approach to deuteration of the H5 of pyrimidines except
that we have used the enzyme CTP synthetase to enzymatically convert 5-dl-UTP into 5-
dl-CTP.
5-D1-UMP 5-dl-UTP 5-dl-CTP
36 37 38
Figure 3.6 Enzymatic conversion of 5-dl-UMP (36) into 5-dl-UTP (37) and 5-
dl-CTP (38). a) nucleoside monophosphate kinase b) pyruvate kinase c) CTP
synthetase
In order to produce both 5-dl-UTP (37) and 5-dl-CTP (38), UMP was first
exchanged with sulfite, and then the sulfite was separated from the 5-dl-UMP (36) with
boronate chromatography at 40 C. Although boronate chromatography is conducted under
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aqueous basic conditions which could possibly lead to loss of the deuterium label of 5-dl-
UMP (36) before it is separated from the sulfite, no loss of the deuterium label was
detected by NMR. In two separate reactions the 5-dl-UMP (36) was enzymatically
phosphorylated into 5-dj-UTP (37), then half of the product from that reaction was used
to produce 5-dl-CTP (38) with CTP synthetase (Figure 3.6). The nucleotides produced in
this manner were used to produce isotopically labeled D5-pyrimidine RNA as described in
Chapter 4.
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Figure 3.7 Exchange of H6 of pyrimidines. a) Orotate
phosphoribosyltransferase b) OMP decarboxylase.
Exchange of the H6 of pyrimidines was accomplished enzymatically utilizing the
pyrimidine biosynthesis enzymes that convert orotic acid and PRPP into UMP, Figure 3.7.
Orotic acid is the biosynthetic precursor to uracil, and it is similar in structure to uracil
except that it has a carboxyl group attached to the C6. In pyrimidine biosynthesis orotate
phosphoribosyltransferase catalyzes the condensation of orotic acid and PRPP to form
OMP, and then OMP decarboxylase catalyzes the decarboxylation of OMP to form UMP.
The decarboxylation catalyzed by OMP decarboxylase occurs without any cofactors, and
the proton that is placed onto the uracil C6 arises from solvent. Decarboxylation of OMP in
D20 results in deuteration of the H6 of UMP. From the H6 deuterated UMP, both 6-dl-
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UTP and 6-dl-CTP can be produced enzymatically using phosphorylating enzymes and
CTP synthetase. l',2',3',4',5',5",6-d7-UTP (39) was produced from deuterated glucose
and orotic acid in a reaction conducted in D20, and NMR spectra of an RNA transcribed
with this nucleotide is discussed in Chapter 4.
H8 deuteration
NH2  NH2
0 8 N4  hrs. O NN
II N N H2  OII N N H2
-0-P-0 2 -0-P-0
I - D20 a
O O
OH OH OH OH
Figure 3.8 Exchange of the H8 of purines
The H8 of purines can be exchanged with D20 by simply heating the purines to 50'
C in D20 (Benevides et al., 1984; Brandes & Ehrenberg, 1986). The exchange of the H8
of AMP was accomplished by heating AMP to 500 C in D20 for 48 hours (Figure 3.8). 8-
dl-AMP was then enzymatically phosphorylated to produce 8-dl-ATP (40). While no
RNA was produced with this nucleotide, deuteration of the H8 of purines will have similar
effects on RNA NMR spectra as deuteration of the H6 of pyrimidines, except that no H5-
H6 crosspeaks will be removed. GMP undergoes a similar H8 exchange with solvent
when heated, so both purine H8s could be specifically deuterated. Removal of specific
ribose to purine H8 NOEs could be used to simplify the assignments of very large RNAs.
Incorporation of heteronuclear labeled bases into RNA
Heteronuclear labeling of the bases of RNA can be accomplished by adding
isotopically labeled bases to the enzymatic nucleotide forming reactions described in both
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Chapter 2 and this chapter. The use of phosphoribosyltransferases to couple bases to
PRPP offers a simple high yielding route to incorporate heteronuclear labeled adenine,
guanine, orotic acid, or uracil into NTPs and then ultimately RNA. Several chemical
methods for synthesizing heteronuclear labeled bases have been published, and some of
the heteronuclear labeled forms are even commercially available (SantaLucia et al., 1995).
In addition, the bacterial CTP synthetase used to convert UTP into CTP in our enzymatic
methods will accept ammonia as a substrate for the amination of UTP. This allows 15N
labeling of the 4 amino of CTP by adding 15N-ammonium sulfate to the CTP forming
reactions. Using enzymatic synthesis to couple bases to PRPP it will be possible to
produce several heteronuclear labeling patterns of the base moieties of RNA in high yield
and minimal effort. To demonstrate the incorporation of heteronuclear labeled bases into
nucleotides, 1,2,3,4,5,6- 13 C6-1,2,3,4,5,6,6'- 2 H7-D-glucose was coupled to 6-amino,9-
15 N2-8_ 13 C 1-adenine, 7,9 - 15 N2-8- 13 C 1-guanine, and 1,3- 15 N2-2,4,5,6-1 3 C4-uracil
in an enzymatic reaction conducted in H20 to produce the nucleotides 41, 42, and 43
(Figure 3.9).
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Figure 3.9 Examples of heteronuclear labeling of base moieties a) 6-amino,9-15 N2-
8,1 ',2',3',4',5'-13C6-1 ',3',4',5',5"- 2H5-ATP (41), 7,9-15N2-8,1 ',2',3',4',5'-13 6-1 ',3',4',5',5"-
2Hs-GTP (42), and 1,3- 15N2-2,4,5,6,1',2',3',4',5'-13C9-1',3',4',5',5"- 2Hs-UTP (43) b) The
N4 of CTP can be 15N labeled with (15NH4) 2SO4 with the enzyme CTP synthetase.
a.
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4. NMR of RNA with Specific Isotopic Labels
Chapters 2 and 3 describe the synthesis of nucleoside triphosphates with several
different specific isotopic labeling patterns. In this chapter those specifically labeled NTPs
are converted into RNA and NMR experiments are conducted on the resulting isotopically
labeled RNA to demonstrate the utility of the different isotopic labeling patterns. Specific
isotopic labeling can be used to increase the size of macromolecules which can be studied
with NMR spectroscopy by focusing on a subset of the total resonances within a
macromolecule. Proper design of specific isotopic labeling patterns will maximize the
amount of structural information in NMR spectra while reducing spectral crowding,
simplifying assignment, and producing narrower linewidths. Examples of these effects on
the NMR spectra of RNA are demonstrated with the isotopic labeling patterns of RNA
discussed in this chapter.
TAR RNA
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Figure 4.1 Secondary structure of the 30 nucleotide HIV-2 TAR RNA.
To test the different isotopic labeling patterns described in this chapter we used the
30 nucleotide HIV-2 TAR RNA, Figure 4.1. The TAR RNA has been well studied with
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NMR spectroscopy in our laboratory, having several proton and heteronuclear NMR
experiments conducted on it during the course of a high resolution structure determination
of its complex with argininamide (Brodsky & Williamson, 1997). Sequential assignments
of the NMR spectra of the RNA alone and in complex with argininamide have been made.
The TAR RNA has well behaved NMR characteristics yielding very good NMR spectra at
25" C. In addition, in T7 RNA polymerase catalyzed transcription reactions the TAR RNA
sequence yields fairly high amounts of RNA, requiring only 80-100 gmoles of each NTP
to produce a 550 gl 1.0-1.7 mmolar TAR RNA NMR sample, meaning that large amounts
of isotopically labeled NTPs do not have to be expended to produce TAR NMR samples.
The TAR RNA is a good RNA for evaluating how well a new isotopic labeling
pattern relieves spectral crowding because the NMR spectra of the unlabeled molecule have
already been assigned, so the reduction of spectral crowding or ease of assignment caused
by a new labeling pattern can be immediately compared to the difficulties encountered with
assigning the unlabeled RNA. Also, since the size of the TAR RNA molecule is not so
large as to make heteronuclear NMR experiments difficult due to relaxation problems, it is
a good RNA to develop new heteronuclear NMR experiments with. We have taken an
iterative approach to the testing of RNA isotopic labeling patterns where new labeling
patterns were tested in NMR experiments as TAR RNA, and then the results were used to
guide the design of other isotopic labeling patterns.
Transcription of RNA. The different isotopically labeled forms of TAR RNA
(5'GGC CAG AUU GAG CCU GGG AGC UCU CUG GCC3') were synthesized by in
vitro transcription (Milligan & Uhlenbeck, 1989) with T7 RNA polymerase using
unlabeled NTPs and the different isotopically labeled NTPs produced in Chapters 2 and 3
of this thesis. Transcription conditions were as described in Wyatt and Puglisi (Wyatt et
al., 1991), except that nucleotide concentrations were approximately 2 mM at the start of
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transcription reactions and the MgCl2 concentration was 35 mM. More detailed description
of transcription reactions can be found in Chapter 6.
Specific Deuteration of RNA.
Specific deuteration of RNA protons can dramatically reduce the spectral crowding
in RNA NMR spectra. Unlike random fractional deuteration, specific deuteration can be
used to simplify NMR spectra as well as alter relaxation rates. In the different TAR RNA
samples presented in this section, certain protons are removed from the NMR spectra to
simplify the interpretation of the remaining spectral information. Structural information is
retained in the spectra but the assignment is simplified due to the removal of several types
of resonances. In addition, the removal of specific protons and replacing them with
deuterium alters the dipolar interactions which give rise to relaxation of the remaining
protons, lengthening the lifetime of their detectable magnetization and thus producing
narrower linewidths.
NOESY spectra of the different deuterated forms of TAR RNA presented in this
section are used to demonstrate the reduction in spectral crowding and simplification of
assignment produced by specific deuteration. Figure 4.2 shows a 200 ms NOESY spectra
of unlabeled TAR RNA. At 30 nucleotides the NOESY spectra of the unlabeled TAR RNA
is fairly crowded, with assignment of the ribose regions of the spectra (regions A, B, and
C) being very difficult because of spectral overlap. All of the NOESY spectra of TAR
RNA within this section were collected with a 200 ms mixing time with the only
differences being due to the different deuteration patterns. The different TAR deuteration
patterns will be compared to Figure 4.2 to demonstrate the reduction of spectral crowding
achieved by deuteration.
H2', H3', H4', H5', H5"
8 7 6 5 4
PPM
Figure 4.2 200 ms NOESY spectra of unlabeled TAR RNA
H8, H6, H2 H1'. H5
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3',4',5',5"-D4-TAR RNA.
3',4',5',5"-d4-TAR RNA (D4-TAR RNA) was produced by T7 RNA polymerase
catalyzed transcription from 3',4',5',5"-d4-ATP (2), 3',4',5',5"-d4-GTP (3),
3',4',5',5"-d4-UTP (4), and 3',4',5',5"-d4-CTP (5), Figure 4.3a. The synthesis of 2-5
from perdeuterated glycerol is described in Chapter 2, and the detailed procedures for the
synthesis are in Chapter 6. The D4-TAR RNA labeling pattern reduces spectral crowding
in RNA NMR spectra by removing 4 of the 6 non-exchangeable ribose protons per
nucleotide while still retaining much of the structural information that can be obtained from
RNA NMR spectroscopy, Figure 4.3b. The remaining ribose protons, the H1' and H2',
yield much of the possible structural information available from RNA NMR spectroscopy
with J-coupling between the H1' and H2' yielding ribose sugar pucker, NOEs between the
H1' and base protons determining glycosidic torsion, and NOEs between base protons and
the HI' and H2' protons yielding sequential connectivity information.
The one dimensional (ID) 1H NMR spectra of both unlabeled and D4-TAR RNA in
D20 are shown in Figure 4.4. A great reduction of spectral crowding is evident in the 4-5
ppm region of the D4-RNA NMR spectra where there are only 30 H2' ribose protons
compared to the 150 ribose protons in the same region of the unlabeled RNA NMR spectra.
In a 2-dimensional NOESY spectra, this reduction in the number of ribose protons in the
4-5 ppm region represents itself as a decrease in spectral crowding in the ribose NOE
regions A, B, and C, Figure 4.5. The advantages of this deuteration pattern are
dramatically illustrated in a comparison of the base to ribose region of a NOESY spectrum
of TAR RNA acquired on unlabeled RNA and D4-RNA, shown in Figure 4.6a and 4.6b,
respectively. The base to H2' NOEs are unambiguously identified in Figure 4.6b, and the
spectral overlap in this region is greatly reduced. A similarly dramatic effect of the d4-
ribonucleotides is observed in the ribose region of the NOESY spectrum, shown in Figure
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Figure 4.3 a) 3',4',5',5"-d4-NTPs which were used to produce D4-TAR RNA
b) schematic of D4-RNA in A-form helical structure. NMR spectra of D4-RNA
are greatly simplified due to the deuteration of the H3', H4', H5', and H5" ribose
protons, but base pairing, sugar pucker, glycosidic torsion, and sequential
sequential connectivity information can still be obtained.
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4.7a and 4.7b. The HI' to H2' cross peaks can be unambiguously identified in Figure
4.7b. The diagonal for the region between 4-5 ppm is completely devoid of cross peaks,
except for one weak peak that results from an unusual H2'-H2' NOE from the loop region
of TAR. This peak was not previously identified in 3D- or 4D- 13C resolved NOESY
spectra using uniformly 13C-labeled TAR RNA, even though all of the ribose protons were
assigned (Brodsky & Williamson, 1997).
Relaxation times of D4-TAR vs. unlabeled TAR RNA
Although the cross peaks in the NOESY spectra of D4-RNA in Figures 4.6b and
4.7b appear marginally narrower than the unlabeled RNA in Figures 4.6a and 4.7a,
relaxation rates were determined to provide a more quantitative measure of the effects of
deuteration on dipolar relaxation. Nonselective T1 and T2 measurements were performed
on unlabeled TAR and D4-TAR RNAs, and the relaxation rates were determined for a
number of resolved peaks, summarized in Tables 1 and 2. The effective Tls and T2s for
the D4-RNA were increased by approximately a factor of two compared to unlabeled RNA.
These results are comparable to the effects of deuteration observed in proteins (Markus et
al., 1994) and DNA (Agback et al., 1994). Although for the 30 nucleotide TAR RNA
studied here, the deuteration does not qualitatively improve the NOESY spectrum by a
relaxation effect, a 50% reduction of relaxation efficiency could significantly improve the
spectra of RNAs that are much larger than 30 nucleotides.
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Table 1 <T1>a
TAR D4-TAR ratiob
H2'/(H3',H4',H5',H5")e 4.3±0.7 9.3±1.0 2.2±0.2
H1'/H5 5.6±0.7 10.3±1.3 1.8±0.1
H8/H2/H6 5.4±1.2 10.2±1.6 1.9±0.2
Table 2 <T2>c
TAR D4-TAR ratiod
H2'/(H3',H4',H5',H5 ")e  0.04±.01 0.12±0.02 2.6±0.3
H1'/H5 0.10±0.02 0.17±0.03 1.8±0.3
H8/H2/H6 0.09±0.03 0.17±0.06 2.0±0.3
a Average T1 relaxation time (s)
b Ratio of D4-TAR and TAR T1 relaxation times
c Average T2 relaxation time (s)
d Ratio of D4-TAR and TAR T2 relaxation times
e The global average of relaxation times were calculated for these protons in the unlabeled
sample due to spectral overlap in this region
Assignment of D4-RNA.
The assignment of the D4-TAR RNA NMR spectra is simplified compared to the
assignment of unlabeled RNA NMR spectra because of the reduction in spectral crowding
of the ribose regions of the NOESY spectra (regions A, B, and C of Figure 4.5). This
allows easier identification of the H2' interactions in those regions because the only types
of NOEs within those regions for the D4-RNA are H2' NOEs. The H2' ribose proton is
useful in sequential assignment since it usually has a very strong NOE to the base proton
that is 3' to it in A-form RNA (see list of distances between protons in A-form RNA
Chapter 1), Figure 4.3b. Unfortunately the identification of H2' to base NOEs in
unlabeled RNAs are complicated by the fact that within the spectral region that the H2'-base
NOEs occur there is a great deal of spectral crowding because of the overlap of the H2',
Chapter 4
H3', H4', H5' and H5" chemical shifts, region C in Figure 4.2. The D4-RNA labeling
pattern simplifies the assignment of H2' to base NOEs because the H2' to base NOEs are
the only type of NOE that occur within region C of NOESY spectra of D4-RNA, shown in
Figure 4.5.
Sequential assignment information obtained from H2' to base NOEs can be linked
to H1' to base NOE information by the intra-nucleotide H1'-H2' NOEs, thus building a
more complete picture of the identity of the different proton resonances. Figure 4.8
demonstrates the linking of H1'-base NOEs to H2'-base NOEs through H1'-H2'
crosspeaks for 4 out of the 6 uracil nucleotides within the TAR RNA. Figure 4.8a shows
the connectivity for unlabeled TAR RNA, and Figure 4.8b demonstrates the same
connectivity for the D4-TAR RNA. Notice that the spectral crowding in the H2' to base
NOE regions and the H1' to H2' NOE regions are greatly reduced in the D4-TAR RNA,
making the identification of the individual peaks and assignment a much easier task.
The NMR experiments presented here demonstrate the reduction of spectral
crowding, increased relaxation times, and simplified assignment of NMR spectra that can
be achieved with the D4-RNA isotopic labeling pattern. A great deal of structural
information is retained within NMR spectra of D4-RNA even though the NMR spectra are
largely simplified, with glycosidic torsion, sugar pucker and base pairing information still
obtainable from D4-RNA NMR spectra. Unlike heteronuclear labeling, which spreads
NMR structural information over an additional heteronuclear dimension with the
disadvantage of broader linewidths, specific deuteration simplifies RNA NMR spectra by
replacing certain protons with deuterium and results in narrower linewidths. This should
allow specific deuteration to be effective on larger RNA molecules than heteronuclear
labeling will be.
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D6-TAR RNA.
As mentioned in Chapter 3, the D4-RNA isotopic labeling pattern would solve
many of the problems of large RNA NMR spectroscopy, but it would not solve all of the
problems. It could be foreseen that there might be spectral crowding problems in large
RNA NMR spectroscopy that were so severe that the D4-RNA labeling pattern alone would
not be sufficient to allow NMR structural studies, and it was with these concerns in mind
that labeling patterns were produced that simplified RNA NMR spectra even further than
D4-RNA pattern. By converting deuterated glucose into nucleotides in an enzymatic
reaction conducted in D20, it was possible to produce nucleotides which had fully
deuterated ribose moieties and fully protonated non-exchangeable base protons.
Conversion of these nucleotides into RNA resulted in highly simplified NMR spectra.
1',2',3',4',5',5"-d6-TAR RNA (D6-TAR RNA) was produced by T7 RNA
polymerase catalyzed transcription from 1',2',3',4',5',5"-d6-ATP (24),
1 ',2',3',4',5,5"-d6-GTP (25), 1',2',3',4',5',5"-d6-UTP (26), and 1',2',3',4',5',5"-
d6-CTP (27), Figure 4.9a. The synthesis of 24-27 from deuterated glucose is described
in Chapter 3, and the detailed procedures for the synthesis are in Chapter 6.
The D6-TAR RNA labeling pattern resulted in extremely simplified RNA NMR
spectra as demonstrated by a NOESY spectra of D6-TAR RNA, Figure 4.10. Removal of
all of the ribose protons from the RNA leaves the remaining non-exchangeable base
protons relatively isolated (Figure 4.9c). This eliminates the majority of interactions which
give rise to NOESY peaks in RNA NMR spectra, because most of the strong NOEs in a
NOESY spectrum of RNA (Figure 4.2) arise from ribose-ribose and ribose-base NOEs.
The only strong NOEs remaining in the D6-RNA NOESY are the intra-base pyrimidine
H5-H6 crosspeaks (Figure 4.9b). While this type of labeling pattern does not yield very
much structural information about the RNA, it does offer the possibility of spectral
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simplification, either by using this labeling pattern in combination with another labeling
pattern, or when studying an RNA-protein complex.
TAR-465 RNA
The TAR RNA discussed in this section, TAR 465, was produced for two
reasons, it was synthesized to determine usefulness of mixing the D6-RNA labeling
pattern with other labeling patterns, and also to test the usefulness of specifically
deuterating the H6 proton of one of the pyrimidine nucleotides. The TAR 465 labeling
pattern was produced by T7 RNA polymerase catalyzed transcription using
1',2',3',4',5',5"-d6-ATP (24), 1',2',3',4',5',5"-d6-GTP (25), 1',2',3',4',5',5",6-d7-
UTP (39), and unlabeled CTP as starting materials, Figure 4.1 la. The synthesis of 24,
25, and 39 from deuterated glucose, adenine, guanine, and orotic acid using D20 is
described in Chapter 3, and detailed reaction procedures are described in Chapter 6. The
ribose portions of 24, 25, and 39 are derived from deuterated glucose and D20 and are
fully deuterated, and the H6 of uracil arises from D20 during the decarboxylation of
l',2',3',4',5',5"-d6-orotidine monophosphate.
Mixing the D6-RNA labeling pattern with unlabeled nucleotides
The extreme spectral simplification caused by D6-RNA labeling pattern even though
all of the base protons were still protonated suggested that mixing D6-RNA labeling with
other types of RNA labeling might be profitable. A large amount of the important inter-
nucleotide information that can be extracted from RNA NMR spectra consists of ribose to
base interactions rather than ribose to ribose interactions, since there are relatively few
inter-nucleotide ribose to ribose interactions. The TAR 465 RNA was synthesized with d6-
ATP, d6-GTP, d7-UTP, and unlabeled CTP, to produce RNA in which all of the ribose
to base interactions, except for uracil H6 NOEs, are present for the cytidine nucleotides,
but none of those interactions are present for the d6-labeled or d7-labeled nucleotides,
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Figure 4.11 a) Nucleotides used to produce the TAR 465 labeling pattern
b) Uracil's H5-H6 crosspeaks are removed from NOESY and COSY spectra
because of deuteration of the H6, but cytidine H5-H6 crosspeaks remain.
c) Inter-nucleotide and intra-nucleotide NOEs for C ribose protons are still
present in TAR 465, but deuteration of A, G, and U ribose protons removes
the corresponding A, G, and U NOEs. U-H6 NOEs are also removed by
deuteration.
Chapter 4
Figure 4.1 ic. The resulting spectral simplification is shown in Figure 4.12. All of the
NOEs falling in regions A, B, and C of the NOESY spectra of TAR 465 arise from C
ribose protons. The 30 nucleotide TAR RNA has 9 cytidines, so there are 21 less of each
type of ribose proton to worry about in regions A, B, and C of Figure 4.12. In region E
of the NOESY spectra, all of the H1' to base NOEs arise from cytidine HI's, and all of the
H5-H6 NOEs arise from cytidines since the H6s of uracil are deuterated. While the mixing
of unlabeled CTP with the D6-RNA labeling pattern did produce a great reduction in
spectral crowding, the labeling pattern was a little disappointing since identification of
individual peaks in Figure 4.12 is still difficult due to the spectral overlap of the different
types of ribose protons in NOESY regions A, B, and C.
Deuteration of the H6 of uracil
Deuteration of the H6 of uracil in TAR 465 removed the strong uracil H5-H6
crosspeaks from NOESY and COSY spectra, and also removed all of the U-H6 to ribose
NOEs from the TAR 465 NOESY spectra. Because only the U-H6 protons were
deuterated, the assignment of pyrimidine H6 protons was greatly simplified in the TAR
465 RNA. An example of this is illustrated in Figure 4.13, in which the H5-H6 crosspeak
region of a COSY spectra of unlabeled TAR RNA and TAR 465 are shown. There are 15
pyrimidines in TAR RNA and 15 H5-H6 crosspeaks can be observed in the COSY of
unlabeled TAR RNA. Identification of which of the pyrimidine H5-H6 crosspeaks belong
to U and which belong to C is not trivial in the unlabeled TAR RNA since the U and C
crosspeaks are overlapping. In the TAR 465 COSY, only the cytidine H5-H6 crosspeaks
are present since the H6 of uridines are deuterated. There are 9 cytidines in TAR, and 9
cytidine H5-H6 crosspeaks can be identified in the COSY of TAR 465. By comparing the
COSY of TAR 465 with the COSY of unlabeled TAR RNA, the uracil H5-H6 crosspeaks
can also be identified unambiguously.
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D4/D6-TAR RNA.
While the TAR 465 RNA type labeling pattern simplified NMR spectra greatly,
there was still a lot of spectral crowding in the ribose regions of the spectra. NOESY
regions A, B, and C of Figure 4.12 were still quite crowded and the identification of types
of NOEs within these regions was complicated by the overlap of the H2', H3', H4', H5',
and H5" protons. To solve some of the ribose overlap problems in NOESY spectra, the
D4-RNA labeling pattern was mixed with the D6-RNA labeling pattern. RNA of this type,
D4/D6-RNA, would benefit from the reduction in spectral crowding of ribose protons due
to the D4-RNA labeling pattern for selected nucleotides, and the ribose protons of other
nucleotides would be removed with D6-RNA labeling.
d4-U/d6-A,G,C-TAR RNA (D4/D6-RNA) was produced by T7 RNA polymerase
catalyzed transcription using 1',2',3',4',5',5"-d6-ATP (24), l',2',3',4',5',5"-d6-GTP
(25), 1',2',3',4',5',5"-d6-CTP (27), and 3',4',5',5"-d4-UTP (4) as starting materials,
Figure 4.14a. The synthesis of 24, 25, 27, and 4 from deuterated glucose is described in
Chapter 3, and the detailed procedures for the synthesis are in Chapter 6.
The only ribose protons in the D4/D6-TAR RNA are the 1' and 2' protons of
uridine nucleotides, but the non-exchangeable base protons for all nucleotide types are still
present. Because of this, all of the base to ribose interactions for uridine nucleotides in the
D4-TAR RNA are still present in the D4/D6-TAR RNA, and all other base to ribose
interactions have been removed, Figure 4.14b. A NOESY spectra of the D4/D6-TAR
RNA, Figure 4.15, illustrates a dramatic decrease in spectral crowding as compared to the
unlabeled RNA NOESY spectra, Figure 4.2, or even the D4-RNA, Figure 4.5. All of
the NOEs in Figure 4.15 sections B and C, and several of the NOEs in section E arise
from uridine 1' and 2' protons. There are 6 uridines in TAR RNA, and it is easy to locate
the 6 strong intra-nucleotide Hi'-H2' crosspeaks and the 6 strong inter-nucleotide H2'-
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base crosspeaks in Figure 4.15. While that information is also present in the D4-RNA
spectra in Figure 4.5, the presence of the NOEs arising from A, G, and C ribose protons
makes assignment of the uridine NOEs more difficult, although it is still a much simpler
case than assigning uridine H1' and H2' NOEs in the unlabeled RNA, Figure 4.2. The
selective spectral editing shown here might be useful in simplifying very complicated
spectra of large RNAs.
Sequential assignment using the D4/D6-TAR RNA is similar to the sequential
assignment of the D4-RNA labeling pattern except that only the U ribose protons are
present in the spectra, Figure 4.16. H2' to base NOEs can be linked to H1' to base NOE
information through the HI' and H2' crosspeaks as in the D4-TAR RNA, but the spectral
crowding in regions B, C, and E is greatly reduced, making identification of the base
protons that are 3' and 5' of the ribose protons much easier. Assignment of all of the
uridine HI' and H2' protons of the D4/D6-TAR RNA is by inspection, without any
overlap problems as illustrated by Figure 4.16b. Unfortunately, complete sequential
assignment of the TAR RNA sequence cannot be made with the D4/D6-TAR RNA sample
since only uridine sequential connectivity information is available. Other NMR samples
containing d4-A, d4-G, and d4-C would have to be made to completely assign the RNA.
While this may be tedious, it may offer a way of obtaining sequential assignments of very
large RNAs where heteronuclear NMR is inefficient.
D5 pyrimidine-TAR RNA
An inspection of the base to Hi 1', H5 region of a NOESY spectra of RNA, Figure
4.17, will reveal two types of NOEs. The first type of NOE is usually weaker than the
other and arises from the interaction between H1' ribose protons and the nonexchangeable
base protons (purine H8, adenine H2, pyrimidine H6); these peaks are shown as the
normal peaks in Figure 4.17. These ribose to base NOEs are important because in A form
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RNA they arise from both inter and intra-nucleotide interactions which can be used to walk
from one nucleotide to another in NOESY based sequential assignment. The other type of
NOE in this region is a strong NOE that arises from the intra-pyrimidine H5-H6 interaction;
these peaks are shown as the shaded peaks in Figure 4.17. The distance between the H5
and H6 protons varies little and is relatively short range (2.4 A), resulting in a strong
NOE. These protons also yield crosspeaks in COSY spectra of RNA, which are used to
help determine which base protons belong to pyrimidines in assignment of NMR spectra.
Unfortunately, the strong H5-H6 NOEs fall in the Hl'-base NOE region making NOESY-
based sequential assignment difficult because the strong H5-H6 NOEs can eclipse some of
the weaker HI' to base NOEs. In the TAR RNA, only a few of the H' to base NOEs fall
under H5-H6 crosspeaks, but this problem becomes much worse as larger RNA molecules
are studied since the spectral width of the NOE region remains the same but the number of
H5-H6 NOEs within the region increases linearly with the number of pyrimidines. In
order to reduce this problem the H5 of pryrimidines can be deuterated chemically, leaving
the H1'-H6 NOEs that are important for sequential assignment within the NMR spectra,
but removing the strong H5-H6 NOEs which obscure sequential assignment, Figure 18b.
D5-pyrimidine-TAR RNA was produced by T7 RNA polymerase catalyzed
transcription using unlabeled ATP, unlabeled GTP, 5-dl-UTP (37), and 5-dl-CTP (38)
as starting materials, Figure 4.18a. The synthesis of 37 and 38 by ammonium bisulfite
exchange of the H5 of UMP is described in Chapter 3, and the detailed procedures for the
synthesis are in Chapter 6.
A NOESY spectra of the D5-pyrimidine RNA was acquired and compared to the
NOESY spectra of unlabeled RNA. Most of the NOE regions of the D5-pyrimidine-TAR
RNA are identical to the unlabeled RNA NMR spectra, but the H1' to base NOE region
(region E Figure 4.2) there are no H5-H6 NOEs. A comparison of this region of NOESY
spectra of D5-pyrimidine-TAR RNA and unlabeled TAR RNA is shown in Figure 4.19.
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Notice that there are several H1' to base NOEs that are obscured by H5-H6 crosspeaks
between 5.6 and 5.5 ppm in the unlabeled TAR RNA, which are uncovered in the D5-
pyrimidine-TAR RNA. In a larger RNA there would be many more H5-H6 NOEs
obscuring this region and covering up the H1' to base NOEs which help in sequential
assignment. Deuteration of the H5 of pyrimidines may help in the sequential assignment of
such larger RNAs.
Specific heteronuclear labeling of RNA.
Heteronuclear labeling has had a great impact on the way NMR structural studies
are carried out on both RNA and proteins. In the past four years much of the NMR
structural work on proteins and RNA has been conducted with heteronuclear labeling that
use heteronuclear chemical shifts to spread out proton resonances and also utilize through
bond assignment procedures (Kay & Gardner, 1997; Varani et al., 1996). All of the
isotopic labeling patterns that have been discussed so far in this chapter have been specific
deuteration patterns. Using glucose as a starting material for preparing RNA as described
in Chapter 3 allows all of the ribose labeling patterns and most of the base labeling patterns
discussed so far to be synthesized with 13C labels in addition to specific deuterium labels.
By combining specific deuteration with 13C labeling, RNA molecules can be created where
fully protonated 13C labeled carbons are adjacent to fully deuterated 13C labeled carbons.
Cases similar to this have been useful in obtaining sequential assignment and side chain
assignment in protein NMR spectroscopy. Exchangeable amide protons of perdeuterated
13C/15N labeled proteins can be used to start NMR experiments and detect magnetization
on (Kay & Gardner, 1997). With the carbons of the protein deuterated, magnetization has
a much longer lifetime and longer transfers of magnetization on larger proteins can be
achieved with deuteration than are otherwise possible . Here we start applying these ideas
to RNA NMR spectroscopy, while also reducing overlap in heteronuclear spectra with
specific deuteration.
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Simplification of heteronuclear spectra with specific deuteration.
1',2',3',4',5'- 13 C5-TAR RNA (13 C5-ribose-TAR RNA) was produced by T7
RNA polymerase catalyzed transcription using 1',2',3',4',5'- 13 C5-ATP (28),
1',2',3',4',5'- 1 3 C5-GTP (29), 1',2',3',4',5'-1 3 C5-UTP (30), and 1',2',3',4',5'-
13 C5-CTP (31) as starting materials, Figure 4.20a. The synthesis of 28-31 from 13 C-
glucose is described in Chapter 3, and the detailed procedures for the synthesis are in
Chapter 6.
1',2',3',4',5'- 1 3 C5-3',4',5',5"-d4-TAR RNA (D4-13 C5-ribose-TAR RNA) was
produced by T7 RNA polymerase catalyzed transcription using 1',2',3',4',5'- 13 C5-
3',4',5',5"-d4-ATP (32), l',2',3',4',5'-13C5-3',4',5',5"-d4-GTP (33), l',2',3',4',5'-
13 C5-3',4',5',5"-d4-UTP (34), and 1',2',3',4',5'-1 3 C5-3',4',5',5"-d4-CTP (35) as
starting materials, Figure 4.20b. The synthesis of 32-35 from 2 H- 13 C-glucose is
described in Chapter 3, and the detailed procedures for the synthesis are in Chapter 6.
HSQC (Heteronuclear Single Quantum Coherence) spectra of 13C-ribose-RNA and
D4-13C-ribose-RNA were acquired, and are shown in Figure 4.21a and 4.21b. As can be
seen in Figure 4.21a, the 13C chemical shifts of ribose are fairly well dispersed by type of
carbon, but the C2' and C3' carbon chemical shifts overlap. This is compounded by the
overlap of the H2' and H3' proton chemical shifts, making the identification of some of the
types of crosspeaks difficult. The crosspeaks within the boxes in Figure 4.21 a are some of
the H3'-C3' crosspeaks of TAR that overlap the H2'-C2' crosspeak region. Deuteration of
the C3' of ribose in the D4-13C-ribose-RNA, Figure 4.21b, makes the identification of
exactly which peaks belong to C2' carbons much easier. The absence of the boxed
crosspeaks in Figure 4.2 1b, that were present in Figure 4.21 a, make it clear that they are
H3'-C3' crosspeaks.
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13C labeling of RNA from glucose offers the possibility of combining the
advantages of multidimensional heteronuclear NMR with the spectral editing advantages of
specific deuteration. Deuteration in this context will alter the relaxation properties of RNA,
and it will be possible to create new types of through bond NMR experiments which utilize
these labeling patterns (Dayie et al., 1997). In addition, the 13C-ribose-RNA offers an
inexpensive and easy way to incorporate 13C labels into the ribose moieties of RNA.
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5. Future Directions
As the field of solution NMR spectroscopy progresses the upper limit of the size of
macromolecules which can be studied is constantly being pushed to new levels by advances
in labeling and NMR experimental techniques (Wagner, 1997; Clore & Gronenborn, 1997;
Kay & Gardner, 1997). The isotopic labeling strategies described in this thesis should
increase the size of RNA molecules which can be effectively studied with NMR
spectroscopy by reducing spectral crowding and linewidth problems which interfere with
NMR structural studies. Using the techniques described in Chapters 2 and 3, the ribose
moieties of RNA can be synthesized with a wide variety of specific deuterium and/or 13 C
labeling patterns. As an example of the flexibility of these methods, Figure 5.1
summarizes how 16 different isotopically labeled ribose moieties can be produced using 4
types of commercially available labeled glucose. The bases of RNA can also be labeled
with 2 H, 13 C, or 15N as described in Chapter 3. Figure 5.2 summarizes how all of
nonexchangeable base protons, except for the H2 of adenine, can be exchanged with
deuterium, and examples of heteronuclear labeling of the base moietiesof RNA are shown
in Figure 3.9 of Chapter 3. By combining the synthetic techniques described in this thesis
with several commercially available, isotopically labeled starting materials, many isotopic
labeling patterns can be synthesized which should increase the size of RNA molecules
which can be studied with NMR spectroscopy. Methods for improving both homonuclear
and heteronuclear NMR spectra of large RNA molecules with labeling patterns produced in
this thesis are discussed in this chapter.
Improving Homonuclear RNA NMR Spectra with Specific
Deuteration
One of the advantages of homonuclear NMR spectroscopy is that it has better
relaxation characteristics than heteronuclear NMR spectroscopy. For two protons with the
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Figure 5.1 Possible labeling of the ribose moieties of RNA which can be
derived from glucose. a) Labeling patterns which can be derived from
1,2,3,4,5,6,6-D 7-glucose. b) Labeling patterns which can be derived from
protonated glucose. 13C labeling of the 1', 2', 3', 4', and 5' carbons can be
incorporated into RNA by using 1,2,3,4,5,6-13C6-1,2,3,4,5,6,6-D7-glucose, to
produce 13C labeled versions of the labeling patterns in the table in part a, and
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same surroundings except for one being attached to 13 C and the other being attached to
12 C, the proton that is attached to 12C will always have a slower relaxation rate because
the 13 C attached proton has additional pathways for relaxation through interactions with the
13 C that it is bound to. This leads to the ironic situation of being able to acquire good
quality proton NMR spectra of large, unlabeled macromolecules when heteronuclear NMR
spectra of heteronuclear labeled versions of the same large macromolecules are of poor
quality due to rapid relaxation. This situation is ironic because although the homonuclear
NMR spectra may be of good quality in terms of signal to noise and linewidths, the proton
NMR spectra of large macromolecules are usually hopelessly crowded due to the number
of resonances in the spectra and the lack of a heteronuclear dimension into which to spread
the information.
The specific deuteration patterns described in this thesis could be used to reduce
spectral crowding in RNA NMR spectra so that even the homonuclear NMR spectra of
very large RNA molecules would be simplified such that interpretation would be possible,
Figure 5.3. Spectral crowding in the ribose regions of large RNA NMR spectra could be
greatly simplified by the D4-RNA labeling pattern. Further reduction of spectral crowding
could be obtained by mixing D4-RNA labeling with D6-RNA labeling as described in
Chapter 4. Rather than making only a single NMR sample such as the [D4-U and D6-
A,G,C]-TAR sample which was synthesized in Chapter 4, four NMR samples could be
prepared with each sample having only one D4-labeled nucleotide so that there was one
D4/D6-RNA for each type of nucleotide. With four D4/D6-RNAs of the type shown in
Figure 5.4b [(D4-A, D6-G,U,C)-RNA, (D4-G, D6-A,U,C)-RNA, (D4-U, D6-A,G,C)-
RNA, and (D4-C, D6-A,G,U)-RNA], all of the spectral information that was available in
uniformly labeled D4-RNA, except for inter-nucleotide ribose to ribose information,
would still be available from the combined spectra of the four D4/D6-RNAs. Spectral
crowding could be reduced by as much as a factor of 4 when compared to uniformly D4-
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D4/D6-RNA labeling
Figure 5.3 Reduction of spectral crowding with specific deuteration. a) Ribose regions of RNA NMR
spectra can be simplified by the D4-RNA labeling pattern. b) Additional spectral simplification can be
obtained by mixing nucleotide specific D4-RNA labeling with D6-RNA labeling. This should reduce spectral
crowding by up to a factor of 4. c) Further spectral simplification can be obtained by using base proton
deuteration (H5, H6, or H8). All of these labeling patterns can be synthesized in 13 0/15N labeled forms.
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D4-RNA
Chapter 5
labeled RNA. Assignment would also be easier because the identification of the type of
ribose NOEs within NOESY spectra would be simplified, since there would be only one
type of nucleotide with ribose protons within each NMR sample. Further spectral
simplification could be obtained by deuterating base protons of the RNA. Deuteration of
the H5 of pyrimidines could be used to remove H5-H6 NOESY crosspeaks, and
deuteration of the H6 or H8 protons of bases could introduce another level of nucleotide
specific spectral simplification. The specific deuteration patterns discussed above could be
combined with heteronuclear labeling of the ribose moieties or bases to allow the use of
multidimensional heteronuclear NMR spectroscopy to reduce spectral crowding even
further if the relaxation properties of the RNA to be studied allowed heteronuclear NMR
spectroscopy to be effective.
Example of reduction of spectral crowding in a large RNA with specific deuteration
As an example of the use of specific deuteration to reduce spectral crowding and
simplify assignment of the NMR spectra of large RNAs, several deuterated forms of the
65 nucleotide RNA F22b have been synthesized. The ribosomal protein S 15 is one of the
first proteins to bind to the 16S ribosomal RNA in the process of ribosomal assembly. The
interaction of the S15 ribosomal protein derived from Bacillus stearothermophilus with a
minimized RNA fragment to which it binds, termed here F22b, has been biochemically
characterized (Batey & Williamson, 1996a; Batey & Williamson, 1996b), and now
attempts are being made to study the structure of the RNA and protein in complex with
NMR spectroscopy. The S15 RNA binding site F22b is 65 nucleotides in size, and the
Bacillus stearothermophilus S15 protein contains 88 amino acids. This makes the F22b-
S15 RNA protein complex a very large and challenging system for NMR spectroscopic
studies with a size of approximately 30 kDa.
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The interaction of the F22b RNA with the Bacillus stearothermophilus S 15 protein
exhibits several of the problems frequently encountered in large macromolecular NMR
spectroscopy. The relaxation rates of the 13C/ 15N labeled complex are so fast that
heteronuclear NMR experiments do not work to any useful extent, limiting NMR structural
studies to homonuclear NMR spectroscopy for the moment. To help resolve some of the
spectral crowding problems of the F22b-S 15 NMR spectra on the RNA side of the
complex, the F22b RNA was prepared with some of the specific deuterium labeling
patterns described in this thesis. At 65 nucleotides the F22b RNA is much larger than the
36 nucleotide ATP-binding aptamer (Dieckmann et al., 1996) or the 39 nucleotide bent
helix hairpin interaction (Marino et al., 1995), which are among the largest RNA NMR
structures to have been determined so far. Although the imino spectra of some 76
nucleotide tRNAs have been assigned (Hall et al., 1989; Choi & Redfield, 1992), no
sequential assignment through the non-exchangeable ribose regions of an RNA of the size
of the F22b RNA have been reported. The spectral crowding in the ribose regions of RNA
NMR spectra has proven a formidable obstacle to the extension of NMR structural studies
to RNAs larger than 40 nucleotides. Homonuclear NMR spectra of the F22b RNA are
extremely crowded due to the large number of nucleotides in the RNA, preventing
sequential assignment of the RNA in complex or alone.
The F22b RNA was synthesized with the D5-pyrimidine RNA labeling pattern, the
D4-RNA labeling pattern, and the D4/D6-RNA labeling pattern that were described in
Chapter 4. An unlabeled F22b RNA was also produced by T7 RNA polymerase catalyzed
transcription for comparison using commercially obtained unlabeled nucleotides. D5-
pyrimidine-F22b RNA was produced using unlabeled ATP, unlabeled GTP, 5-dl-UTP
(37), and 5-dl-CTP (38) as starting materials (same nucleotides as in Figure 4.18a). d4--
F22b RNA (D4-F22b) was produced using 3',4',5',5"-d4-ATP (2), 3',4',5',5"-d4-GTP
(3), 3',4',5',5"-d4-UTP (4), and 3',4',5',5"-d4-CTP (5) as starting materials (same
nucleotides as in Figure 4.3a). d4-U/d6-A,G,C-F22b RNA (D4/D6-F22b) was produced
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using l',2',3',4',5',5"-d6-ATP (24), l',2',3',4',5',5"-d6-GTP (25), 1',2',3',4',5',5"-
d6-CTP (27), and 3',4',5',5"-d4-UTP (4) as starting materials (same nucleotides as in
Figure 4.14).
NOESY spectra of the unlabeled F22b (Figure 5.4) and the deuterated forms of
F22b (Figures 5.5-5.7) demonstrate the dramatic reduction in spectral crowding afforded
by deuteration. Figure 5.5 shows a comparison of the base to H1' NOE regions of
unlabeled F22b and D5-pyrimidines F22b. Deuteration of the H5 of pyrimidines in Figure
5.5b results in the removal of the strong H5-H6 pyrimidine crosspeaks from the NOESY
spectra. Several HI'-H2' and H2'-base crosspeaks are clearly resolved in the NOESY
spectra of D4-F22b RNA, Figure 5.6, which were buried in spectral overlap in the
unlabeled F22b NOESY Figure 5.4. Finally, the NOESY spectra of the D4/D6-F22b
RNA, Figure 5.7, is extremely simplified compared to the unlabeled F22b RNA NOESY
spectra, having only uridine H1' and H2' ribose protons.
Even without the S15 protein there are things which can be seen from the NMR
spectra of the deuterated forms of F22b. For instance, the H2' proton that is shifted far
downfield to 3.80 ppm can be deduced to be a U H2' from the presence of an H2' NOE at
3.80 ppm in the D4/D6-F22b RNA NMR spectra, Figure 5.7. The H1' to base NOE
region of the F22b RNA is still quite crowded, even after the removal of the H5-H6
crosspeaks, Figure 5.5b, but this overlap of H1' to base NOEs should spread out after
titration of the S 15 protein. Examination of the D4/D6-F22b RNA NMR spectra allows
identification of all eleven U-HI' and U-H2' chemical shifts. In addition, NOE contacts
between the eleven U-H2' protons and non-exchangeable base protons are easily extracted
from the D4/D6-F22b RNA NOESY spectra. Tables 5.1 and 5.2 summarize the chemical
shift information described above which was extracted from the D4/D6-F22b RNA
NOESY spectra.
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Table 5.1 Chemical Shifts of Hi's and H2's of Uridine Nucleotides in F22b
U nucleotide UH1' (ppm) UH2' (ppm)
1 5.68 3.80
2 5.74 4.14
3 5.76 4.24
4 5.52 4.29
5 5.61 4.39
6 5.57 4.44
7 5.60 4.55
8 5.60 4.57
9 5.65 4.63
10 5.49 4.64
11 6.11 4.68
Table 5.2 Chemical Shifts of UH2' to Base Proton NOEs in F22b
U nucleotide UH2' Base proton Base proton
Strong NOE Weak NOE
(ppm) (ppm) (ppm)
1 3.80 7.72
2 4.14 7.55 7.67
3 4.24 7.68
4 4.29 7.81 7.72
5 4.39 7.73
6 4.44 7.67
7 4.55 7.93 7.73
8 4.57 7.79
9 4.63 7.75
10 4.64 7.72
11 4.68 8.06
The information in Tables 5.1 and 5.2 establishes a starting point for the sequential
assignment of F22b. With this information, all of the chemical shifts of the UH 's and
UH2's within the F22b RNA have been identified. In addition, through space
connectivity between UH2' protons and non-exchangeable base protons of yet unknown
identity have been established. Extension of the D4/D6-RNA labeling strategy to
nucleotides other than uridine would yield similar information for the other nucleotides and
build a more complete picture of the sequential assignment of the F22b RNA.
124
Chapter 5
Specific deuteration and heteronuclear (1 3 C/ 1 5 N) labeling combined
in RNA NMR spectroscopy
RNA heteronuclear NMR spectra can also be improved with the labeling patterns
and strategies discussed in this thesis. Spectral overlap in heteronuclear NMR spectra can
be removed by using specific deuteration in combination with heteronuclear labeling. An
example of this has already been discussed in Chapter 4 where the chemical shift overlap of
the H3'-C3' and H2'-C2' crosspeaks in an RNA HSQC spectra was removed with the D4-
13 C5-ribose-RNA labeling pattern. In addition to removing spectral overlap, the
combination of specific deuteration with heteronuclear labeling can be used to extend the
useful range of heteronuclear NMR experiments to larger RNA molecules.
Deuteration greatly increases the T2's of heteronuclei by replacing the strong
dipolar coupling between 13 C and hydrogen with the weaker 13 C-deuterium interaction.
The increase in the lifetime of carbon magnetization increases the intensity of signal in
NMR experiments which transfer magnetization through heteronuclei. In this way
deuteration can be used to counteract the rapid relaxation of larger macromolecules, and
thus increase the size of macromolecules where acceptable signal to noise ratios can be
achieved in heteronuclear NMR experiments. The combination of deuteration with
heteronuclear labeling in protein NMR spectroscopy has been very successful in extending
the size of proteins where heteronuclear NMR spectroscopy can be utilized. 13 C/ 15N
labeled proteins which are also random fractionally deuterated to a high level have been
applied successfully to the study proteins on the order of 40-60 kDa (Kay & Gardner,
1997). With such dramatic progress in the protein NMR field it is likely that some gains
can be made by combining heteronuclear labeling with specific deuteration in RNA NMR
spectroscopy.
One difference between protein NMR spectroscopy and RNA NMR spectroscopy is
that protein NMR spectroscopy benefits from having an exchangeable amide proton central
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to sequential assignment strategies. Protein NMR spectroscopists are able to deuterate
proteins to high levels, but then conduct NMR experiments in H20 to exchange the amide
proton for 1H. This allows protein NMR spectroscopist to benefit from narrow
heteronuclear linewidths due to high deuteration levels, but also have good signal to noise
ratios because the amide protons are present as 90% 1H. Unfortunately RNA lacks an
exchangeable proton which is strategically located to help with nonexchangeable proton
sequential assignment in highly deuterated, heteronuclear labeled RNAs. Although the
exchangeable imino protons are extremely important for the sequential assignment of RNA
exchangeable proton NMR spectra, they are relatively isolated and do not help very much
with RNA non-exchangeable sequential assignment. The synthetic techniques described in
this thesis can be used to specifically place protons into highly deuterated, 13 C labeled
ribose moieties in order to reap the relaxation benefits of high deuteration levels while still
having protons present as 1H to initiate and detect magnetization on during NMR
experiments.
Example of specific deuteration in combination with heteronuclear labeling.
As a demonstration of the benefits of specific deuteration of RNA in combination
with heteronuclear labeling, the C5' to Hi' crosspeaks of an CCH-TOCSY NMR spectra
(CCH-total correlation spectroscopy) (Dayie et al., 1997) can be examined for the two 13 C
labeled TAR RNAs produced in Chapter 4. The CCH-TOCSY NMR experiment was
developed by Dr. Kwaku Dayie to utilize the benefits of the D4-13 C5-ribose-RNA labeling
pattern to improve RNA sequential assignment. The CCH-TOCSY NMR experiment takes
advantage of the deuteration of the C3', C4', and C5' carbons in the D4-13 C5-ribose-RNA
labeling pattern by initiating magnetization on 13 C rather than 1H. Starting magnetization
on 13 C rather than 1H has two effects; the length of the pulse sequence is reduced as
compared to HCCH-TOCSY NMR experiments (which has signal to noise benefits in large
RNA molecules), and the chemical shifts of fully deuterated carbons can be correlated to
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the remaining ribose protons. The ability to observe magnetization from fully deuterated
carbons in the CCH-TOCSY NMR experiment allows the observation of increased carbon
magnetization lifetime due to deuteration.
The CCH-TOCSY experiment starts transverse magnetization on carbon, transfers
magnetization through the ribose ring, and then transfers carbon magnetization to protons
for detection. In a two dimensional CCH-TOCSY experiment, each ribose proton will
have crosspeaks correlating it to every carbon within the ribose. For the C5' carbon,
magnetization starts on the C5', and it is transferred through the C4', C3', C2', and Cl',
then C1' magnetization is transferred to the H1' and detected to produce a crosspeak
correlating the C5' carbon to the H ' proton. This transfer of magnetization is schematized
for the C5' in Figure 5.8. In Figure 5.9 the CCH-TOCSY spectra of 13 C5-ribose-labeled
RNA and D4-13 C5-ribose-RNA are shown. In the CCH-TOCSY of the non-deuterated
13 C5-ribose-RNA, the C5'-Hl' crosspeaks are difficult to detect in large RNAs because
of the rapid relaxation of heteronuclei. Deuteration of the C5', C4', and C3' in D4-1 3 C5 -
ribose-RNA dramatically increases the intensity of C5'-H1' crosspeaks in CCH-TOCSY
NMR spectra due to longer relaxation rates of the deuterated heteronuclei. The increased
efficiency of magnetization transfer due to deuteration will allow heteronuclear NMR
experiments like CCH-TOCSY to work on larger RNA molecules than otherwise possible.
Conclusion
The isotopic labeling patterns and strategies described in this thesis may aid in the
assignment of large RNA NMR spectra. Already the specifically deuterated forms of the
F22b RNA that were discussed in this chapter are simplifying the assignment of the RNA.
The previously unidentified chemical shifts of the H' and H2' protons of all 11 uridine
nucleotides in F22b are now known. Our combination of specific deuteration with 13 C
and 15 N labeling also shows promise in being useful in RNA NMR spectroscopy. There
are several interesting possibilities, like the CCH-TOCSY experiments, to investigate that
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Figure 5.8 Transfer of magnetization from the C5' to the H1' using CCH-TOCSY
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represent magnetization transfer in the CCH-TOCSY NMR experiment. Dashed
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may allow the through bond sequential assignment of large RNAs where rapid relaxation
prevented through bond assignment before. Spectral crowding might be further reduced in
RNA NMR spectra by combining the labeling strategies described in this thesis with "NMR
window" (Yamakage et al., 1993) or "segmental isotopic labeling" (Xu et al., 1996)
strategies. These strategies use chemical RNA synthesis or ligation of T7 transcripts to
isotopically label specific sections of large RNAs in order to focus NMR studies on those
sections. The use of glucose as a starting material for incorporating isotopic labels into
RNA shows promise in reducing the cost of isotopically labeled RNA greatly. Fully
13C/15N labeled forms of UTP and CTP can be prepared from glucose and isotopically
labeled uracil at a fraction of the cost required to produce the same nucleotides from bacteria
grown on isotopically labeled media. This might make chemical synthesis of isotopically
labeled RNA more feasible, since the starting materials (isotopically labeled nucleotides)
for synthesizing phosphoramidites would be much less expensive, causing losses during
the conversion of nucleotides into phosphoramidites to be less costly. The use of
enzymatic synthesis to convert ribose and glucose into isotopically labeled nucleotides
which would be useful in NMR spectroscopy was very successful, and it is possible that
similar chemical and enzymatic techniques could be developed for the isotopic labeling of
other biological molecules. Efficient methods for isotopically labeling DNA and
oligosaccharides which would be of use in NMR spectroscopy could be developed using a
combination of chemical and enzymatic synthesis. Application of the isotopic labeling
patterns and synthetic strategies described in this thesis to NMR studies of RNA should
prove very valuable.
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6. Experimental
General Procedures.
Materials and Methods. Reactions were conducted under argon atmosphere
unless otherwise noted, and solvents were dried and distilled (Perrin & Armarego, 1988).
Chemicals were purchased from Aldrich and Sigma. Glycerol (U-d8), 1,2,3,4,5,6- 13 C6-
D-glucose (>99% 13 C), D20, and CDC13 were purchased from Cambridge Isotopes
Laboratories. 1,2,3,4,5,6,6- 2 H7-D-glucose (>97% 2 H) and 1,2,3,4,5,6,6-2H7 -
1,2,3,4,5,6- 13 C6-D-glucose (>97% 2 H, >98% 13 C) were purchased from Martek
Corporation. Nucleoside monophosphate kinase from beef liver (catalog number 107 948,
1 unit per mg protein) was purchased from Boehringer Mannheim. Phosphoglycerate
mutase from rabbit muscle (catalog number P-9885, 470 units per mg protein), enolase
from baker's yeast (catalog number E-6126, 73 units per mg protein), myokinase from
chicken muscle (catalog number M-5520, 1500-3000 units per mg protein), pyruvate
kinase type I1 from rabbit muscle (catalog number P-9136, 350-600 units per mg
protein), guanylate kinase from porcine brain (catalog number G-9385, 20-60 units per
mg protein), hexokinase type V from bakers yeast (catalog number H-5250, 40-60 units
per mg protein), phosphoglucose isomerase type II from bakers yeast (catalog number P-
5381, 500-800 units per mg protein), glucose-6-phosphate dehydrogenase type V from
bakers yeast (catalog number G-7750, 230 units per mg protein), 6-phosphogluconic
dehydrogenase from yeast (catalog number P-4553, 3-6 units per mg protein),
phosphoriboisomerase from torula yeast (catalog number P-7434, 200-600 units per mg
protein), and L-glutamic dehydrogenase type III from bovine liver (catalog number G-
7882, 40 units per mg protein) were purchased from Sigma. One unit of enzyme
corresponds to 1 jmole/min of activity under assay conditions. The pH of aqueous
solutions was determined by colorpHast Indicator Strips pH 0-14 made by EM Science.
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Flash chromatography was conducted on either a medium column (3.5 cm diameter, 10-15
cm height) or a small column (2 cm diameter, 6-12 cm height), depending on the amount
of material to be purified, using ICN silica 32-63, 60A obtained from ICN Biomedicals.
NMR spectra were recorded on a Varian XL-300, Varian VXR-500, or a Varian Inova-
600 MHz spectrometer. Infrared spectra were recorded on a Perkin Elmer 1600 series FT-
IR, and ultraviolet spectra were recorded on a Hitachi U-2000 UV/Vis spectrophotometer.
Mass spectra were obtained with a Hewlett Packard 5890/5971 GC/mass spectrometer for
low resolution, a Finnigan MAT 8200 for high resolution, or on a Hewlett Packard
electrospray mass spectrometer for NTPs.
Preparation of sodium 3-phosphoglycerate from barium 3-
phosphoglycerate. The sodium salt of 3-phosphoglycerate was prepared from the less
expensive barium form of 3-phosphoglycerate by exchanging the barium for sodium with
amberlite IR-120PLUS strongly acidic cation exchanger, sodium form (16-50 mesh). The
cation exchanger (60 g) was first washed thoroughly with water, and then stirred with 5g
of barium 3-phosphoglycerate and 75 mL of H20. After 2-1/2 hours the majority of the
barium 3-phosphoglycerate, visible in the solution as an insoluble white precipitate, had
dissolved. The mixture was filtered and the pH of the filtrate was adjusted to around 7
with NaOH. This resulted in approximately 80 mL of a solution that was 165 mM sodium
3-phosphoglycerate.
Boronate affinity purification of nucleotides. All of the nucleotides from
the enzymatic reactions were purified by boronate affinity chromatography (Affigel 601
boronate affinity resin obtained from Biorad), which removes the majority of proteins and
salts used in the enzymatic reactions and prepares the nucleotides for transcription. The
nucleotide forming reactions were concentrated under vacuum and then dissolved in a
minimum amount of IM triethylammonium bicarbonate (TEABC) solution pH = 9.5-10
(which is prepared by bubbling carbon dioxide into a solution of 140 mL triethylamine and
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860 mL of H20.). Once the residue was dissolved, the solution was allowed to rest at
room temperature for 15-30 minutes while a white precipitate usually formed (probably
precipitated protein), then the precipitate was removed from the solution by filtration or
centrifugation. The filtrate was loaded onto an Affigel 601 boronate affinity column
(containing 10 g of Affigel 601) that had been pre-equilibrated with IM TEABC pH = 9.5-
10. After loading, the column was washed with 3-5 column volumes of IM TEABC pH =
9.5-10, then the nucleotides were eluted from the column with water that had been acidified
by bubbling carbon dioxide through it (pH -4-5.5). All of the acidified H20 elution was
collected in a single flask, and concentrated under vacuum. Triethylammonium bicarbonate
was removed from the residue by repeatedly dissolving the residue in ethanol and removing
the ethanol under vacuum. This procedure does not separate nucleotides from one another,
but does remove the majority of contaminants which interfere with transcription reactions.
Nucleotides prepared in this manner a ready for transcription without any further
purification steps. The boronate resin can be used repeatedly, and is stable when stored in
H20 at 40 C.
Chapter 2 Experimental
Chemical synthesis of D,L-3',4',5',5"-d4-ribose from perdeuterated glycerol
(Figure 6.1)
D,L-2:3-O-cyclohexylidene-1,1',2,3,3'-d5-glycerol (11).
Cyclohexanone (3.49 g, 35.6 mmol) and trimethylorthoformate (3.77 g, 35.6 mmol) were
dissolved in CH2Cl2 (150 mL). Glycerol (U-d8, 98%) (10) (3.56 g, 35.6 mmol) and a
catalytic amount of p-toluenesulfonic acid (10 mg, 50 pmol) were added, and the
heterogeneous mixture was stirred at room temperature. After stirring for 9 hours the
solution was homogeneous and the reaction was complete as judged by TLC and the
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disappearance of the immiscible glycerol (U-d8). The reaction mixture was concentrated
and the product purified by flash chromatography (5 to 40% EtOAc in hexane) to yield
6.07 g (34.1 mmol, 95%) of 11 as colorless oil. 1H NMR (300 MHz, CDC13) 8 2.86 (s
br, 1H), 1.85-1.28 (m, 10 H); 13 C NMR (75 MHz, CDC13) 8 109.7, 75.0 (t, J = 23 Hz),
64.6 (quintet, J = 23 Hz), 62.2 (quintet, J = 21 Hz), 36.2, 34.6, 24.9, 23.8, 23.6; IR
(neat) 3442, 2944, 2860, 2215, 2106, 1449, 1367, 1333, 1288, 1257, 1231, 1169, 1105,
1063, 1011, 974, 941, 907; HRMS m/z 177.1409 (177.1408 calcd for C9H11032 H5,
M+)
D,L-2:3-O-cyclohexylidene-1,2,3,3'-d4-glyceraldehyde (12). Alcohol
11 was dissolved in CH30D and evaporated two times to exchange the hydroxyl proton,
to remove protons and prevent 1H exchange that can occur with the aldehyde under basic
conditions. Oxalyl chloride (2.18 g, 17.2 mmol) was added to CH2C12 (200 mL) in a
flask cooled to - 780 C, and DMSO (2.68 g, 34.4 mmol) was added slowly via syringe.
The resulting mixture was stirred for five minutes before 11 (2.78 g, 15.6 mmol) was
added. The mixture was stirred for 30 min. at -78" C, and then triethylamine (6.32 g, 62.5
mmol) was added slowly. After stirring for 15 minutes at -78" C, the dry ice/acetone bath
was removed and the reaction was stirred at room temperature. After 30 min., the reaction
was quenched with 75 mL of 0.55M HC1. The organic layer was separated and washed
with saturated NaHCO3 (75 mL) and saturated NaCl (75 mL). The organic layer was dried
over MgSO4 and then concentrated. The crude aldehyde 12 was carried on directly to the
next reaction without purification.
Ethyl-(Z)-D,L-4:5-O-cyclohexylidene-3,4,5,5'-d4-2-pentenoate (13).
The crude aldehyde 12 was dissolved in 100 mL of methanol and cooled to 40 C.
Ph3P=CHCO2Et, (carbethoxymethylene)triphenylphosphorane obtained from Aldrich,
was added, and the reaction was stirred for 24 hours at 40 C. After concentration in vacuo
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the residue was purified by flash chromatography (5% Et20 in petroleum ether) to yield
2.91 g (11.9 mmol, 76%) of a light yellow oil. 1H NMR (300 MHz, CDC13) 8 5.83 (s, 1
H), 4.17 (q, 2 H, J = 7.1 Hz), 1.75-1.33 (m, 10 H), 1.29 (t, 3 H, J = 7.1 Hz); 13 C NMR
(75 MHz, CDC13) 8 165.5, 149.0 (t, J = 23 Hz), 120.4, 110.1, 72.5 (t, J = 24 Hz), 68.2
(quintet, J = 23 Hz), 60.2, 36.1, 34.8, 25.0, 23.8, 23.7, 14.0; IR (neat) 2981, 2935,
2862, 2229, 2174, 2111, 1716, 1634, 1448, 1372, 1349, 1272, 1198, 1164, 1117, 1036;
HRMS m/z 244.1610 (244.1608 calcd for C13H1604 2H4, M+)
(Z)-D,L-4:5-O-cyclohexylidene-3,4,5,5'-d4-2-penten-l-ol (14). Z
ester 13 (4.21 g, 17.2 mmol) was added to 200 mL of CH2C12, and was cooled to O0 C.
Diisobutyl aluminum hydride (DIBAL-H) obtained from Aldrich (1 M in hexanes, 43.1
mmol) was slowly added with a syringe over a period of ten minutes. The mixture was
stirred at 0-4* C for 30 minutes, then the reaction was quenched with 100 mL of 1 M
NaOH. The sodium hydroxide solution was added dropwise to prevent explosive
evolution of hydrogen. The quenched reaction was stirred for 8 hours at room temperature
to hydrolyze the aluminum adducts, then the aqueous and organic layers were separated.
The aqueous layer was extracted with 3x100 mL of EtOAc. The organic layers were
combined and dried over MgSO4, concentrated, and purified by flash chromatography (15
to 30% EtOAc in hexane), affording 3.24 g (16.0 mmol, 93%) of a light yellow oil (14).
1H NMR (300 MHz, CDC13) 8 5.81 (t, 1 H, J = 6.5 Hz), 4.28 (dd, 1 H, J = 13.2, 6.9
Hz), 4.15 (dd, 1 H, J = 13.2, 6.1 Hz), 2.95 (s br, 1 H), 1.75-1.30 (m, 10 H); 13 C NMR
(75 MHz, CDC13) 5 132.9, 129.0 (t, J = 24 Hz), 109.9, 70.8 (t, J = 22 Hz), 68.2
(quintet, J = 24 Hz), 58.2, 36.2, 35.3, 24.9, 23.8, 23.7; IR (neat) 3416, 2934, 2861,
2226, 2175, 2108, 1448, 1366, 1338, 1285, 1234, 1166, 1116, 1081, 1035, 978, 928;
HRMS m/z 202.1503 (202.1503 calcd for C11H14032 H4, M+ )
(Z)-D,L-1-benzyloxy-4:5-O-cyclohexylidene-3,4,5,5'-d4-2-pentene
(15). Sodium hydride, 60% dispersion in mineral oil, (2.56 g, 64.1 mmol) was washed
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with hexane to remove the mineral oil. THF (100 mL) was added to the sodium hydride.
Allylic deuterated alcohol 14 (3.24 g, 16.0 mmol), benzyl bromide (3.01 g, 17.6 mmol),
and tetrabutylammonium iodide (100 mg, 0.3 mmol) were added to this mixture. The
reaction was stirred for 24 hours at room temperature, and was quenched by addition of
saturated NaCl (75 mL). Water was added to dissolve precipitated salts, and the aqueous
layer was separated. The aqueous layer was extracted with three 50 mL portions of EtOAc,
then the combined organic layers were dried over MgSO4 and concentrated. Purification
by flash chromatography (5-15% Et20 in petroleum ether) yielded 4.49 g of the yellow oil
(15) (15.4 mmol, 96%). 1H NMR (300 MHz, CDC13) 5 7.41-7.20 (m, 5 H), 5.80 (t, 1
H, J = 6.4 Hz), 4.53 (d, 1 H, J = 11.8 Hz), 4.48 (d, 1 H, J = 11.8 Hz), 4.11 (d, 2 H, J =
6.4 Hz), 1.75-1.33 (m, 10 H); 13 C NMR (75 MHz, CDC13) 5 137.9, 130.5 (t, J = 24
Hz), 129.8, 128.1 (2 C), 127.5 (2 C), 127.4, 109.6, 71.9, 70.9 (t, J = 23 Hz), 68.1
(quintet, J = 22 Hz), 65.4, 36.1, 35.2, 24.9, 23.7, 23.6; IR (neat) 2934, 2860, 2226,
2174, 2107, 1451, 1365, 1166, 1086, 1028, 1011, 738, 698; HRMS m/z 292.1970
(292.1972 calcd for C18H2003 2H4, M+)
D,L-1-benzyloxy-4:5-O-cyclohexylidene-3,4,5,5'-d4-ribitol (±11).
Benzyl deuterated allyl alcohol 15 (1.71 g, 5.85 mmol), N-methyl morpholine N-oxide
(1.37 g, 11.7 mmol), and osmium tetroxide 2.5% in tBuOH (3.05 g, 0.3 mmol Os04)
were combined in a solution of 1:8 D20/acetone (72 mL), and stirred for 12 hours at room
temperature. The reaction was quenched by addition of 40 mL of 30% Na2SO3. After
stirring for 1 hour, the solution was extracted with four 75 mL portions of EtOAc. The
combined organic layers were dried over Na2SO4 and concentrated. Separation of
diastereomers was accomplished by careful flash chromatography (15% EtOAc in hexane).
The slower running diastereomer corresponds to the ribitol configuration (±16), 1.21 g
(3.7 mmol, 63%) of the yellow oil ±16 was separated from the faster eluting diastereomer.
1H NMR (300 MHz, CDC13) 5 7.41-7.22 (m, 5 H), 4.56 (d, 1 H, J = 11.9 Hz), 4.51 (d,
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1 H, J = 11.9 Hz), 3.85 (t, 1 H, J = 4.9 Hz), 3.68 (d, 2 H, J = 4.9 Hz), 3.31 (s br, 1 H),
3.10 (s br, 1 H), 1.70-1.30 (m, 10 H); 13 C NMR (75 MHz, CDC13) 8 137.5, 128.3 (2
C), 127.8, 127.7 (2 C), 109.7, 75.2 (t, J = 23 Hz), 73.5, 72.3 (t, J = 22 Hz), 71.5, 70.9,
65.2 (quintet, J = 23 Hz), 36.1, 34.6, 25.0, 23.9, 23.6; IR (neat) 3442, 2934, 2861,
2153, 1452, 1367, 1286, 1106, 1008, 909, 738, 699; HRMS m/z 326.2028 (326.2027
calcd for C 18H2205 2 H4, M+)
D,L-1-benzyloxy-4:5-O-cyclohexylidene-3,4,5,5'-d4-2:3-0-
isopropylidene-ribitol (±17). Diol ±16 (2.03 g, 6.2 mmol), 2-methoxy propene
(0.54 g, 7.5 mmol), and CH2C12 (100 mL) were combined, and a single anhydrous crystal
of p-toluene sulfonic acid was added. The reaction was stirred for 1 hour and then
concentrated. Purification by flash chromatography (10-20% Et20 in petroleum ether)
yielded 2.11 g of the yellow oil ±17 (5.8 mmol, 93%). 1H NMR (300 MHz, CDC13) 8
7.46-7.22 (m, 5 H), 4.67 (d, 1 H, J = 12.1 Hz), 4.55 (d, 1 H, J = 12.1 Hz), 4.41 (dd, 1
H, J = 7.9, 3.1 Hz), 3.83 (dd, 1 H, J = 10.6, 3.1 Hz), 3.63 (dd, 1 H, J = 10.6, 7.9 Hz),
1.42 (s, 3 H), 1.34 (s, 3 H), 1.67-1.24 (m, 10 H); 13 C NMR (75 MHz, CDC13) 8 137.9,
128.1 (2 C), 127.7 (2 C), 127.4, 109.9, 108.7, 77.2 (t, J = 22 Hz), 76.7, 73.3, 72.2 (t, J
= 23 Hz), 68.5, 66.7 (quintet, J = 23 Hz), 36.3, 34.7, 27.7, 25.2, 24.9, 23.8, 23.7; IR
(neat) 2934, 2861, 2117, 1452, 1380, 1370, 1271, 1243, 1219, 1182, 1109, 1070, 1052,
736, 698; HRMS m/z 366.2339 (366.2340 calcd for C21H2605 2H4, M+)
D,L-4:5-O-cyclohexylidene-3,4,5,5'-d4-2:3-0-isopropylidene-ribitol
(±13). The benzyl ribitol ±17 (2.34 g, 6.4 mmol) was dissolved in 75 mL of THF and
hydrogenated over 5% palladium on carbon (0.4 g) at 1 atmosphere of hydrogen for 22
hours. The reaction was filtered through celite and the filtrate was concentrated.
Purification by flash chromatography (20-40% Et20 in petroleum ether) afforded 1.62 g
(5.9 mmol, 92%) of alcohol (±18). 1H NMR (300 MHz, CDC13) 8 4.36 (dd, 1 H, J =
7.3, 5.7 Hz), 3.90 (dd, 1 H, J = 11.9, 7.3 Hz), 3.83 (dd, 1 H, J = 11.9, 5.7 Hz), 2.99
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(s, 1 H), 1.72-1.25 (m, 10 H), 1.40 (s, 3H), 1.35 (s, 3H); 13 C NMR (75 MHz, CDC13)
8 110.4, 108.5, 77.6 (t, J = 24 Hz), 77.4, 72.2 (t, J = 23 Hz), 66.9 (quintet, J = 22 Hz),
60.6, 36.2, 34.6, 27.6, 25.0, 24.8, 23.9, 23.7; IR (neat) 3512, 2986, 2935, 2862, 2175,
2118, 1449, 1371, 1219, 1180, 1112, 1062, 861; HRMS m/z 276.1870 (276.1871 calcd
for C14H20052H4, M+)
D,L-4:5-O-cyclohexylidene-3,4,5,5'-d4 -2:3-O-isopropylidene-ribose
(+19). Oxalyl chloride (53 mg, 0.42 mmol) was added to CH2C12 (200 mL), and cooled
to - 78' C. DMSO (66 mg, 0.84 mmol) was added slowly via syringe, and the mixture
was stirred for five minutes before the deuterated alcohol ±18 (104 mg, 0.38 mmol) was
added to the flask as a solution in CH2C12 (30 mL). After stirring for 30 minutes at -78*
C, triethylamine (154 mg, 1.52 mmol) was added slowly to the mixture. After stirring for
15 minutes a -78' C, the dry ice/acetone bath was removed and the solution was stirred at
room temperature. Thirty minutes later, the reaction was quenched with an aqueous HCI
solution (15 mL, 0.12 M). The organic and aqueous layers were immediately separated
and the organic layer was washed with saturated aqueous NaHCO3 solution (20 mL) and
saturated aqueous NaCl solution (20 mL). The organic layer was dried over MgSO4 and
then concentrated. Purification by flash chromatography (20-40% Et20 in petroleum ether)
yielded 94 mg (0.34 mmol, 90%) of protected ribose (±19). 1H NMR (300 MHz,
CDC13) 5 9.75 (d, 1 H, J = 1.8 Hz), 4.63 (d, 1 H, J = 1.8 Hz), 1.73-1.28 (m, 10 H),
1.54 (s, 3 H), 1.38 (s, 3 H); 13C NMR (75 MHz, CDC13) 8 197.2, 111.2, 110.7, 81.8,
78.4 (t, J = 23 Hz), 72.6 (t, J = 23 Hz), 66.5 (quintet, J = 23 Hz), 36.5, 34.5, 27.3,
25.4, 25.0, 23.9, 23.7; HRMS m/z 274.1715 (274.1714 calcd for C14H18052 H4, M +)
D,L-3',4',5',5"-d4-ribose ±1. The protected deuterated ribose ±19 (22 mg,
78 gmol) was dissolved in 7 mL of H20 : THF : AcOH (3:3:1). The flask was attached to
a reflux condenser and heated to 600 C for 24 hours. The mixture was evaporated under
vacuum affording crude D,L-3',4',5',5"-d4-ribose (+1). The amount of D-3',4',5',5"-
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d4-ribose (-1) produced was determined to be 31 gmoles using the enzymatic ribose assay
described below. This corresponds to a 78% yield from the starting protected D-
3',4',5',5"-d4-ribose (-19), and a 39% yield from the racemic mixture of protected
ribose (±19). NMR revealed the presence of the expected complex mixture of ac and f3
anomers of the furanose and pyranose forms of ribose. HRFABMS (glycerol) m/z
137.0747 (137.0748 calcd for C5H5042 H4, [M-OH] + )
Ribokinase
D-Ribose . -. R5P
ATP ADP
L-lactic
dehydrogenase
Lactate - Pyruvate PEP
7 .pyruvate
NAD* INADHI kinase
Observe at 340 nm
Figure 6.2 Enzymatic D-Ribose assay utilizing ribokinase, pyruvate kinase and
L-lactic dehydrogenase to quantitate the amount of D-ribose produced by the chemical
synthesis.
Enzymatic D-ribose Assay. The amount of D-d4-ribose present in the crude
racemic mixture produced by the chemical synthesis was quantitated by coupling D-ribose
phosphorylation by ribokinase to the oxidation of NADH using the enzymes pyruvate
kinase and lactate dehydrogenase, Figure 6.2. This assay is similar to the ribokinase assay
of Gross et. al. (Gross et al., 1983), except that the amount of D-ribose is limiting and the
absolute amount of NADH consumed is measured. The ADP that is formed during the
phosphorylation of ribose by ribokinase is subsequently rephosphorylated by PEP in a
reaction catalyzed by pyruvate kinase. The conversion of ADP into ATP by pyruvate
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kinase results in the formation of pyruvate, which is then reduced by lactate
dehydrogenase using NADH as a cofactor to form lactic acid and NAD+. The
disappearance of NADH is monitored at 340 nm to determine the concentration of ribose in
solution. In this assay there is a 1:1 relationship between NADH oxidation by lactate
dehydrogenase and D-ribose phosphorylation by ribokinase, so the concentration of D-
ribose can be calculated by determining the amount of NADH consumed. The assay
solution (1 mL) contained 0.2 mM NADH, ImM PEP, 10 mM MgCl2, 3 mM ATP, 50
mM Tris-HCI buffer pH 7.8, 2 units of lactate dehydrogenase, 2 units of pyruvate kinase,
and 1 unit of ribokinase. The assay solution was equilibrated after the addition of the
enzymes, and then the assay was started by addition of a small aliquot of the unknown D-
ribose solution. The absorbance of NADH at 340 nm was monitored until no further
change was observed, and the total change in absorbance was used to calculate the amount
of NADH consumed, and therefore the amount of D-ribose present in the aliquot, using an
extinction coefficient of 6220 cm- 1M-1.
Enzyme purification and cloning
Several of the enzymes that were required for the enzymatic nucleotide forming
reactions are not commercially available, and those enzymes were obtained by purifying
them from strains of E. coli which overexpress the desired enzymes. Many plasmids and
overexpressing strains were generously donated to us by researchers who had previously
constructed or obtained these strains. In three cases (APRT, XGPRT, and UPRT) where
we were unable to obtain overexpressing strains, we constructed overexpressing strains
from the reported gene sequences of the desired proteins. Overexpression of the desired
enzymes allowed significant amounts of enzyme activity to be isolated with a minimum
amount of work, and this allowed a single protein purification to produce enough enzyme
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for multiple nucleotide forming reactions. Crude purifications (having only one column
chromatography step) of the overexpressed enzymes were found to be sufficient in
removing enzyme activities which would interfere with the nucleotide forming reactions,
and a general procedure for these purifications is described in this section.
Cloning the gene for adenine phosphoribosyltransferase. The gene
encoding E. coli adenine phosphoribosyltransferase (APRT) was cloned from the E. coli
strain JM109 genome based on the reported gene sequence (Hershey & Taylor, 1986)
using PCR with the oligonucleotides dCCG CGC GAA TTC ATG ACC GCG ACT GCA
CAG CAG CTT and dCCG GCG CTG CAG TTA ATG GCC CGG GAA CGG GAC
AAG as primers. The PCR product was digested with EcoR I and Pst I, and ligated into
expression plasmid pKK223-3, that had been prepared by digestion with EcoR I and Pst I
and dephosphorylation with calf intestinal alkaline phosphatase. Transformation of this
construct into E. coli strain JM109 produced an IPTG inducible adenine
phosphoribosyltransferase overproducing strain JM109/pTTA6. Overproduction of
adenine phosphoribosyltransferase by strain JM109/pTTA6 was confirmed by comparing
the activity of APRT in the crude lysate of IPTG induced strain JM109/pTTA6 with the
APRT activity in untransformed JM109 crude lysate. The crude lysate of strain
JM109/pTTA6 has over a hundred fold increase in adenine phosphoribosyltransferase
activity as compared to untransformed JM109 crude lysate.
Cloning the gene for xanthine-guanine phosphoribosyltransferase.
The gene encoding E. coli xanthine-guanine phosphoribosyltransferase (XGPRT) was
cloned from the E. coli strain JM109 genome based on the reported gene sequence (Pratt &
Subramani, 1983) using PCR with the oligonucleotides dCCG CGC GAA TTC ATG AGC
GAA AAA TAC ATC GTC ACC and dCCG GCG CTG CAG TTA GCG ACC GGA
GAT TGG CGG GAC as primers. The PCR product was digested with EcoR I and Pst I,
and ligated into expression plasmid pKK223-3, that had been prepared by digestion with
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EcoR I and Pst I and dephosphorylation with calf intestinal alkaline phosphatase.
Transformation of this construct into E. coli strain JM109 produced an IPTG inducible
xanthine-guanine phosphoribosyltransferase overproducing strain JM 109/pTTG2.
Overproduction of xanthine-guanine phosphoribosyltransferase by strain JM109/pTTG2
was confirmed by comparing the activity of XGPRT in the crude lysate of IPTG induced
strain JM109/pTTG2 with the XGPRT activity in untransformed JM109 crude lysate. The
crude lysate of strain JM109/pTTG2 has over a fifty fold increase in xanthine-guanine
phosphoribosyltransferase activity as compared to untransformed JM 109 crude lysate.
General Enzyme Purification scheme. All seven of the enzymes not
obtained commercially were overexpressed and purified using a similar purification
procedure. Cells were disrupted by sonication, and then cellular nucleic acids were
precipitated with streptomycin sulfate. After the streptomycin sulfate precipitation, an
ammonium sulfate precipitation of the desired proteins and subsequent dialysis of the
resupended ammonium sulfate pellets was used as a purification step and also to
concentrate and desalt the protein solution to prepare it for DEAE chromatography. The
concentrated and desalted protein solution was then submitted to DEAE anion exchange
chromatography as the final purification step. The general outline of this purification is
given below, with specific details and exceptions for each enzyme following.
Cells were grown at 370 C in either LB media or A+B minimal media of Clark and
Maalce (Clark & Maal0e, 1967) containing 50 gg/mL of ampicillin and supplemented as
indicated. All steps after cell growth were carried out in a 4' C cold room or on ice, unless
otherwise specified. Cells were harvested by centrifugation at 6000 g for 15 min. The cell
pellets were resuspended in the appropriate buffer and disrupted with thirty, 30 second
sonication bursts using a Fisher Scientific 550 Sonic Dismembrator on a setting of 7, with
a 2.5 minute interval between bursts. Cellular debris was removed by centrifugation at
31,000 g for 30 minutes. A 0.1 volume of a 20% streptomycin sulfate solution was then
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added to the protein supernatant. After stirring for 15 minutes, the resulting precipitate was
removed by centrifugation at 31000 g for 30 minutes. The supernatant was then
fractionated by ammonium sulfate precipitation. The ammonium sulfate pellets were
dissolved in the appropriate buffer and dialyzed against 2 L of buffer for 12 hours. The
resulting solution was then loaded onto a 2.5 x 14 cm DEAE column (DEAE-650M
Toyopearl resin from Supelco) that had been washed thoroughly with 3M KCl and then
equilibrated with H20. After loading the protein solution, the column was washed with
100 mL of H20, and the enzymes were eluted with a salt gradient collecting fractions every
8 mL. The column fractions were assayed for protein, then pooled and concentrated by
ammonium sulfate precipitation. Enzymes were stored at -20 ° C in 40-50% glycerol buffer
solutions.
Ribokinase. The partial purification of ribokinase was accomplished by a
simplified form of the method of Hope et. al. (Hope et al., 1986) using E coli. strain
MRi240 harboring the plasmid pJGK10. Hope et. al. report over 1000 fold increase in
ribokinase activity when strain MRi240/pJGK10 is grown on a ribose media and induced
with 3-p-indoleacrylic acid when compared to ribokinase activity of MRi240 which does
not contain plasmid pJGK10. After a five step purification with a 6.9% total recovery of
ribokinase activity, Hope et. al. report obtaining 780 units of ribokinase with a specific
activity of 156 units/mg protein from 38.6 g of wet cells. Here we report a shortened
version (with a higher % recovery) of the purification of Hope et. al. which results in
partially purified ribokinase which is suitable for enzymatic nucleotide forming reactions.
Inducible strain MRi240/pJGK10 was grown on A+B minimal media (Clark &
Maalae, 1967) supplemented with glucose (4g/liter), ribose (4g/liter), and thiamine (7
mg/liter). One liter of media was inoculated with a 5 mL overnight of MRi240/pJGK10.
The cells were grown to an OD of 0.6, then 1 mL of a solution of 3-f-indoleacrylic acid
dissolved in ethanol (25 mg/mL) was added to the culture to induce ribokinase production.
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Cells were harvested 14 hrs after the addition of 3-3-indoleacrylic acid, and the cell pellet
was resuspended in 40 mL of 50 mM potassium phosphate buffer pH 7.5, 2 mM 2-
mercaptoethanol (buffer A). Cell disruption, removal of cell debris, and streptomycin
sulfate precipitation were carried out as described in the general procedure. The 0-80%
saturation ammonium sulfate pellet was collected and dissolved in buffer A and dialysed
against 2 L of buffer A (this step concentrates and desalts the protein solution to prepare it
for DEAE chromatography). DEAE chromatography (2.5 x 14 cm DEAE column DEAE-
650M Toyopearl resin from Supelco) was performed with a 500 mL linear gradient of 0 to
300 mM KCl in buffer A. Column fractions were assayed for ribokinase activity using the
assay of Gross et. al. (Gross et al., 1983), and the ribokinase activity eluted at
approximately 160 mM KC1. Column fractions containing ribokinase activity were pooled
and concentrated with ammonium sulfate precipitation. The final ammonium sulfate pellet
was dissolved in a minimum amount of buffer A containing 40% glycerol. 700 units of
ribokinase were obtained from 1 liter of bacterial culture.
5-Phosphoribosyl-a-l-pyrophosphate synthetase. The partial
purification of 5-Phosphoribosyl-a--1-pyrophosphate synthetase (PRPP synthetase) was
accomplished by a modified form of the procedure that Switzer et. al. (Switzer & Gibson,
1978) used to purify PRPP synthetase from Salmonella typhimurium. Switzer et. al.
report obtaining 5400 units of PRPP synthetase with a specific activity of 103 units/mg
protein from 500 g of Salmonella typhimurium. cells after a six step purification. Here we
report a shortened version of the purification of Switzer et. al. conducted on cells from E.
coli plasmid harboring strain H0561/pHO 11 (Bjarne, 1985) which constitutively
overproduces PRPP synthetase.
A 5 mL overnight of strain H0561/pHO 11 (Bjarne, 1985), which constitutively
expresses PRPP synthetase, was used to inoculate a one liter culture in LB media which
was then grown for 12 hours. After cell harvest, the cell pellet was resuspended in 40 mL
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of 50 mM potassium phosphate buffer pH 7.5, 2 mM 2-mercaptoethanol (buffer A).
After sonication and removal of cellular debris, a 0.1 volume of 20% streptomycin sulfate
solution was added to the supernatant and stirred at 0* C for 15 minutes. Before
centrifuging, the streptomycin sulfate mixture (50 mL in a 125 mL glass Erlenmyer) was
heat treated in a water bath at 550 C for 5 minutes, and then immediately poured into a 500
mL stainless steel beaker which had been cooled to 0* C in an ice bath. The solution was
cooled at 00 C for 4-5 minutes, and then was poured into a centrifuge tube and the
resulting precipitate was removed by centrifugation at 31000 g for 30 minutes. The
supernatant was brought to 35% saturation of ammonium sulfate and stirred for 15
minutes. The ammonium sulfate pellet was collected and dissolved in 25 mL buffer A.
The pH of this solution was adjusted to 4.6 by addition of 1 M acetic acid at 00 C, followed
by immediate centrifugation for 10 minutes at 31000 g. The acid precipitate was collected
and dissolved in buffer A. No DEAE chromatography was used in the purification of
PRPP synthetase. The resulting solution was concentrated by ammonium sulfate
precipitation and stored in buffer A containing 50% glycerol. PRPP synthetase activity
was assayed using the method of Gross et. al. (Gross et al., 1983). From 1 liter of
bacterial culture, 47 units of PRPP synthetase were obtained.
Orotate phosphoribosyltransferase. The partial purification of orotate
phosphoribosyltransferase (OPRT) was accomplished by a modified form of the procedure
of Poulsen et. al. (Poulsen et al., 1983). After a six step purification Poulsen et. al. report
obtaining 2940 units of OPRT (specific activity of 397 units/mg protein) from 222 g of E.
coli cells containing the plasmid pKK6 which causes the overexpression of OPRT. Here
we report a shortened version of the purification of Poulsen et. al. conducted on E. coli
strain JM 109 harboring the plasmid pJTA43 (Jensen et al., 1992) which causes similar
overexpression of OPRT compared to the plasmid pKK6.
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Strain JM109/pJTA43 (Jensen et al., 1992), which constitutively expresses OPRT,
was grown on LB media. One liter of medium was inoculated with a 25 mL overnight
culture, and shaken for 14 hours at 370 C. The cells were harvested and resuspended in 40
mL of 100 mM Tris buffer pH 7.6, 2 mM EDTA, 2 mM 2-mercaptoethanol (buffer B).
Sonication, removal of cellular debris, and streptomycin sulfate precipitation were carried
out as described in the general procedure. The 0-75% saturation ammonium sulfate pellet
was collected from the supernatant of the streptomycin sulfate precipitation, and then
dialyzed against buffer B (this step concentrates and desalts the protein solution to prepare
it for DEAE chromatography). The dialysate was subjected to DEAE chromatography (2.5
x 14 cm DEAE column DEAE-650M Toyopearl resin from Supelco), eluting with 500 mL
linear gradient from 50-300 mM KCl in buffer B. Column fractions were assayed for
OPRT activity according to the method of Schwartz and Neuhard (Schwartz & Neuhard,
1975). Fractions containing OPRT (eluting at approximately 170 mM KC1) were pooled
and ammonium sulfate precipitated. The ammonium sulfate pellet was dissolved in a
minimum amount of buffer B containing 40% glycerol. From one liter of culture, 31 units
of orotate phosphoribosyltransferase were obtained.
Orotidine-5'-monophosphate decarboxylase. The partial purification of
OMP decarboxylase was accomplished by a modified version of the procedure of
Turnbough et al. (Turnbough et al., 1987). After a five step purification Turnbough et al.
report obtaining 294 units of OMP decarboxylase (specific activity 146 units/mg) from 2L
of E. coli strain N 100 containing the plasmid pDK26, which causes constitutive
overexpression of OMP decarboxylase. Here we report a shortened version of the
purification of Turnbough et al., also conducted on strain N100/pDK26, which produces
OMP decarboxylase which is suitable for use in enzymatic nucleotide forming reactions.
Strain N100/pDK26 (Turnbough et al., 1987), which constitutively overproduces
orotidine-5'-monophosphate decarboxylase (OMP decarboxylase), was grown on A+B
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minimal media (Clark & Maal0e, 1967) supplemented with 8 g glucose, 0.5 g of casamino
acids, 1 mL of 240 mM UMP, and thiamine (7 mg/liter). One liter of medium was
inoculated with a 5 mL overnight culture, then shaken at 370 C for 12 hours. After cell
harvest, the cells were resuspended in 40 mL of 64 mM Tris buffer (pH 7.8) with 5 mM 2-
mercaptoethanol (buffer C). Sonication, removal of cellular debris, and streptomycin
sulfate precipitation were carried out as described in the general procedure. The 45-75%
ammonium sulfate pellet was collected from the supernatant of the streptomycin sulfate
precipitation, and dissolved in buffer C for dialysis. The resulting dialysate was subjected
to DEAE chromatography (2.5 x 14 cm DEAE column DEAE-650M Toyopearl resin from
Supelco), eluting with a 500 mL linear gradient of 0-300 mM NaCl in buffer C. Column
fractions containing OMP decarboxylase were detected by the method of Turnbough et. al..
(Turnbough et al., 1987). Active fractions (eluting at approximately 140 mM NaCl) were
pooled, ammonium sulfate precipitated, and stored in buffer C containing 40% glycerol.
From one liter of culture, 400 units of OMP decarboxylase were obtained.
Adenine Phosphoribosyltransferase. Adenine phosphoribosyltransferase
(APRT) was purified from an IPTG inducible, APRT overproducing strain which we
constructed (JM109/pTTA6). The purification of APRT is based upon the general
purification scheme that was used for the other enzymes in this section. Parkin et. al.
(Parkin et al., 1984) report a purification of APRT from E. coli strain K12 (no
overexpression) where they obtain 2.5 units of APRT (specific activity 2.1 units/mg) from
cells obtained from 12 liters of media. The overexpression of APRT in E. coli strain
JM109/pTTA6 greatly increases the number of units of activity which can be obtained per
liter of media.
IPTG inducible, adenine phosphoribosyltransferase (APRT) overproducing strain
JM109/pTTA6 was grown on A+B minimal medium (Clark & Maal0e, 1967)
supplemented with 22 mL glycerol, 2 g of glucose, and thiamine (7 mg/liter). The medium
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was inoculated with a 5 mL overnight culture and grown for 12 hours, then induced with
IPTG (.234g/liter) and grown for another 6 hours. Cell harvest and streptomycin sulfate
precipitation were carried out as described in the general procedure using 64 mM Tris
buffer (pH 7.8) with 5 mM 2-mercaptoethanol (buffer C). The 0-80% ammonium sulfate
precipitate was collected from the supernatant of the streptomycin sulfate precipitation, and
the ammonium sulfate pellet was dialyzed against buffer C (this step concentrates and
desalts the protein solution to prepare it for DEAE chromatography). Then the protein
solution was subjected to DEAE chromatography (2.5 x 14 cm DEAE column DEAE-650M
Toyopearl resin from Supelco) with a 500 mL linear gradient of 0-300 mM KCI in buffer
C. Column fractions containing APRT (eluting at approximately 150 mM KC1) were
detected by the non radioactive APRT assay described below. The fractions containing
APRT were pooled, ammonium sulfate precipitated, and finally dissolved in a minimum
amount of buffer C containing 50% glycerol and stored at -20 ° C. From 1 liter of culture,
360 units of APRT were obtained.
Adenine PPi
myokinase
PRPP AMP
APRT (
ATP DP)
L-lactic
dehydrogenase
Lactate Pyruvate pyruva PEP
pyruvate
NAD* INADHI kinase
t
Observe at 340 nm
Figure 6.3 Adenine phosphoribosyltransferase (APRT) assay utilizing
myokinase, pyruvate kinase, and L-lactic dehydrogenase to couple AMP formation by
APRT to NADH oxidation. (Note: two equivalents of ADP are produced for each AMP
formed by APRT.)
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Adenine Phosphoribosyltransferase Assay. Adenine
phosphoribosyltransferase (APRT) activity was measured by coupling the APRT reaction
to oxidation of NADH with the enzymes myokinase, pyruvate kinase, and L-lactic
dehydrogenase, Figure 6.3. This assay is similar to the PRPP synthetase assay of Gross
et al. (Gross et al., 1983). AMP that is formed by APRT is then phosphorylated by
myokinase and ATP to form 2 equivalents of ADP. ADP is then phosphorylated by PEP
and pyruvate kinase to form pyruvate, which is reduced by L-lactic dehydrogenase and
NADH to produce lactate. Two equivalents of NADH are consumed for each AMP formed
by APRT. Conversion of NADH to NAD+ was monitored at 340 nm. The assay solution
(1 mL) contained 0.2 mM NADH, 1 mM PEP, 10 mM MgCl2, 1.5 mM PRPP, 1.5 mM
adenine hydrochloride, 3 mM ATP, 50 mM Tris-HCI buffer pH 7.8, 2 units of lactate
dehydrogenase, 2 units of pyruvate kinase, and 2 units of myokinase. The assay solution
was equilibrated, a 20 gl aliquot of APRT solution was added to start the assay, and the
absorbance change at 340 nm was monitored as a function of time. The activity was
obtained using an extinction coefficient of 6220 cm-1M-1 for NADH.
Xanthine-Guanine Phosphoribosyltransferase. Xanthine-guanine
phosphoribosyltransferase (XGPRT) was purified from an IPTG inducible, XGPRT
overproducing strain which we constructed (JM109/pTTG2). The purification of XGPRT
is based upon the general purification scheme that was used for the other enzymes in this
section.
IPTG inducible, xanthine-guanine phosphoribosyltransferase (XGPRT)
overproducing strain JM109/pTTG2 was grown on 1 liter of LB media inoculated with a 5
mL overnight culture for 12 hours, then induced with IPTG (.234g/liter) and grown for
another 6 hours. Cells were harvested and streptomycin sulfate precipitated as in the
general procedure using 64 mM Tris buffer (pH 7.8) with 5 mM 2-mercaptoethanol
(buffer C). The 0-75% ammonium sulfate fraction was collected from the supernatant of
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the streptomycin precipitation, then dialyzed against buffer C (this step concentrates and
desalts the protein solution to prepare it for DEAE chromatography). The dialysate was
subjected to DEAE chromatography (2.5 x 14 cm DEAE column DEAE-650M Toyopearl
resin from Supelco) with a 500 mL gradient of 50-300 mM KCI in buffer C. Column
fractions containing XGPRT were identified by SDS PAGE gel electrophoresis, pooled,
concentrated by ammonium sulfate precipitation, and stored in buffer C containing 50%
glycerol. Xanthine-guanine phosphoribosyltransferase activity was estimated by the
method described below, and from 1 liter of culture, 28 units of XGPRT were obtained.
Xanthine-Guanine Phosphoribosyltransferase Assay. Xanthine-guanine
phosphoribosyltransferase activity was estimated by observing GMP formation in a small
(2 mL) GMP forming reaction by injecting aliquots onto an HPLC column as described in
the preparative nucleotide synthesis section below. The assay conditions were as follows
for a 2 mL reaction: 1 mM PRPP, 10 mM MgCl2, 50 mM potassium phosphate buffer pH
7.5, 1 mg of solid guanine, and 1 unit of inorganic pyrophosphatase (obtained from
Sigma). The reaction was stirred at room temperature and initiated by adding an aliquot of
XGPRT solution. The time elapsed before the reaction was complete, determined by GMP
formation observed by HPLC, was used to calculate the activity of the XGPRT solution.
This method provides a very rough estimate of the activity of the XGPRT solution since the
rate of the reaction is dependent upon the rate of the dissolution of guanine as well as the
activity of the XGPRT solution. However, the assay is very similar to our GTP forming
reactions, and thus suitable for empirical determination of the amount of XGPRT required
for preparative reactions.
CTP Synthetase. CTP synthetase was purified by a modified form of the
procedure of Anderson (Anderson, 1983). After a five step purification Anderson reports
obtaining 96 units of CTP synthetase from 200g of E. coli B (no overexpression), specific
activity 8.7 units/mg. Here we report a shortened version of the purification of Anderson
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which is conducted on E. coli strain JM109 harboring the plasmid pMW5 (Weng et al.,
1986), which causes a 50-fold increase in CTP synthetase activity.
A 1 liter flask of LB medium was inoculated with a 5 mL overnight culture of strain
JM109/pMW5 (Weng et al., 1986), which constitutively overproduces CTP synthetase.
The cells were grown for 12 hours, and then harvested. Sonication was performed as
described in the general procedure in 64 mM Tris buffer (pH 7.8) with 5 mM 2-
mercaptoethanol (buffer C) containing 20 mM glutamine. Removal of cellular debris and
streptomycin sulfate precipitation were conducted as in the general procedure. From the
resulting supernatant, the 0-65% ammonium sulfate pellet was extracted, and the
ammonium sulfate pellet was dissolved in buffer C containing 4 mM glutamine and
dialyzed against the same buffer (this step concentrates and desalts the protein solution to
prepare it for DEAE chromatography). The dialysate was subjected to DEAE
chromatography (2.5 x 14 cm DEAE column DEAE-650M Toyopearl resin from Supelco)
with a 500 mL gradient of 50-300 mM potassium phosphate buffer, pH 7.5, containing 70
mM 2-mercaptoethanol and 4 mM glutamine. Column fractions were assayed by the
method of Anderson (Anderson, 1983), and fractions containing CTP synthetase (eluting
at approximately 170 mM potassium phosphate) were pooled, ammonium sulfate
precipitated, and dissolved in a minimum amount of buffer B containing 50% glycerol.
From 1 liter of culture, 38 units of CTP synthetase activity were obtained.
Enzymatic synthesis of NTPs from D-3',4',5'.5"-d4-ribose (Figures 6.4-6.6)
Previously reported procedures (Gross et al., 1983, Parkin et al., 1984, Simon et
al., 1989, Nikonowicz et al., 1992; Batey et al., 1992) were used as the starting point for
the design of the enzymatic reactions presented here. The enzymatic reactions which
convert ribose into NTPs require several enzymes some of which are commercially
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available and others which had to be purified from overexpressing strains. Smaller
amounts of the more expensive enzymes or those enzymes which had to be purified from
overexpressing strains were used in the enzymatic reactions because those enzymes were
difficult to obtain and valuable. Larger amounts of the inexpensive enzymes (such as the
ATP regeneration enzymes enolase and pyruvate kinase) were added to the enzymatic
reactions to insure that the rates of the reactions were not dependent upon those inexpensive
enzyme activities. The rates of the nucleotide forming reactions were highly dependent
upon the concentration of ATP in the reactions as well as the amount of the different
enzymes added. Longer reaction times were required for the enzymatic GTP and UTP
forming reactions compared to the ATP forming reaction because only small catalytic
amounts of ATP were added to the GTP and UTP forming reactions. The enzymatic
reactions were monitored by HPLC using a Vydac nucleotide column which allowed
detection and rough quantitation of all of the NMPs, NDPs, and NTPs formed in the
nucleotide reactions as well as the bases adenine and orotic acid (guanine was not detected
by HPLC because of its low solubility in H20). The disappearance of starting material
(adenine or orotic acid) and the appearance of the final product (NTPs) could be monitored
in the enzymatic reactions using HPLC. In addition, ATP regeneration could also be
monitored by HPLC by observing the phosphorylated state of the catalytic ATP in HPLC
traces (that is, whether the majority of adenine nucleotides are present as ATP, ADP or
AMP).
Preparative Nucleotide Synthesis. All enzymatic reactions were carried out
under argon to reduce the rate of oxidation of enzymes. Reactions were monitored by
HPLC on a 25x4.6 mm Vydac 303NT405 nucleotide column, using a linear gradient from
100% buffer A (0.045M ammonium formate brought to pH 4.6 with phosphoric acid) to
100% buffer B (0.5M NaH2PO4 brought to pH 2.7 with formic acid) in 10 min at a flow
rate of 1 mL/min, with detection at 254 nm. Potassium phosphate buffer (50mM) was
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used in reactions containing PRPP synthetase because the enzyme is inactivated in
solutions with low phosphate concentration (Switzer & Gibson, 1978). The pH of the
reactions was determined every 6-12 hours using pH paper, and adjusted periodically with
1M NaOH or HCI to maintain the pH between 7.0 and 7.9. NTPs were purified by using
boronate affinity chromatography as described in the general procedures section of this
chapter.
3', 4', 5', 5"-d4-Adenosine 5'-triphosphate (2). Crude 3',4',5',5"-d4-
ribose (+1) containing 42.3 mg, 275 gmoles D-3',4',5',5"-d4-ribose, as determined by
enzymatic ribose assay, was placed in a three neck flask containing adenine hydrochloride
(87.5 mg, 510 pmol) and sodium 3-phosphoglycerate (2.55 mmol). This was dissolved in
50 mL of a solution containing 10 mM MgC12, 10 mM dithiothreitol, and 50 mM
potassium phosphate buffer pH 7.5. Argon was bubbled through this solution for 5
minutes to remove oxygen. To this solution was added 125 units of phosphoglycerate
mutase, 50 units of enolase, 200 units of pyruvate kinase, 25 units of myokinase, 5 units
of ribokinase, 2 units of PRPP synthetase, and 2 units of adenine
phosphoribosyltransferase. The reaction was initiated by adding a catalytic amount of ATP
(0.5 mg, 0.9 gmol) to this solution. The reaction was stirred at 250 C and monitored by
HPLC. The pH was maintained between 7.0 and 7.9 with IM HC1. An additional 0.5
mmol of 3-phosphoglycerate was added every 5 hours. Formation of ATP was initially
slow , but increased as the reaction proceeded due to the increase in ATP concentration.
The reaction was stopped after 29 hours by concentration under vacuum and storage at -20 °
C. Purification of the 3',4',5',5"-d4-ATP (2) was accomplished by boronate affinity
chromatography. The 3',4',5',5"-d4-ATP (2) was quantitated by absorption at 259 nm
(6259 = 15400 cm-lmol-1). This reaction yielded 213 gmoles of 3',4',5',5"-d4-ATP (2)
(78% yield). 1H NMR (500 MHz, D20) 5 8.55 (s, 1H), 8.26 (s, 1H), 6.14 (d, 1H, J =
6.0 Hz), 4.80 (d, 1H, J = 6.0 Hz); MS m/z 510.1 (510.07 calcd for
C10H11 2 H4N5013P3).
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3',4',5',5"-d4-Guanosine 5'-triphosphate (3). Crude 3',4',5',5"-d4-
ribose (+1) containing 42.3 mg, 275 gmoles D-3',4',5',5"-d4-ribose, as determined by
enzymatic ribose assay, was placed into a three neck flask containing guanine (77.1 mg,
510 gmol) and sodium 3-phosphoglycerate (2.55 mmol). This was mixed with 50 mL of a
solution containing 10 mM MgCl2, 10 mM dithiothreitol, and 50 mM potassium phosphate
buffer pH 7.5. Argon was bubbled through this inhomogeneous solution for 5 minutes to
remove oxygen. To this mixture was added 250 units of phosphoglycerate mutase, 100
units of enolase, 200 units of pyruvate kinase, 38 units of myokinase, 5 units of
ribokinase, 2 units of PRPP synthetase, and (0.2 units) units of xanthine-guanine
phosphoribosyltransferase. The reaction was initiated by adding 4.4 pmoles of
3',4',5',5"-d4-ATP (2). The reaction was stirred at 250 C and monitored by HPLC. The
pH was maintained between 7.0 and 7.9 with IM HC1. Additional 3-phosphoglycerate
was added to the reaction at a rate of 0.24 mmol every 5 hours. After four hours 2 units of
guanylate kinase were added, and after 21 hours, an additional 4.4 gmoles of 3',4',5',5"-
d4-ATP (2) were added. The reaction was stopped after 72 hours by concentration under
vacuum and storage at -20' C. Purification of the 3',4',5',5"-d4-GTP (3) was
accomplished by boronate affinity chromatography. The 3',4',5',5"-d4-GTP (3) was
quantitated by the absorbance at 253 nm ( GTP 8253 = 13700 cm-lmol-1). This reaction
yielded 206 gmoles of (3) (75% yield). 1H NMR (500 MHz, D20) 8 8.14 (s, 1H), 5.93
(d, 1H, J = 6.0 Hz), 4.80 (d, 1H, J = 6.0 Hz); MS m/z 526.2 (526.07 calcd for
C 10H11 2 H4N5014P3).
3',4',5',5"-d4-Uridine 5'-triphosphate (4). Crude 3',4',5',5"-d4-ribose
(+±1) containing 84.7 mg, 550 gmoles D-3',4',5',5"-d4-ribose, as determined by
enzymatic ribose assay, was placed into a three neck flask containing potassium orotate
(198 mg, 1.02 mmol) and sodium 3-phosphoglycerate (10.2 mmol). This was dissolved
in 100 mL of a solution that contained 10 mM MgCl2, 10 mM dithiothreitol, and 50 mM
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potassium phosphate buffer pH 7.5. Argon was bubbled through this solution for 5
minutes to remove oxygen. To this solution was added 375 units of phosphoglycerate
mutase, 150 units of enolase, 300 units of pyruvate kinase, 38 units of myokinase, 5 units
of ribokinase, 2 units of PRPP synthetase, 1.5 units of orotate phosphoribosyltransferase,
and 10 units of orotidine-5'-monophosphate decarboxylase. The reaction was initiated by
adding 6.5 gmoles of 3',4',5',5"-d4-ATP (2), and then stirred at 250 C. The reaction was
monitored by HPLC, and the pH was maintained between 7.0 and 7.9 with IM HC1. An
additional 0.35 mmol of 3-phosphoglycerate was added every 5 hours. After four hours 1
unit of nucleoside monophosphate kinase was added to catalyze the formation of UDP from
UMP. After 21 hours, 10.9 .moles of 3',4',5',5"-d4-ATP (2) was added to stimulate the
rate of UTP formation. The reaction was stopped after 72 hours by concentration under
vacuum and storage at -20 ° C. Purification of the 3',4',5',5"-d4-UTP (4) was
accomplished by boronate affinity chromatography. The 3',4',5',5"-d4-UTP (4) was
quantitated by the absorbance at 260 nm ( e260 = 10000 cm-1mol-1). This reaction yielded
495 gmoles of 3',4',5',5"-d4-UTP (4) (90% yield). 1H NMR (500 MHz, D20) 8 7.96
(d, 1H, J = 8.1 Hz), 5.99 (d, 1H, J = 5.4 Hz), 5.97 (d, 1H, J = 8.4 Hz), 4.38 (d, 1H, J =
5.4 Hz); MS m/z 487.1 (487.05 calcd for C9H10 2 H4N2015P3).
3',4',5',5"-d4-Cytidine 5'-triphosphate (5). 3',4',5',5"-d4-UTP (4)
(247 jmol), glutamine (369 mg, 2.52 mmol), and sodium 3-phosphoglycerate (505 tmol)
were placed into a three neck flask. This was dissolved in 250 mL of a solution containing
10 mM MgCl2 and 50 mM Tris-HCI buffer pH 7.8. Argon was bubbled through this
solution for 5 minutes to remove oxygen. To this solution was added 250 units of
phosphoglycerate mutase, 100 units of enolase, 200 units of pyruvate kinase, and 5.5 units
of cytidine 5'-triphosphate synthetase. To initiate the reaction 26.9 gmoles of 3',4',5',5"-
d4-ATP (2) and 2.5 gmoles of 3',4',5',5"-d4-GTP (3) were added. The reaction was
stirred at 250 C and monitored by HPLC. After 3.5 hours, 26.9 gmoles of 3',4',5',5"-d4-
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ATP, 2.5 gmoles of 3',4',5',5"-d4-GTP, and 0.86 mmoles of 3-phosphoglycerate were
added to stimulate the rate of the reaction. The reaction was stopped after 8 hours by
concentration under vacuum and storage at -20' C. Purification of the 3',4',5',5"-d4-CTP
(5) was accomplished by DEAE chromatography. The 3',4',5',5"-d4-CTP was eluted
from the DEAE resin with a triethylammonium bicarbonate (TEABC) salt gradient (0-500
mM TEABC, the nucleotides eluted from 250-500 mM TEABC.). Boronate affinity
chromatography was not possible due to the use of tris buffer, which binds to the boronate
affinity resin. The 3',4',5',5"-d4-CTP (5) was quantitated by absorbance at 259 nm and
280 nm, using the extinction coefficients 8259ATP=15400, S280ATP=1911,
E259CTP=7204, and e280CTP=6905. This reaction yielded 215 gmoles of 3',4',5',5"-
d4-CTP (5) (87% yield). 1H NMR (500 MHz, D20) 8 8.07 (d, 1H, J = 7.7 Hz), 6.21 (d,
1H, J = 7.7 Hz), 5.99 (d, 1H, J = 4.4 Hz), 4.34 (d, 1H, J = 4.4 Hz); MS m/z 486.1
(486.06 calcd for C9H1 12 H4N3014P3).
Chapter 3 Experimental
Cloning and Purification of Uracil Phosphoribosyltransferase
Cloning the gene for uracil phosphoribosyltransferase. The gene
encoding E. coli uracil phosphoribosyltransferase was cloned from the E. coli strain JM109
genome based on the reported gene sequence (Andersen et al., 1992) using PCR with the
oligonucleotides dCCG CGC GAA TTC TTG AAG ATC GTG GAA GTC AAA CAC and
dCCG GCG AAG CTT TTT CGT ACC AAA GAT TTT GTC ACC as primers. The PCR
product was digested with EcoR I and Hind III, and ligated into expression plasmid
pKK223-3, that had been prepared by digestion with EcoR I and Hind III and
dephosphorylation with calf intestinal alkaline phosphatase. Transformation of this
construct into E. coli strain JM109 produced an IPTG inducible uracil
160
Chapter 6
phosphoribosyltransferase overproducing strain JM109/pTTU2. Overproduction of uracil
phosphoribosyltransferase by strain JM109/pTTU2 was confirmed by comparing the
activity of UPRT in the crude lysate of IPTG induced strain JM109/pTTU2 with the UPRT
activity in untransformed JM109 crude lysate. Due to the sensitivity of the
spectrophotometric UPRT assay (described below), no UPRT activity could be detected in
the untransformed JM109 crude lysate, but overproduction of UPRT in strain
JM109/pTTU2 allowed detection of UPRT activity in its crude lysate (indicating at least a
ten fold increase in UPRT activity).
Purification of Uracil Phosphoribosyltransferase Uracil
phosphoribosyltransferase (UPRT) was purified from an IPTG inducible, UPRT
overproducing strain which we constructed (JM109/pTTU2). The purification of UPRT is
based upon the general purification scheme that was used for the other enzymes in this
section. Rasmussen et. al. (Rasmussen et al., 1986) report a purification of UPRT from a
plasmid harboring strain of E. coli which overproduces UPRT 15-fold. From 72g of cells,
Rasmussen et. al. report obtaining 73 units of UPRT with a specific activity of 6.6
units/mg.
IPTG inducible, uracil phosphoribosyltransferase (UPRT) overproducing strain
JM109/pTTU2 was grown on 2 liters of LB media containing 50 pg/mL of ampicillin for
12 hours at 370 C after being inoculated with a 5 mL overnight culture, then induced with
IPTG (0.23 g/liter) and grown for another 6 hours. All steps after cell growth were carried
out in a 40 C cold room or on ice. Cells were harvested by centrifugation at 6000 g for 15
min. The cell pellets were resuspended in 65 mM Tris buffer (pH 7.8) with 5 mM 2-
mercaptoethanol (buffer A) and disrupted with thirty, 30 second sonication bursts using a
Fisher Scientific 550 Sonic Dismembrator on a setting of 7, with a 2.5 minute interval
between bursts. Cellular debris was removed by centrifugation at 31,000 g for 30 minutes.
A 0.1 volume of a 20% streptomycin sulfate solution was then added to the protein
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supernatant. After stirring for 15 minutes, the resulting precipitate was removed by
centrifugation at 31000 g for 30 minutes. The 0-75% ammonium sulfate fraction was
collected from the supernatant of the streptomycin precipitation, then dialyzed against
buffer A (this step concentrates and desalts the protein solution to prepare it for DEAE
chromatography). The dialysate was subjected to DEAE chromatography (2.5 x 14 cm
DEAE column DEAE-650M Toyopearl resin from Supelco) with a 500 mL gradient of 50-
300 mM KCl in buffer A. Column fractions containing UPRT were identified by UPRT
assay (peak fractions eluted at approximately 140 mM KC1), pooled, concentrated by
ammonium sulfate precipitation, and stored at -20' C in buffer A containing 50% glycerol.
Uracil phosphoribosyltransferase activity was determined by the method described below,
and from 2 liters of culture, approximately 40 units of UPRT were obtained.
O
H2N H5 X
oil N I H6 HH5H
Uracil . 1 0 N H6
+ O-P-
o OI  UPRT
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- 0O OH OH
PPi UMP
OH OH
PRPP
Figure 6.7 The spectrophotometric uracil phosphoribosyltransferase assay is
based upon the change in extinction coefficients at 271 nm between uracil and UMP
(AE271=2763 cm-1M- 1).
Uracil phosphoribosyltransferase assay. A spectrophotometric assay of
uracil phosphoribosyltransferase (UPRT) activity was developed to detect and quantitate
UPRT activity, Figure 6.7. This assay was based on the change of absorbance at 271 nm
that occurs when uracil is converted into UMP. The assay solution (1 mL) contained 50
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mM tris-HCl, 5 mM MgCl2, 0.1 mM uracil, and 1.5 mM PRPP. The assay was started by
addition of a small aliquot of UPRT solution, and the absorbance of the solution was
monitored at 271 nm as a function of time. The activity of the UPRT solution was
determined using a change in extinction coefficient at 271 nm of 2763 cm-1M-1 for the
conversion of uracil into UMP.
Enzymatic synthesis of NTPs from Glucose (Figures 6.8 and 6.9)
The enzymatic conversions of glucose into the 4 NTPs of RNA described in this
section were based upon previously reported procedures (Parkin et al., 1984; Parkin &
Schramm, 1987; Rising & Schramm, 1994) and also the enzymatic reactions which are
described in Chapter 2 of this thesis. All of the additional pentose phosphate pathway
enzymes required to convert glucose into PRPP are commercially available. Uracil
phosphoribosyltransferase was cloned and purified in order to be able to use uracil as the
starting base for the pyrimidine nucleotides instead of orotic acid. Instead of producing
each nucleotide separately as described in Chapter 2, many of the procedures in this
section describe the conversion of glucose into ATP, GTP, and UTP in a single enzymatic
reaction. This was done to reduce the number of reactions and the amount of work
necessary to produce isotopically labeled RNA from glucose. The rates of the glucose
nucleotide forming reactions were highly dependent upon the concentration of cofactors
(ATP and NADP+) in the reactions as well as the amount of the different enzymes added.
In reactions where ATP was to be synthesized in combination with other nucleotides, ATP
was synthesized first in order to increase the activity of enzymes whose activities depended
on ATP concentration, and then the other nucleotides were synthesized. Catalytic amounts
of ATP and NADP+ were used in the glucose enzymatic reactions, and this resulted in
slow enzymatic reactions which could take up to a week or more to go to completion.
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Figure 6.8 Enzymatic conversion of fully deuterated glucose into PRPP
showing possible hydrogen exchange of what will become the H1' and H2'
of NTPs and subsequent conversion of PRPP into the four NTPs of RNA.
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Figure 6.9 Different isotopically labeled NTPs synthesized from
1,2,3,4,5,6,6-drglucose (21), 1,2,3,4,5,6- 13C6-glucose (22), and
1,2,3,4,5,6,6-dr1,2,3,4,5,6- 13C6-glucose (23) in this thesis. The
solvent (which determines H2' labeling), and whether glucose-
6-phosphate isomerase was used to exchange the H1' is indicated
for each type of nucleotide forming reaction.
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Preparative Nucleotide Synthesis. Reactions were monitored by HPLC on a
25x4.6 mm Vydac 303NT405 nucleotide column, using a linear gradient from 100% buffer
A (0.045M ammonium formate brought to pH 4.6 with phosphoric acid) to 100% buffer B
(0.5M NaH2PO4 brought to pH 2.7 with formic acid) in 10 minutes at a flow rate of 1
mL/min, with detection at 260 or 254 nm. Potassium phosphate buffer (50mM) was used
in reactions containing PRPP synthetase because the enzyme is inactivated in solutions with
low phosphate concentration (Switzer & Gibson, 1978). The pH of the reactions was
determined every 6-12 hours using pH paper, and adjusted periodically with IM NaOH or
HCl (or NaOD or DCl for reactions run in D20) to maintain the pH between 7.0 and 7.9.
In reactions that are to be conducted for an extended periods of time it is useful to add some
ampicillin (=50 gg/mL) to prevent bacterial growth in the reactions. Generally, in reactions
where ATP was to be formed, a small catalytic amount of ATP was added to start the
reaction, and the enzymes required for ATP formation were added first. Once a significant
amount of ATP had formed in the reaction, the remaining enzymes for the other NTP
formation were added. This was done to increase the rate of the reactions since the
activities of many of te enzymes in the reactions are dependent on ATP concentration. In
reactions where no ATP was to be formed, a greater initial amount of ATP is added to the
reaction.
Preparation of 1',2',3',4',5',5'-2 H6[-ATP (24), -GTP (25), and
-UTP (26)]. Into a Millipore 10,000 MWC centricon were placed 188 units of
phosphoglycerate mutase, 100 units of enolase, 75 units of pyruvate kinase, 50 units of
myokinase, 75 units of L-glutamic dehydrogenase, 60 units of hexokinase, 15 units of
glucose-6-phosphate dehydrogenase, 5 units of 6-phosphogluconic dehydrogenase, 100
units of phosphoriboisomerase, 2.7 units of PRPP synthetase, 1.3 unit of adenine
phosphoribosyltransferase, 2 units of xanthine-guanine phosphoribosyltransferase, 2 units
of uracil phosphoribosyltransferase, 1 unit of guanylate kinase, and 0.5 units of nucleoside
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monophosphate kinase. The enzyme solution was centrifuged at 6000 rpm until 90-95% of
its original volume had passed through the centricon dialysis membrane. Then 1.5 mL of
D20 were added to the centricon, and the centricon was again centrifuged at 6000 rpm until
90-95% of the liquid had passed through the filter. This was repeated twice more, and then
the enzymes were considered to have been exchanged into D20 and ready to be added to
the reaction.
Into a 300 mL round bottom flask were placed sodium 3-phosphoglycerate (6.8
mmol), adenine hydrochloride (0.034 g, 0.2 mmol), o-ketoglutaric acid (0.580 g, 4.0
mmol), NH4Cl (0.30 g, 5.6 mmol), MgC12 (0.6 mmol), dithiothreitol (0.21 g, 1.4 mmol),
3 mL of IM potassium phosphate buffer pH = 7.5, and 60 mL of H20. The pH of the
resulting solution was adjusted to 7.7 with IM NaOH, and then the mixture was
concentrated to dryness under vacuum. The residue was dissolved in 10 mL of D20 and
concentrated to dryness under vacuum, this was repeated three times total. The D20
exchanged residue was dissolved in 60 mL of D20, and the pD of the solution was
adjusted to 7.5 with DC1 and NaOD. The D20 exchanged enzyme solution was added to
the mixture, and then d6-ATP (1.7 gmole) from a previous reaction, NADP+ (0.005 g, 7
gmol), and 1',2',3',4',5',6',6- 2 H7-glucose (0.150 g, 0.8 mmol) were added to start the
reaction. After 40 hours a significant amount of the adenine had been converted into d6-
ATP (24), and so guanine (0.30 g, 0.2 mmol) and uracil (0.45 g, 0.4 mmol) were added
to the reaction to begin GTP and UTP formation. Additional D20 exchanged 3-PGA (1
mmol) was added to the reaction after 6 days, and the reaction was stopped by freezing it
after 7 days. The mixture was purified by boronate chromatography, and nucleotides were
quantitated by UV absorbance at 260 nm, assuming a 1:1:2 ratio of ATP:GTP:UTP. Using
this quantification, 84% of the 2 H7-glucose was converted into nucleotides and recovered.
Half of this product was used to make d6-CTP (27), and half was used directly in
transcription reactions. Characterization was conducted on the mixture of products
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resulting from this reaction, 1H NMR and mass spectrometry analysis were consistent
with a mixture of d6-ATP (24), d6-GTP (25), and d6-UTP (26) in a 1:1:2 ratio. 1H
NMR (600 MHz, D20) 8 8.55 (s, 1H), 8.29 (s, 1H), 8.13 (s, 1H), 7.97 (d, 1H, J = 8.4
Hz), 5.98 (d, 1H, J = 8.4 Hz); MS nm/z 512.0, 528.0, 489.0 (512.08, 528.08, 489.06
calcd for C 10H9D6013N5P3, C 10H9D6014N5P3, C9H8D6015N2P3 respectively).
Preparation of 1',2',3',4',5',5'-2 H6-CTP (27) from a mixture of d6-
ATP (24), d6-GTP (25), and d6-UTP (26). Into a 500 mL 3-neck flask were
placed half of the purified nucleotide mixture from the previous reaction containing d6-ATP
(24) (0.084 mmol), d6-GTP (25) (0.084 mmol), and d6-UTP (26) (0.168 mmol). To
this were added NH4Cl (0.535 g, 10.0 mmol), sodium 3-phosphoglycerate (0.5 mmol),
and 250 mL of a solution containing 5 mM MgCl2 and 1 mM dithiothreitol. To start the
reaction, 62 units of phosphoglycerate mutase, 50 units of enolase, 50 units of pyruvate
kinase, 5 units of myokinase, and 3 units of CTP synthetase were added to the reaction.
This was stirred for 48 hours and then the reaction was purified by boronate
chromatography. The yield for this reaction was 97% as determined by UV absorbance.
Characterization was conducted on the mixture of products resulting from this reaction, 1H
NMR and mass spectrometry analysis were consistent with a mixture of d6-ATP (24), d6-
GTP (25), d6-CTP (27) in a 1:1:2 ratio. 1H NMR (600 MHz, D20) 8 8.53 (s, 1H), 8.27
(s, 1H), 8.13 (s, 1H), 7.99 (d, 1H, J = 7.2 Hz), 6.17 (d, 1H, J = 7.2 Hz); MS m/z 512.0,
528.0, 488.0 (512.08, 528.08, 488.07 calcd for C10H9D6013N5P3,
C10H9D6014N5P3, C9H9D6014N3P3 respectively).
Preparation of 3',4',5',5'- 2 H4-UTP (4). Into a three neck flask were
placed sodium 3-phosphoglycerate (1.3 mmol), oa-ketoglutaric acid (0.29 g, 2.0 mmol),
and NH4Cl (0.15 g, 2.8 mmol). This was dissolved in 40 mL of a solution containing 10
mM MgCl2, 20 mM dithiothreitol, and 50 mM potassium phosphate buffer pH 7.5, and the
pH of this solution was adjusted to 7.5 with IM NaOH. After the solution had been
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neutralized, d6-ATP (20 gmol) and 1,2,3,4,5,6,6- 2 H7-glucose (0.075 g, 0.4 mmol) were
added to the mixture. The phosphorylation of glucose to G6P and G6P's isomerization
was started by adding 188 units of phosphoglycerate mutase, 50 units of enolase, 75 units
of pyruvate kinase, 38 units of myokinase, 60 units of hexokinase, and 75 units of
glucose-6-phosphate isomerase. After 30 hours, the phosphorylation of glucose appeared
to be complete by HPLC analysis of the ATP in the reaction, and the reaction was heated to
340 C for 20 hours to speed up the exchange of the H2 with solvent. The reaction was
cooled to room temperature and 30 units of glutamic dehydrogenase, 6 units of glucose-6-
phosphate dehydrogenase, 2.5 units of 6-phosphogluconic dehydrogenase, 100 units of
phosphoriboisomerase, 1 unit of PRPP synthetase, 2 units of uracil
phosphoribosyltransferase, 0.5 units of nucleoside monophosphate kinase, 125 units of
phosphoglycerate mutase, 50 units of enolase, 50 units of pyruvate kinase, 38 units of
myokinase, NADP+ (0.009 g, 12 gmol), sodium 3PGA (2.7 mmol) were added to begin
formation of d4-UTP (4). After 8 days the reaction was frozen to stop it, and purified by
boronate chromatography. The yield of this reaction was 67% as determined by UV
absorbance. 1H NMR (600 MHz, D20) 8 7.95 (d, 1H, J = 8.4 Hz), 5.99 (d, 1H, J = 6
Hz), 5.98 (d, 1H, J = 8.4 Hz), 4.39 (d, 1H, J = 4.8 Hz); MS m/z 487.0 (487.05 calcd for
C9H10D4015N2P3).
Preparation of 1',2',3',4',5'-1 3 C5[-ATP (28), -GTP (29), and -UTP
(30)]. Into a three neck flask were placed sodium 3-phosphoglycerate (6.0 mmol),
adenine hydrochloride (0.034 g, 0.2 mmol), ox-ketoglutaric acid (0.58 g, 4.0 mmol), and
NH4C1 (0.30 g, 5.6 mmol). This was dissolved in 80 mL of a solution containing 10 mM
MgCl2, 20 mM dithiothreitol, and 50 mM potassium phosphate buffer pH 7.5, and the pH
of this solution was adjusted to 7.5 with IM NaOH. After the solution had been
neutralized, ATP (8 gmol), NADP + (0.005 g, 7 gmol), and 1,2,3,4,5,6-1 3 C6-D-glucose
(0.150 g, 0.8 mmol) were added to the mixture. The reaction was started by adding 125
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units of phosphoglycerate mutase, 50 units of enolase, 50 units of pyruvate kinase, 50
units of myokinase, 50 units of L-glutamic dehydrogenase, 60 units of hexokinase, 10
units of glucose-6-phosphate dehydrogenase, 2.5 units of 6-phosphogluconic
dehydrogenase, 40 units of phosphoriboisomerase, 2 units of PRPP synthetase, 1 unit of
adenine phosphoribosyltransferase, 2 units of xanthine-guanine phosphoribosyltransferase,
2 units of uracil phosphoribosyltransferase, 1 unit of guanylate kinase, and 0.5 units of
nucleoside monophosphate kinase. At 24 hours a significant amount of ATP had formed,
and guanine (0.030 g, 0.2 mmol), and uracil (0.045 g, 0.4 mmol) were added to the
reaction to begin GTP and UTP formation. After 3 days an additional 2.0 mmol of sodium
3-phosphoglycerate was added to the reaction, and the reaction was stopped after five days.
Boronate purification of the reaction and quantification of the purified products by UV
absorbance indicated that 88% of the glucose had been converted into isotopically labeled
nucleotides and recovered. Characterization was conducted on the mixture of products
resulting from this reaction, 1H NMR, 13 C HSQC, and mass spectrometry analysis were
consistent with a mixture of 1',2',3',4',5'- 13 C5[-ATP (28), -GTP (29), and -UTP (30)]
in a 1:1:2 ratio. 1H NMR (600 MHz, D20) 8 8.55 (s, 1H), 8.28 (s, 1H), 8.13 (s, 1H),
7.98 (dd, 1H, J = 8.4, 2.4 Hz), 6.15 (d, 1H, J = 165.5 Hz), 6.00 (d, 1H, J = 170.4 Hz),
5.93 (d, 1H, J = 166.2 Hz), 5.99 (d, 1H, J = 8.4 Hz), 4.95-4.0 (m, 15 H); 13 C HSQC
crosspeaks (5 proton, 8 carbon): (6.18, 89.81), (6.03, 91.23), (5.95, 89.81), (4.85,
76.49), (4.83, 77.38), (4.60, 73.47), (4.45, 72.76), (4.42, 76.85), (4.43, 87.14), (4.38,
86.97), (4.32, 86.43), (4.30, 68.32), (4.28, 68.15), (4.26, 68.32); MS m/z 511.0,
527.0, 488.0 (511.06, 527.06, 488.04 calcd for (12 C5)( 13 C5)H15013N5P3,
(12 C5)( 1 3 C5)H15014N5P3, (12 C4)( 1 3 C5)H14015N2P3 respectively).
Preparation of 1',2',3',4',5'-1 3 C5-CTP (31) from a mixture of
1',2',3',4',5'-1 3 C5[-ATP (28), -GTP (29), and -UTP (30)]. 1',2',3',4',5'-
13C5-CTP (31) was prepared from the purified mixture of NTPs 28-30 from the previous
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reaction in a procedure similar to the one used to produce d6-CTP (27). The yield of this
reaction was 80%. Characterization was conducted on the mixture of products resulting
from this reaction, 1H NMR, 13 C HSQC, and mass spectrometry analysis were
consistent with a mixture of 1',2',3',4',5'- 13 C5[-ATP (28), -GTP (29), and -CTP (31)]
in a 1:1:2 ratio. 1H NMR (600 MHz, D20) 8 8.54 (s, 1H), 8.27 (s, 1H), 8.14 (s, 1H),
7.98 (d, 1H, J = 7.2 Hz), 6.16 (d, 1H, J = 7.2 Hz), 6.15 (d, 1H, J = 165.6 Hz), 6.01 (d,
1H, J = 169.2 Hz), 5.94 (d, 1H, J = 165.6 Hz), 4.94-4.00 (m, 15 H); 13 C HSQC
crosspeaks (6 proton, 5 carbon): (6.18, 89.81), (6.04, 92.11), (5.96, 89.81), (4.85,
76.49), (4.83, 77.38), (4.60, 73.47), (4.43, 87.14), (4.42, 72.23), (4.39, 86.97), (4.36,
77.20), (4.31, 85.90), (4.31, 68.32), (4.31, 67.79), (4.26, 68.32); MS m/z 511.0,
527.0, 487.0 (511.06, 527.06, 487.05 calcd for (12 C5)( 13 C5)H15013N5P3,
(12 C5)( 13 C5)H15014N5P3, (12 C4)( 13 C5)H15014N3P3 respectively).
Preparation of 3',4',5',5'-2 H4-1',2',3',4',5'-1 3 C5[-ATP (32),
-GTP (33), -UTP (34)]. Into a three neck flask were placed sodium 3-
phosphoglycerate (2.1 mmol), adenine hydrochloride (0.034 g, 0.2 mmol), a-ketoglutaric
acid (0.76 g, 4.0 mmol), and NH4C1 (0.30 g, 5.6 mmol). This was dissolved in 80 mL of
a solution containing 10 mM MgCl2, 20 mM dithiothreitol, and 50 mM potassium
phosphate buffer pH 7.5, and the pH of this solution was adjusted to 7.5 with IM NaOH.
After the solution had been neutralized, d6-ATP (7 gtmol) and 1,2,3,4,5,6,6- 2 H7-
1,2,3,4,5,6- 1 3C6-D-glucose (0.155 g, 0.8 mmol) were added to the mixture. The
phosphorylation of the glucose to G6P and G6P's isomerization was started by adding 188
units of phosphoglycerate mutase, 50 units of enolase, 75 units of pyruvate kinase, 38
units of myokinase, 60 units of hexokinase, and 75 units of glucose-6-phosphate
isomerase. After stirring for 48 hours, 30 units of glutamic dehydrogenase, 7.5 units of
glucose-6-phosphate dehydrogenase, 2.5 units of 6-phosphogluconic dehydrogenase, 100
units of phosphoriboisomerase, 1 unit of PRPP synthetase, 1 unit of adenine
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phosphoribosyltransferase, NADP + (0.007 g, 10 gmol), sodium 3PGA (2.7 mmol) were
added to begin d4-13 C5-ATP (32) formation. At 72 hours, guanine (0.030 g, 0.2 mmol),
uracil (0.45 g, 0.4 mmol), 2 units of xanthine-guanine phosphoribosyltransferase, 2 units
of uracil phosphoribosyltransferase, 1 unit of guanylate kinase, and 0.5 units of nucleoside
monophosphate kinase were added to the reaction to begin GTP and UTP formation. After
5 days, additional 3- phosphoglycerate (1.7 mmol) were added to the reaction, and after 7
days the reaction was stopped and purified. Boronate purification of the reaction and
quantification of the purified products by UV absorbance indicated that 92% of the glucose
had been converted into isotopically labeled nucleotides and recovered. Characterization
was conducted on the complex mixture of products resulting from this reaction. 1H NMR,
13 C HSQC, and mass spectrometry analysis were consistent with a mixture of
3',4',5',5'-2H4-1',2,3',4',5'-13C5-ATP, 1',3',4',5',5'-2H5-1',2',3',4',5'-13C5-
ATP, 3',4',5',5'- 2 H4-1',2',3',4',5'-1 3 C5-GTP, 1',3',4',5',5'- 2 H5-1 ',2',3',4',5'-
13 C5-GTP, 3',4',5',5'- 2 H4-1',2',3',4',5'-1 3 C5-UTP, and 1',3',4',5',5'- 2 H5-
1',2',3',4',5'- 13 C5-UTP resulting from complete hydrogen exchange of the H2' in the
nucleotides, and approximately 60% hydrogen exchange of the HI'. 1H NMR (600 MHz,
D20) 8 8.54 (s, 1H), 8.28 (s, 1H), 8.13 (s, 1H), 7.97 (d, 1H, J = 8.4 Hz), 6.14 (d,
0.6H, J = 173.4 Hz), 6.00 (d, 0.6H, J = 169.2 Hz), 5.93 (d, 0.6H, J = 167.4 Hz), 5.99
(d, 1H, J = 8.4 Hz), 4.81 (d, 1H, J = 150 Hz), 4.79 (d, 1H, J = 150 Hz), 4.39 (d, 1H, J
= 151.2 Hz); 13 C HSQC crosspeaks (6 proton, 6 carbon): (6.17, 89.81), (6.03, 91.23),
(5.95, 89.81), (4.84, 76.49), (4.82, 77.20), (4.42, 76.67); MS m/z 515.1, 516.1, 531.1,
532.1, 492.0, 493.0 (515.09, 516.10, 531.08, 532.09, 492.06, 493.07 calcd for
(12 C5)( 13C5)H11D4013N5P3, (12 C5)( 13 C5)H10D5013N5P3,
(12 C5)( 13C5)H11D4014N5P3, (12 C5)( 13 C5)H10D5014N5P3,
(1 2 C4)(1 3 C5)H 10D4015N2P3, (12 C4)(1 3 C5)H9D5015N2P3 respectively).
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Preparation of 3',4',5',5'-2 H4-1',2',3',4',5'- 1 3 C5-CTP (35) from a
mixture of 3',4',5',5'-2 H4-1',2',3',4',5'- 1 3 C5[-ATP (32), -GTP (33),
and -UTP (34)] 3',4',5',5'-2 H4-1',2',3',4',5'- 13 C5-CTP (35) was prepared from
the mixture of 32, 33, and 34 from the previous reaction in a procedure similar to the one
used to produce d6-CTP (27). The yield of this reaction was 89%. Characterization was
conducted on the complex mixture of products resulting from this reaction, 1H NMR,
13 C HSQC, and mass spectrometry analysis were consistent with a mixture of
3',4',5',5'-2H4-1',2',3',4',5'-13C5-ATP, 1',3',4',5',5'-2H5-1',2',3',4',5'-13C5-
ATP, 3',4',5',5'-2H4-1',2',3',4',5'-13C5-GTP, 1',3',4',5',5'-2H5-1',2',3',4',5 '-
13 C5-GTP, 3',4',5',5'- 2 H4-1',2',3',4',5'- 1 3 C5-CTP, and 1',3',4',5',5'-2 H5 -
1',2',3',4',5'-1 3 C5-CTP. 1H NMR (600 MHz, D20) 5 8.54 (s, 1H), 8.27 (s, 1H), 8.13
(s, 1H), 8.00 (d, 1H, J = 6.6 Hz), 6.15 (d, 0.6H, J = 166.2 Hz), 6.17 (d, 0.6H, J = 7.8
Hz), 5.93 (d, 0.6H, J = 165.6 Hz), 6.00 (d, 1H, J = 171.0 Hz), 4.81 (d, 2H, J = 150
Hz), 4.33 (d, 1H, J = 152.4 Hz); 13 C HSQC crosspeaks (6 proton, 8 carbon): (6.17,
89.81), (6.03, 92.11), (5.96, 89.81), (4.84, 76.49), (4.82, 77.20), (4.36, 77.20); MS
m/z 515.1, 516.1, 531.1, 532.1, 491.0, 492.0 (515.09, 516.10, 531.08, 532.09, 491.08,
492.08 calcd for (12 C5)( 13 C5)H11D4013N5P3, (12 C5)( 13 C5)H10D5013N5P3,
(12 C5)( 13 C5)H11D4014N5P3, (12 C5)( 13 C5)H10D5014N5P3,
(12 C4)( 13 C5)H 11D4014N4P3, (12 C4)(1 3 C5)H10D5014N3P3 respectively).
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Isotopic labeling of the base moieties of nucleotides
Deuteration of the H5 of pyrimidines with ammonium sulfite
O O O
S OO O 0
S- t OH61 1J N SO - . I O : N H6O-P-O O-P-O' 3 O-P-O
OH OH OH OH OH OH
UMP UMP-sulfite adduct 5-dI-UMP, 3 6
Figure 6.10 Treatment of UMP with Ammonium Sulfite in D20
Preparation of 5-2 Hi-UMP (36) from UMP. Into a 25 mL round bottom
flask were placed ammonium sulfite (1.68 g), the sodium salt of UMP (0.30 g, 0.81
mmol), and 5 mL of H20. Once all of the solid had been dissolved in the water, the pH
of the solution was adjusted to approximately 8.5 with IM NaOH. The H20 was removed
under vacuum with a rotovap, and then the residue exchanged 4 times with 4 mL of D20.
The exchanged residue was dissolved in 6 mL of D20 and a reflux condenser was
connected to the round bottom flask. The reaction was stirred and heated to 55" C for
approximately 70 hours, at which time NMR analysis of the reaction indicated that all of
the H5 protons of UMP had been exchanged for deuterium. The pH of the reaction was
adjusted to between 9.5-10.5 with 20% NaOD in D20, and then stirred at room
temperature for an hour. An NMR spectra of the reaction at this point showed that over
99% of the sulfite adduct had been converted back into UMP. The reaction was purified
with boronate chromatography in a manner similar to the purification of the NTPs from the
nucleotide forming reactions except that the column was conducted at 4" C to prevent
exchange of the H5 with H20 before the sulfite was separated from the UMP. No loss of
the deuterium label was detected by NMR after the purification. This reaction yielded 0.66
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mmol (81% yield) of 5-2 H1-UMP (36) as determined by absorbance at 260 nm. 1H NMR
(300 MHz, D20) 5 7.84 (s, 1H), 5.93 (d, 1H, J = 6.0 Hz), 4.80-3.90 (m, 5H).
a,b c5-D 1-UMP 5-d_-UTP I 15-d/-CTP1
36 37 38
Figure 6.11 Enzymatic conversion of 5-dl-UMP (36) into 5-dl-UTP (37) and
5-dl-CTP (38). a) nucleoside monophosphate kinase b) pyruvate kinase c) CTP
synthetase.
Preparation of 5- 2 H1-UTP (37) from 5-2 H1-UMP (36). 5- 2 H1-UMP
(36) (0.66 mmol), sodium 3-phosphoglycerate (2.64 mmol), 10 mg of ampicillin, and
ATP (0.033 g, 0.06 mmol) were placed into a 250 mL flask and dissolved in 60 mL of a
solution containing 10 mM MgCl2 and 10 mM dithiothreitol. The pH of the solution was
adjusted to 7.2 with IM NaOH, and then phosphoglycerate mutase (125 units), enolase
(50 units), myokinase (25 units), pyruvate kinase (50 units), and nucleoside
monophosphate kinase (0.5 units) were added to begin the reaction. The reaction was
stirred at room temperature for 48 hours and then an additional 0.5 mmol of 3-
phosphoglycerate was added to the reaction. The reaction was stopped after 80 hours and
purified by boronate chromatography. This reaction produced 0.48 mmol (72% yield) of
5- 2 H1-UTP (37). Half of this reaction was used in the next reaction to produce 5-2 H1-
CTP (38) and half of the reaction was used directly in transcription reactions to produce
D5-pyrimidine RNA.
Preparation of 5-2 H1-CTP (38) from 5-2 H1-UTP (37). 5- 2 H1-UTP
(37) (0.24 mmol) and ATP (0.18 g, 0.33 mmol) were placed into a 500 mL round bottom
flask and dissolved in 330 mL of a solution which contained 50 mM ammonium chloride,
5 mM MgCl2, and 5 mM dithiothreitol. The pH of the solution was adjusted to 7.7 with
IM NaOH, and then phosphoglycerate mutase (125 units), enolase (50 units), pyruvate
kinase (50 units), and CTP synthetase (2 units) were added to begin the reaction. The
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reaction was stirred for 48 hours at room temperature and then concentrated.
Approximately 0.23 mmol (96% yield) of 5-2 H1-CTP (38) was produced by this
reaction. The 5-2 H1-CTP (38) was used directly in transcription reactions with 5- 2 H1-
UTP (37) to produce D5-pyrimidine RNA.
Enzymatic deuteration of the H6 of Uracil
O
HN H5  O O
S N C0H HN HN
Orotic acid 0i N CO2- C2 N D6
+1 0 - 0
0 D20
-O-P-O
O OH OH OH OH
PPi OMP 6-d 1-UMP
OH OH
PRPP
Figure 6.12 Exchange of H6 of pyrimidines. a) Orotate
phosphoribosyltransferase b) OMP decarboxylase.
Preparation of 1',2',3',4',5',5'-2 H6[-ATP (24), -GTP (25)] and
1',2',3',4',5',5',5-2 H7-UTP (39). This reaction is very similar to the reaction
used to form 1',2',3',4',5',5'- 2 H6-[ATP (24), GTP (25), and UTP (26)], but instead of
forming UTP from uracil with uracil phosphoribosyltransferase, this reaction forms UTP
from orotic acid with the enzymes orotate phosphoribosyltransferase and OMP
decarboxylase. The reaction is conducted in D20 to prevent the loss of the deuterium label
at the 2' position, and this also has the effect of deuterating the H6 of UMP during the
conversion of OMP into UMP by OMP decarboxylase (Figure 6.12). The synthesis of
1',2',3',4',5',5'- 2 H6-ATP (24) and l',2',3',4',5',5'- 2 H6-GTP (25) has been described
previously in the experimental of Chapter 3, but the synthesis of 1',2',3',4',5',5',5- 2 H7-
UTP (39) is new and demonstrates how the H6 of pyrimidines can be deuterated using
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OMP decarboxylase. The nucleotides produced in this reaction were used to produce the
TAR 465 labeling pattern described in Chapter 4.
Into a Millipore 10,000 MWC centricon were placed 188 units of phosphoglycerate
mutase, 100 units of enolase, 75 units of pyruvate kinase, 50 units of myokinase, 75 units
of L-glutamic dehydrogenase, 60 units of hexokinase, 12 units of glucose-6-phosphate
dehydrogenase, 5 units of 6-phosphogluconic dehydrogenase, 100 units of
phosphoriboisomerase, 2.7 units of PRPP synthetase, 1.3 unit of adenine
phosphoribosyltransferase, 2 units of xanthine-guanine phosphoribosyltransferase, 1.4
unit of orotate phosphoribosyltransferase, 2.9 units of OMP decarboxylase, 1 unit of
guanylate kinase, and 0.5 units of nucleoside monophosphate kinase. The enzyme solution
was centrifuged at 6000 rpm until 90-95% of its original volume had passed through the
centricon dialysis membrane. Then 1.5 mL of D20 were added to the centricon, and the
centricon was again centrifuged at 6000 rpm until 90-95% of the liquid had passed through
the filter. This was repeated twice more, and then the enzymes were considered to have
been exchanged into D20 and ready to be added to the reaction.
Into a 300 mL round bottom flask were placed sodium 3-phosphoglycerate (4.0
mmol), adenine hydrochloride (0.029 g, 0.17 mmol), a-ketoglutaric acid (0.37 g, 2.5
mmol), NH4C1 (0.19 g, 3.5 mmol), MgCl2 (0.5 mmol), dithiothreitol (0.18 g, 1.2 mmol),
2.5 mL of IM potassium phosphate buffer pH = 7.5, and 50 mL of H20. The pH of the
resulting solution was adjusted to 7.7 with 1M NaOH, and then the mixture was
concentrated to dryness under vacuum. The residue was dissolved in 10 mL of D20 and
concentrated to dryness under vacuum, this was repeated three times total. The D20
exchanged residue was dissolved in 50 mL of D20, and the pD of the solution was
adjusted to 7.5 with DCl and NaOD. The D20 exchanged enzyme solution was added to
the mixture, and then d6-ATP (1.7 gmole) from a previous reaction, NADP+ (0.003 g, 4.0
gmol), and l',2',3',4',5',6',6- 2 H7-glucose (0.094 g, 0.5 mmol) were added to start the
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reaction. After 40 hours a significant amount of the adenine had been converted into d6-
ATP (24), and so guanine (0.025 g, 0.17 mmol) and orotic acid (0.032 g, 0.17 mmol)
were added to the reaction to begin GTP and UTP formation. Additional D20 exchanged
3-PGA (1 mmol) was added to the reaction after 3 days, and the reaction was stopped by
freezing it after 4 days. The mixture was purified by boronate chromatography, and
nucleotides were quantitated by UV absorbance at 260 nm, assuming a 1:1:1 ratio of
ATP:GTP:UTP. Using this quantification, 95% of the 2 H7-glucose was converted into
nucleotides and recovered. 1H NMR (600 MHz, D20) 8 8.55 (s, 1H), 8.29 (s, 1H), 8.13
(s, 1H), 5.98 (s, 1H).
Deuteration of the H8 of Adenine
NH2  NH2
N N50"C,
0 H8KX t 48 hrs. O D8O - N N H2 1O1- N N H
O-PH -O -0-P-0
1 0 D20 0O O
OH OH OH OH
Figure 6.13 Exchange of the H8 of purines
Preparation of 8- 2 H1-ATP (40) from AMP. Adenosine-5'-monophosphate
(0.5 g, 1.18 mmol) was placed into a 25 mL round bottom flask and exchanged 3 times
with 3 mL of D20. The residue was dissolved in 4 mL of D20, a reflux condenser was
attached to the flask, and the solution was heated to 70' C for 60 hours. A proton NMR
spectra of the reaction at 60 hours revealed that the H8 proton had been exchanged with
D20.
The D20 was removed from the reaction under vacuum and the residue was
dissolved in 100 mL of an H20 solution which contained 10 mM MgCl2, 10 mM
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dithiothreitol, and 50 mM potassium phosphate buffer (pH = 7.5). Sodium 3-
phosphoglycerate (4.7 mmol) and a small catalytic amount of ATP (.001 g) were added to
the mixture, and the pH of the solution was adjusted to 7.7 with 1M NaOH.
Phosphoglycerate mutase (250 units), enolase (50 units), pyruvate kinase (100 units),
and myokinase (125 units) were added to the mixture to start phosphorylation of the 8-
2 H1-AMP. After 30 hours the reaction was stopped by freezing. The 8-2 H1-ATP (40)
produced in this reaction was purified by boronate chromatography. 0.83 mmol of 8-2 H1-
ATP (40) (70% yield) were recovered from the boronate column. 1H NMR (300 MHz,
D20) 8 8.16 (s, 1H), 6.04 (d, 1H, J = 6.0 Hz), 4.80-3.90 (m, 5H).
Heteronuclear labeling of Bases (13 C/15N)
Preparation of 6-amino,9- 1 5 N2-8,1',2',3',4',5'- 1 3 C6-
1',3',4',5,5',5"- 2 H5-ATP (41), 7,9- 1 5 N2-8,1',2',3',4',5'- 1 3 C6-
1',3',4',5',5"-2 H5-GTP (42), and 1,3-15N2-2,4,5,6,1',2',3',4',5'-13C9 -
1',3',4',5',5"-2 H5-UTP (43). Into a three neck flask were placed sodium 3-
phosphoglycerate (8.0 mmol), 6-amino,9- 15N2-8- 13 C1-adenine (0.035 g, 0.2 mmol), a-
ketoglutaric acid (0.76 g, 4.0 mmol), and NH4Cl (0.30 g, 5.6 mmol). This was dissolved
in 80 mL of an H20 solution containing 10 mM MgCl2, 20 mM dithiothreitol, and 50 mM
potassium phosphate buffer pH 7.5, and the pH of this solution was adjusted to 7.4 with
IM NaOH. After the solution had been neutralized, ATP (8 gmol), NADP+ (0.007 g, 9
gmol), and 1,2,3,4,5,6- 13 C6-1,2,3,4,5,6,6'- 2 H7-D-glucose (0.155 g, 0.8 mmol) were
added to the mixture. The reaction was started by adding 375 units of phosphoglycerate
mutase, 200 units of enolase, 150 units of pyruvate kinase, 50 units of myokinase, 60
units of L-glutamic dehydrogenase, 120 units of hexokinase, 25 units of glucose-6-
phosphate dehydrogenase, 5 units of 6-phosphogluconic dehydrogenase, 100 units of
phosphoriboisomerase, 4 units of PRPP synthetase, 3 unit of adenine
phosphoribosyltransferase, 4 units of xanthine-guanine phosphoribosyltransferase, 6 units
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of uracil phosphoribosyltransferase, 1 unit of guanylate kinase, and 0.5 units of nucleoside
monophosphate kinase. At 72 hours a significant amount of ATP had formed, and 7,9-
15 N2-8-1 3 C1-guanine (0.043 g, 0.28 mmol), and 1,3- 15 N2-2,4,5,6- 1 3 C4-uracil (0.047
g, 0.4 mmol) were added to the reaction to begin GTP and UTP formation. After 7 days an
additional 2.0 mmol of sodium 3-phosphoglycerate was added to the reaction, and the
reaction was stopped after 11 days. Boronate purification of the reaction and quantification
of the purified products by UV absorbance indicated that 80% of the glucose had been
converted into isotopically labeled nucleotides and recovered. Characterization was
conducted on the mixture of products resulting from this reaction. 1H NMR (600 MHz,
D20) 8 8.53 (dd, 1H, J = 216, 6 Hz), 8.26 (s, 1H), 8.11 (ddd, 1H, J = 216, 12, 12 Hz),
7.95 (dd, 1H, J = 186, 6 Hz), 5.97 (d, 1H, J = 180 Hz), 4.80 (d, 1H, J = 150 Hz), 4.78
(d, 1H, J = 156 Hz), 4.38 (d, 1H, J = 156).
Chapter 4 Experimental
Preparation of Isotopically Labeled RNA from Isotopically Labeled Nucleotides
(Figure 6.14)
Isotopically labeled RNA was synthesized by in vitro transcription (Milligan &
Uhlenbeck, 1989) with T7 RNA polymerase using slight variations of the procedure of
Wyatt and Puglisi (Wyatt et al., 1991). Small scale (20-25 RIl) transcription trials
containing trace amounts of [o(-32 p] GTP (which allows detection of RNA transcripts with
autoradiography) were used to find optimal transcription reaction conditions. RNA
transcription reactions were optimized for the amount RNA produced per isotopically
labeled nucleotide added to a transcription reaction because of the expense of isotopically
labeled nucleotides. Transcription reactions were first optimized with commercially
obtained unlabeled nucleotides to find optimal RNA transcription conditions, then small
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Top strand
51TAATACGACTCACTATAG3'
3'ATTATGCTGAGTGATATCCGGTCTAACTCGGACCCTCGAGAGACCGG 5 '
Template strand
ATP GTP UTP CTP
T7 RNA Polymerase
5 GGCCAGAUUGAGCCUGGGAGCUCUCUGGCC 3
RNA
Figure 6.14 T7 RNA polymerase catalyzed transcription
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scale transcription trials were conducted using the same transcription conditions for both
unlabeled and isotopically labeled nucleotides to compare transcriptional efficiencies of the
nucleotides derived from different sources. Once similar yields were obtained for both
isotopically labeled nucleotides and commercially obtained nucleotides in RNA
transcription trials, large scale transcription reactions were conducted as described below.
TAR RNA synthesis. TAR RNA (5'GGC CAG AUU GAG CCU GGG AGC
UCU CUG GCC3') was synthesized by in vitro transcription (Milligan & Uhlenbeck,
1989) with T7 RNA polymerase using unlabeled NTPs from Sigma and the different
isotopically labeled NTPs produced in this thesis. Transcription reactions were conducted
in a solution which contained 40 mM Tris-HCl buffer (pH=8.1), 1 mM spermidine,
0.01% triton X-100, 12 mM dithiothreitol, 80 mg/mL polyethylene glycol, 35 mM
MgCl2, 450 nM top strand DNA, and 450 nM TAR template DNA. The procedures of
Wyatt and Puglisi (Wyatt et al., 1991) were followed for conducting transcription
reactions. TAR RNA was purified by 20% PAGE, electro-eluted, and dialyzed against 50
mM NaCi, 0.1 mM EDTA, 10 mM sodium phosphate pH 6.4. For each labeling pattern
produced in Chapter 4, the nucleotides used to produce it, the amount of each nucleotide
used, and the concentration and volume of the final NMR sample produced from the
transcription reaction is listed below.
Unlabeled TAR RNA. Unlabeled TAR RNA was produced in a 50 mL
transcription reaction using unlabeled ATP (200 gmoles), unlabeled GTP (200 jmoles),
unlabeled UTP (200 gmoles), and unlabeled CTP (200 jimoles). The final NMR sample
produced from this transcription reaction was 0.83 mM, 500 pliters.
D4-TAR RNA. D4-TAR RNA was produced in a 45 mL transcription reaction
using 3',4',5',5"-d4-ATP (2) (90 gmoles), 3',4',5',5"-d4-GTP (3) (90 gmoles),
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3',4',5',5"-d4-UTP (4) (90 gmoles), and 3',4',5',5"-d4-CTP (5) (90 p~moles). The final
NMR sample produced from this transcription reaction was 1.1 mM, 500 gliters.
D6-TAR RNA. D6-TAR RNA was produced in a 40.5 mL transcription reaction
using 1',2',3',4',5',5"-d6-ATP (24) (81 gmoles), 1',2',3',4',5',5"-d6-GTP (25) (81
gmoles), 1',2',3',4',5',5"-d6-UTP (26) (81 gmoles), and 1',2',3',4',5',5"-d6-CTP
(27) (81 gmoles). The final NMR sample produced from this transcription reaction was
1.6 mM, 500 gliters.
TAR-465 RNA. TAR-465 RNA was produced in a 40.5 mL transcription
reaction using 1',2',3',4',5',5"-d6-ATP (24) (81 gmoles), 1',2',3',4',5',5"-d6-GTP
(25) (81 gmoles), 1',2',3',4',5',5",6-d7-UTP (39) (81 gmoles), and unlabeled CTP
(162 gmoles). The final NMR sample produced from this transcription reaction was 1.4
mM, 550 pliters.
D4/D6-TAR RNA. D4/D6-TAR RNA was produced in a 14 mL transcription
reaction using 1',2',3',4',5',5"-d6-ATP (24) (22 gmoles), 1',2',3',4',5',5"-d6-GTP
(25) (22 gmoles), 3',4',5',5"-d4-UTP (4) (31 gmoles), and 1',2',3',4',5',5"-d6-CTP
(27) (43 gmoles). The final NMR sample produced from this transcription reaction was
0.46 mM, 300 gliters.
D5-pyrimidine TAR RNA. D5-pyrimidine TAR RNA was produced in a 40
mL transcription reaction using unlabeled ATP (87 gmoles), unlabeled GTP (80 gmoles),
5-dl-UTP (37) (79 gmoles), and 5-dl-CTP (38) (79 gmoles). The final NMR sample
produced from this transcription reaction was 1.1 mM, 500 gliters.
13 CS-ribose-TAR RNA. 13 C5-ribose-TAR RNA was produced in a 40 mL
transcription reaction using 1',2',3',4',5'- 1 3 C5-ATP (28) (80 gmoles), 1',2',3',4',5'-
13 C5-GTP (29) (80 gmoles), 1',2',3',4',5'- 13 C5-UTP (30) (80 gmoles), and
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1',2',3',4',5'- 1 3 C5-CTP (31) (80 gmoles). The final NMR sample produced from this
transcription reaction was 1.7 mM, 600 gliters.
3',4',5',5"-D4-1 3 C5-ribose-TAR RNA. 3',4',5',5"-D4-1 3 C5-ribose-TAR
RNA was produced in a 40 mL transcription reaction using 3',4',5',5"-d4-1',2',3',4',5'-
1 3 C5-ATP (32) (80 gmoles), 3',4',5',5"-d4-1',2',3',4',5'- 13 C5-GTP (33) (80
gmoles), 3',4',5',5"-d4-1',2',3',4',5' - 1 3 C5 -UTP (34) (80 gmoles), and 3',4',5',5"-
d4-1',2',3',4',5'- 13 C5-CTP (35) (80 gmoles). The final NMR sample produced from
this transcription reaction was 1.1 mM, 600 gliters.
TAR NMR experiments.
Unlabeled TAR and D4-TAR RNA: NOESY spectra of TAR and D4-TAR
were recorded on a Varian VXR-500 spectrometer with a spectral width of 5500 Hz,
acquiring 4096 complex points in t2 and 644 in tl, 64 or 32 scans per FID for TAR and
D4-TAR respectively, a relaxation delay of 1.6 s, and a mixing time of 0.200 s. Sample
conditions were 50 mM NaC1, 0.1 mM EDTA, 10mM sodium phosphate pH 6.4, 250.
RNA concentrations were 0.83 mM for TAR and 1.12 mM for D4-TAR. Twice the number
of scans were acquired per FID for the unlabeled TAR sample to compensate for the
difference in concentrations between the two RNA samples.
Nonselective T 1 relaxation rates for individual resonances were measured using
inversion recovery, and nonselective T2 relaxation rates were measured using a CPMG
experiment. For both T 1 and T2 measurements a relaxation delay of 75 seconds between
each of 4 scans was used.
All other TAR NMR experiments. All other TAR NMR experiments were
recorded on a Varian Inova-600 MHz spectrometer. RNA sample conditions were 50 mM
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NaC1, 0.1 mM EDTA, 10mM sodium phosphate pH 6.4, and experiments were conducted
at 250 C. NOESY spectra were acquired with a spectral width of 8000 Hz, acquiring 4096
complex points in t2 and 1024 in t , with 32 scans per FID, a relaxation delay of 2.6 s,
and a mixing time of 200 ms. HSQC-CT spectra were acquired with a constant time
interval of 25 ms with spectral widths of 6500 and 5000 Hz for proton and carbon
dimensions respectively. 1024 and 224 complex points were acquired for tl and t2
respectively, with 8 scans per FID.
Chapter 5 Experimental
F22b RNA transcription and NMR sample preparation
F22b RNA synthesis. The 65 nucleotide F22b RNA (5'GGG UUG CGG
UCG AAA GAC UUG AGG GCA GGA GAG GAC UUC GGU CUG GCC UGC ACC
UGA CGC AAC CC3') was synthesized by in vitro transcription with T7 RNA
polymerase using unlabeled NTPs from Sigma and the different isotopically labeled NTPs
produced in this thesis. Transcription reactions were conducted in a solution which
contained 40 mM Tris-HCI buffer (pH=8.1), 1 mM spermidine, 0.01% triton X-100, 12
mM dithiothreitol, 8 mM MgCl2, and 63 pg/mL of SmaI digested pB 16SF22b template
DNA. The procedures of Wyatt and Puglisi were followed for conducting transcription
reactions. F22b RNA was purified by 20% PAGE, electro-eluted, and dialyzed against 50
mM KC1, 0.1 mM EDTA, 10 mM potassium phosphate pH 6.5. For each F22b labeling
pattern produced in Chapter 5, the nucleotides used to produce it, the amount of each
nucleotide used, and the concentration and volume of the final NMR sample produced
from the transcription reaction is listed below.
Unlabeled F22b RNA. Unlabeled F22b RNA was produced in a 40 mL
transcription reaction using unlabeled ATP (80 gmoles), unlabeled GTP (80 gmoles),
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unlabeled UTP (80 gmoles), and unlabeled CTP (80 gmoles). The final NMR sample
produced from this transcription reaction was 0.89 mM, 500 gliters.
D5-pyrimidine F22b RNA. D5-pyrimidine F22b RNA was produced in a 40
mL transcription reaction using unlabeled ATP (87 gmoles), unlabeled GTP (80 gmoles),
5-dl-UTP (37) (80 gmoles), and 5-dj-CTP (38) (80 gmoles). The final NMR sample
produced from this transcription reaction was 0.83 mM, 500 gliters.
D4-F22b RNA. D4-F22b RNA was produced in a 40 mL transcription reaction
using 3',4',5',5"-d4-ATP (2) (86 gmoles), 3',4',5',5"-d4-GTP (3) (88 gmoles),
3',4',5',5"-d4-UTP (4) (88 gmoles), and 3',4',5',5"-d4-CTP (5) (80 gmoles). The final
NMR sample produced from this transcription reaction was 0.82 mM, 500 gliters.
D4/D6-F22b RNA. D4/D6-F22b RNA was produced in a 33 mL transcription
reaction using 1',2',3',4',5',5"-d6-ATP (24) (51 gmoles), 1',2',3',4',5',5"-d6-GTP
(25) (51 gmoles), 3',4',5',5"-d4-UTP (4) (72 gmoles), and 1',2',3',4',5',5"-d6-CTP
(27) (102 gmoles). The final NMR sample produced from this transcription reaction was
0.44 mM, 500 gliters.
NMR experiments
F22b NMR experiments. NMR experiments were recorded on a Varian Inova-
600 MHz spectrometer. RNA sample conditions were 50 mM KC1, 0.1 mM EDTA,
10mM potassium phosphate pH 6.5, and experiments were conducted at 350 C. NOESY
spectra were acquired with a spectral width of 8000 Hz, acquiring 4096 complex points in
t2 and 1024 in t1 , with 32 scans per FID, a relaxation delay of 2.6 s, and a mixing time of
200 ms.
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2D CCH-TOCSY NMR experiments. The 2D CCH-TOCSY NMR
experiments were conducted as described in Dayie et. al. (Dayie et al., 1997) on both
13 C5-ribose-TAR RNA and 3',4',5',5"-D4-13 C5-ribose-TAR RNA.
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List of Improvements
While the procedures in this thesis work fairly well, there is always room for
improvement...
1. Several times during the course of these studies the bacteria containing the
plasmid for CTP synthetase overexpression and ampicillin resistance, plasmid pMW5,
apparently lost the plasmid stopped producing CTP synthetase. A plasmid construct with a
antibiotic resistance which would be more difficult to lose than ampicillin resistance would
be a good improvement.
2. Several of the enzymes which were purified are only moderately overexpressed.
Construction of plasmids which would highly overexpress PRPP synthetase, orotate
phosphoribosyltransferase, and CTP synthetase would increase the yield of those enzymes
in protein purifications and potentially reduce the amount of work necessary to produce
isotopically labeled NTPs.
3. The rates of many of the enzymatic reactions discussed in this thesis are slow
because of the small amount of catalytic ATP added to the reactions to prevent isotopic
dilution of the final nucleotides. Developing methods to add larger initial amounts of ATP
to the reactions and then being able to remove that ATP later would potentially speed up the
rate of NTP formation. This might be done by using deoxy-ATP (which some of the
enzymes will accept as a substrate) and then removing that dATP with a boronate column.
It also might be done in UTP and GTP forming reactions by adding a large amount of ATP
to catalyze UTP and GTP formation, and then adding an enzyme which will selectively
dephosphorylate ATP to form AMP. This would allow the separation of unlabeled AMP
from isotopically labeled UTP and GTP by anion exchange chromatography.
188
Chapter 6
4. Developing methods to add larger initial amounts of NADP+ to the glucose
nucleotide forming reactions and then being able to remove that NADP+ later would
potentially speed up the rate of NTP formation.
5. Base protons on adenine, guanine and uracil could be exchanged in D20 before
the bases were coupled to PRPP. This could reduce the number of chemical steps required
to produce nucleotides with deuterium labels in both the bases and the ribose moieties.
6. Developing some method that would allow CTP to be produced in the ribose
and glucose nucleotide forming reactions would reduce the number of enzymatic reactions
necessary to produced isotopically labeled RNA.
7. Warming the enzymatic nucleotide forming reactions to 370 C may speed the rate
of product formation without any bad side effects.
8. For most of the enzymes purified in this thesis, LB media will probably work
just as well or better than minimal media for purification of overexpressed enzymes.
9. Addition of antibiotics like ampicillin to all of the enzymatic nucleotide forming
reactions may reduce bacterial contamination problems.
10. Ribulose phosphate 3-epimerase might be used to exchange the H3' with H20
or D20 in the reactions where nucleotides are enzymatically converted into NTPs.
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